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SUMMARY.
In this study, the cardiovascular effects of reduced glutathione (GSH) and related 
compounds have been investigated using coronary and mesenteric vascular beds 
and the thoracic aorta of the rat In addition, the effects of thiol compounds on an 
isolated bovine ventricular Na/K ATPase preparation and Na-pump current and 
free cytosolic calcium ([CaJj) in isolated rat ventricular myocytes and rabbit 
platelets were also studied These investigations were performed in order to 
determine how reduced glutathione may partly exert its antiarrhythmic action in 
the ischaemic/reperfused rat heart
Ischaemically-induced and potentially arrhythmogenic noradrenaline release from 
the myocardium was not affected by GSH suggesting an alternative mode of action 
by which GSH is antiarrhythmic. Myocardial ischaemia also resulted in 
contracture, the onset of which was delayed by GSH. This serendipitous finding 
led to investigations into how GSH and other sulphydryl compounds exert their 
protective, antiarrhythmic effect in the ischaemic/reperfused myocardium. Reduced 
glutathione significantly attenuated reperfusion-induced 86Rb efflux, suggesting a 
potassium sparing action which is considered to be antiarrhythmic. The activity of 
an isolated bovine Na/K ATPase preparation was significantly potentiated and 
reduced, in a concentration-dependent manner, by reduced and oxidised glutathione 
(GSSG), respectively. GSH also lessened an ischaemically-induced loss of Na/K 
ATPase activity in isolated rat hearts. A stimulatory action of GSH on the Na/K 
pump may partly explain its effect on potassium loss during ischaemia. A 
concomitant reduction of intracellular sodium and Na/Ca exchange, as a result of 
Na/K pump stimulation, may also explain how GSH delays ischaemic contracture 
which is due to calcium overload. In isolated rat myocytes, the intracellular 
dialysis and extracellular superfusion of GSH and GSSG potentiated and decreased 
Na-pump current at all voltages, respectively, which correlates with the data 
obtained from the experiments with an isolated bovine Na/K ATPase preparation. 
Capacitance normalised Na-pump current, at OmV, was also reduced in isolated 
myocytes prepared from glutathione-depleted hearts.
GSH lowered [Ca]j levels in isolated myocytes and platelets, while GSSG 
increased [Cajj in a concentration-dependent manner. In both myocytes and
platelets, a GSSG-induced increase in [Ca]j was partly reversed by GSH. In
addition, GSH reversed the increase in [Ca]i caused by the sulphydryl-reactive-?
agents, /?-hydroxymercuriphenylsulphonic acid and diamide, and by a thromboxane 
A2 mimetic, U44619.
In experiments designed to study the effects of thiol compounds on the Na/H 
exchange mechanism, the physiological response of the heart in response to 
acidosis, in the presence and absence of reduced glutathione and related 
compounds, was investigated. In the Langendorff isolated rat heart, myocardial 
acidosis resulted in a pH-dependent rise in coronary perfusion pressure, indictative 
of coronary constriction. This effect was potentiated and attenuated by GSH and 
cysteine, respectively, in a concentration-dependent manner. Acidosis relaxed 
pre-contracted thoracic aorta but had no effect on the tone of pre-contracted 
mesenteric vascular beds. GSH caused an increase in tone only in pre-contracted 
mesenteric beds. Cyclooxygenase products are implicated in the pH-dependent 
constriction of the coronary bed, and its potentiation by GSH, as seen by the 
ability of flurbiprofen, indomethacin and a selective thromboxane A2 receptor 
antagonist, GR 3219IB, to attenuate these responses. Phentolamine significantly 
attenuated the effect of acidosis on coronary tone both in the presence and absence 
of GSH. In addition, the pH-dependent constriction was attenuated in hearts from 
animals previously depleted of catecholamines using 6-hydroxydopamine. This 
data suggests the some involvement of catecholamines and alpha-adrenoceptors in 
this coronary constriction, although no direct measurement of catecholamine 
release under acidotic conditions, in the presence and absence of reduced 
glutathione, was made. The sulphydryl-containing compounds, cysteine, reduced 
dithiothreitol, penicillamine and captopril all significantly attenuated the pH- 
dependent coronary constriction in a concentration-dependent manner, cysteine 
being the most potent. The involvement of endothelium-dependent relaxant factor 
in this effect was eliminated by the use of the reversible inhibitor of 
EDRF-dependent vasodilation, L-NG-nitro-arginine. Finally, some data was 
obtained to suggest that cysteine may attenuate thromboxane A2 release and 
increase the release of cGMP during acidosis which may explain how it attenuates 
a pH-dependent constriction in the coronary vasculature.
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Table 1. The effect of various pharmacological agents on the time to the onset 
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1.1 METABOLIC AND IONIC CHANGES DURING MYOCARDIAL 
ISCHAEMIA.
Myocardial ischaemia is described as a deficit in the supply and demand of 
oxygen and metabolic substrates. During relatively severe periods of myocardial 
ischaemia, but prior to the onset of cell necrosis (infarction), there are a series of 
physiological and biochemical changes that occur. These are of a highly 
heterogeneous nature with respect to time and regional differences and many of 
them are potentially arrhythmogenic (Hearse and Dennis, 1982).
One of the first biochemical changes to occur following the onset of ischaemia is 
a rapid reduction in myocardial oxidative metabolism, due to a rapid depletion of 
available oxygen, which in turn results in a reduction in intracellular ATP. The 
most obvious mechanical change at this time is a depression of myocardial 
contractility and an increase in diastolic tension that occurs as a result of calcium 
overload (Hearse et al., 1977). Recovery from these changes upon reperfusion is 
dependent on the length of the preceding ischaemic period. Anaerobic glycolysis 
rapidly becomes the predominant metabolic pathway following the onset of 
ischaemia, causing an accumulation of lactate and H+ (Hearse and Dennis,
1982). There is also a concomitant increase in the extracellular potassium 
concentration (Knopf et al., 1990) which may be the consequence of a parallel 
reduction in Na/K ATPase activity (Kim and Aker a, 1987). There is also 
catecholamine release elevating tissue cAMP levels (Podzuweit, 1982). Although 
many of these changes have been implicated in arrhythmogenesis, the 
accumulation of extracellular potassium ([K+]0) is an important factor in the 
development of re-entry type dysrhythmia. Such an increase in [K+]0 reduces 
resting membrane potential and inactivates the fast sodium current, resulting in 
slow-response action potentials (Corr and Sobel, 1979). An enhanced arachidonic 
acid metabolism and other changes, such as the conversion of xanthine 
dehydrogenase to xanthine oxidase and the accumulation of hypoxanthine, may 
pre-dispose the ischaemic myocardium to the production of highly reactive and 
potentially damaging oxygen-derived free radicals upon reperfusion and the 
simultaneous re-introduction of molecular oxygen {Mturphy et al., 1987). Free 
radicals have been indirectly implicated in reperfiision-induced arrhythmogenesis
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from data showing the efficacy of selected free radical scavengers and 
antioxidants, such as reduced glutathione, in reducing their incidence {Woodward 
and Zakaria, 1985). However, the exact source and nature of these reactive and 
potentially damaging species is unknown and is the subject of considerable 
controversy.
1.2 FREE RADICALS AND OXIDATIVE STRESS.
1.2.1 Background.
Free radicals, and their effects in many organs and tissues, are recognised as an 
important factor in the aetiology of many disease states {Shlafer et al., 1982; Sies, 
1985; Simpson et al., 1987; Halliwell and Gutteridge, 1989). Despite considerable 
evidence for a burst of oxygen-derived free radical production during the 
reperfusion of a previously ischaemic myocardium and the relatively low 
antioxidant capacity of the heart, the mode of action by which oxidant stress 
causes myocardial injury is unclear. Oxidative stress contributes to myocardial 
stunning (Bolli, 1990), the rate of myocardial infarction (Engler and Gilpin, 
1989), impared endothelial function and vascular responsiveness (Jackson et al., 
1986; Hearse and Bolli, 1991) and electrophysiological disturbances leading to 
ionic imbalance and arrhythmogenesis (Bernier et al., 1986; Hearse, 1988). In 
support of this, antioxidants or agents that inhibit radical production exert a 
protective effect against free radical-induced injury (Bernier et al., 1986; Miura et 
al., 1988; Lucchesi et al., 1989). However, the identity, the sites of production and 
the mechanism by which these reactive species cause cell damage are still to be 
elucidated.
1.2.2 Oxidant stress and protein redox state.
Despite the fact that most radical-induced myocardial injury involves an 
imbalance of intracellular ionic homeostasis, that is controlled by both 
intracellular and intrinsic membrane-bound proteins, the vast majority of 
publications regarding this type of injury cite lipid peroxidation as the most likely 
mechanism by which this effect is mediated. Reeves et al. (1986) and Abramson
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and Salama (1989) have shown, however, that several crucial ion-translocating 
proteins (such as the sodium/potassium pump, sarcolemmal Na/Ca exchange and 
the sarcoplasmic reticulum Ca-release protein) may be modulated by changes in 
redox state (thiol-disulphide interchange or mixed thiol formation) of free 
sulphydryl group(s) (-SH) on protein molecules. With this in mind, there is the 
possibility that either oxidative or reductive stress during reperfusion (radical burst 
or the accumulation of reducing equivalents, respectively) could alter protein 
redox state with great rapidity, resulting in the activation or inactivation of ion 
translocating processes, which may manifest as a loss of ionic homeostasis, 
myocardial stunning, abnormal vascular reactivity, contractile failure and 
arrhythmias.
1.2.3 Thiol groups and the control of protein and enzyme activity.
The activity of some proteins and enzymes depends on the regulation of the redox 
state of one or more thiol groups within the protein structure (Rothstein, 1970; 
Brigelius, 1985; Zeigler, 1985). In the tertiary structure of these proteins and 
enzymes the sulphydryl (-SH) groups, arising from cysteine residues, are often in 
close proximity to each other and may contribute, together with disulphide bonds, 
to the conformation of the active site. The formation of intramolecular disulphide 
bonds between adjacent -SH groups or their oxidation to intermolecular mixed 
thiols by interaction with low molecular weight sulphydryl compounds, such as 
reduced glutathione (GSH), can determine the conformation of proteins and 
thereby regulate enzyme activity (Brigelius, 1985). These intermolecular 
disulphide bridges are readily reversible and provide a switching mechanism that 
is sensitive to cellular redox state. Intramolecular bridges are not reversed so 
easily and may lead to the permanent inactivation of proteins and/or enzymes. 
Therefore, the extent and type of disulphide bridge formation may be an index of 
the degree and duration of oxidative stress. Several enzyme systems, including 
phosphofructokinase, hexokinase, glutathione reductase, glucose-6-phosphatase, 
adenylate cyclase, guanylate cyclase, cAMP-dependent protein kinase and cellular 
systems such as the cytoskeleton are regulated by this type of thiol-disulphide 
interchange mechanism (Brigelius, 1985; Zeigler, 1985; Miller et al., 1990). 
Glutathione reductase provides a good illustration of the rapidity with which
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redox state can control enzyme activity since it can go through a cycle of 
activation and inactivation within a few milliseconds by switching pairs of protein 
thiol groups between the dithiol and disulphide state (Jrimm et al., 1986). 
Therefore, cellular redox state (e.g intracellular reduced and oxidised glutathione 
content) may exert a regulatory role in cellular metabolism in a comparable 
manner to the phosphorylation and dephosphorylation of proteins and enzymes.
Under pathological conditions, the oxidation of protein thiols results in the 
impairment of transmembrane metabolite and ion transport, a loss of enzyme 
activity and the disturbance of contractile function {Jones, 1985). Cardiac thiol 
content can be reduced by sulphydryl oxidising agents (such as GSSG, cystamine 
and diamide) which correlates closely with a concomitant increase in heart rate 
and coronary flow (Kosower, 1970; Gailis and Nguyen, 1975; Caparrotta et al.,
1983). In addition, diamide has a profound effect on inotropic state which is 
antagonised by ruthenium red, an inhibitor of sarcoplasmic reticulum (SR) 
calcium transport. If thiol-disulphide interchange is involved in the rapid 
modulation of ion translocating protein activity in cardiac membranes, then this 
may help to explain the rapid molecular events which initiate reperfusion 
arrhythmias, contractile failure and vascular injury.
1.2.4 Cellular thiol status.
Under normal conditions, intracellular concentrations of reduced glutathione are in 
the millimolar range whereas levels of oxidised glutathione are relatively low and 
maintained in the micromolar range {Meister and Anderson, 1983). The 
maintainance of a high GSH/GSSG ratio would be expected to keep the majority 
of protein-SH groups in the reduced state which may be critical for normal 
cellular function as most enzymes or proteins require free -SH groups for activity 
whereas the formation of disulphides is usually inhibitory.
1.2.5 Adrenergic receptors.
The binding of a beta-adrenoceptor agonist to an appropriate receptor stimulates 
the accumulation of cAMP by increasing the activity of adenylate cyclase via the
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activation of a GTP-binding stimulatory protein, Gs {Gilman, 1989). It has been 
suggested that adrenergic receptor activity may be controlled by the formation of 
disulphide bridges between several cysteinyl residues that are known to be present 
in the transmembrane-spanning regions of the Gs protein {Malbon et al., 1987). 
Evidence in support of this comes from the work of Pendersen and Ross (1985) 
who have shown that thiol compounds, such as reduced dithiothreitol, can activate 
beta-adrenoceptors reconstituted in phospholipid vesicles in the absence of an 
agonist The treatment of the Gs protein alone with dithiothreitol had no effect 
This suggests that thiol activation is targetted at the receptor protein itself and not 
further downstream in the receptor-effector cascade. The recent work of Cotecchia 
et al. (1988) and Lefkowitz et al. (1989) has demonstrated major homology 
between the amino acid sequences of alphaj, betaj and beta2-adrenergic receptors 
with strict conservation of the cysteinyl residues that are thought to be located in 
the transmembrane spanning regions. Myocardial ischaemia leads to a significant 
increase in both alpha and beta adrenergic receptor numbers {Corr et al. 1981; 
Strasser et al. 1988) and sensitivity to catecholamines, in addition to 
noradrenaline release and accumulation in the synaptic cleft (Schdmig and 
Richardt, 1990). During ischaemia, reductive stress, due to the accumulation of 
reducing equivalents, may further potentiate the adrenergic receptor activation via 
the reduction of intramolecular disulphide bonds in receptor proteins. Reperfusion- 
induced arrhythmias have been associated with both increased alpha- and 
beta-adrenergic stimulation and increased cAMP levels {Sheriden et al., 1980; 
Corr et al., 1981). Therefore, an increase in adrenergic receptor activity due to 
ischaemically-induced reductive stress may be deleterious in the face of increased 
receptor density and a net increase in noradrenaline release. Alternatively, it has 
been proposed that oxidant stress may desensitize adrenergic receptors thereby 
providing an explanation for the loss of contractile function during the early phase 
of myocardial reperfusion {Pendersen and Ross, 1985). In support of this, Schultz 
et al. (1990) have shown that myocardial contractile responses in the 
anaesthetized dog to exogenous noradrenaline are depressed during reperfusion 
following a 15 minute ischaemic period; full recovery of responsiveness was 
achieved after 24 hours. Both alpha and beta-adrenoceptors may, therefore, have a 
reduced responsiveness during reperfusion and the oxidation of free -SH groups in
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the receptor protein may be responsible for this effect.
1.2.6 The sarcoplasmic reticulum.
The redox regulation of ion channel activity in the sarcoplasmic reticulum (SR) 
may be important in view of its role in the control of free cytosolic calcium. In a 
series of studies, Abramson et al. (1988a, 1988b) have shown that the opening 
and closing of calcium-release channels in the terminal cistemae in rabbit skeletal 
SR vesicles can be mediated via the reversible oxidation and reduction of -SH 
groups. Calcium release from the SR can be induced using micromolar 
concentrations of oxidising agents to promote disulphide formation. Reducing 
agents, such as reduced glutathione and reduced dithiothreitol, reverse this 
activation and promote calcium re-accumulation within the SR. From this work, 
Abramson et al. (1988a, 1988b) suggested a model to explain how oxidant stress 
could alter the gating of the SR calcium release channel leading to calcium 
overload and electrophysiological abnormalities (Abramson and Salama, 1989). 
With respect to this, the effect of oxidant stress on the ability of the SR to control 
cytosolic calcium has been demonstrated (Matsuura and Shattock, 1989). Oxidant 
stress, induced by the photoactivation of rose bengal, resulted in arrhythmias 
associated with calcium redistribution. A strong correlation between the SR 
content of a particular species and the degree of oxidant stress-induced damage 
was also shown. For example, the frog has no SR and is very resistant to the 
effects of rose bengal photoactivation (Nakata and Hearse, 1990; Shattock et al., 
1991). Additional studies using isolated myocytes have shown that oxidant stress 
can induce oscillatory SR calcium release leading to arrhythmogenic transient 
inward currents (Shattock et al., 1991; Matsuura and Shattock, 1991a). This data 
is supported by the work of Scherer and Deamer (1986) and Yoshida and 
Tonomura (1976) who have shown that the activity of the SR Ca-ATPase can be 
reduced by the oxidation of -SH groups.
1.2.7 The sarcolemma.
Sodium/calcium exchange has been studied in sarcolemmal vesicles under 
oxidative stress (Reeves et al., 1986). Under these conditions Na/Ca exchange was 
stimulated up to 10 fold and this stimulation was inhibited by anaerobis and
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catalase. Reduced and oxidised glutathione were both found to activate exchange 
and it has been suggested that the conformation of the Na/Ca exchange protein 
can be altered by the oxidation of three adjacent sulphydryl groups resulting in a 
modulation of channel activity. This system would be expected to be extremely 
vunerable to oxidative stress as at this time there is a net increase in the synthesis 
of superoxide, GSSG and hydrogen peroxide and the cell may be sodium-loaded 
and therefore susceptible to calcium gain. It is important to note that Reeves et al.
(1986) observed these changes in Na/Ca exchange in the absence of detectable 
lipid peroxidation. This adds support to the hypothesis that changes in protein 
conformation as opposed to gross changes in membrane phospholipid content are 
important with regard to the early phase of oxidant stress in the myocardium.
In support of the theory that oxidative stress can selectively and adversely affect 
sarcolemmal function is the work of Bhatnager et al. (1990), Kim and Akera
(1987) and Kramer et al. (1987). These groups have reported on the deleterious 
effect of oxygen-derived free radicals on ouabain binding to guinea-pig, frog and 
dog myocardial Na/K ATPase. Neutrophil-derived free radicals have also been 
shown to inhibit this ion translocating system (Kukreja et al., 1988, 1989). 
Kaneko et al. (1989a, 1989b) have shown that superoxide radical generating 
systems can inhibit rat myocardial sarcolemmal ATPase activity which can be 
reversed by superoxide dismutase, catalase or mannitol. Nitrendipine binding 
studies have shown that calcium channel activity is also reduced in the 
sarcolemmal membrane under conditions of oxidant stress (Kaneko et al., 1989al, 
1989b). In studies involving exogenous oxidant stress, Dixon et al. (1990) also 
showed that oxidant stress results in alterations in Na/Ca exchange and 
Ca-ATPase activity that are matched by changes resulting from 30 minutes 
myocardial ischaemia and 5 minutes of subsequent reperfiision. This inhibition of 
Ca-ATPase activity could be attenuated by reducing agents such as dithiothreitol 
and cysteine and therefore it was speculated that Ca-pump activity may be 
modified by the oxidation of sulphydryl groups (Kaneko et al., 1989a., 1989b).
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1.3 GLUTATHIONE.
The thiol compound, reduced glutathione, constitutes a major part of the cell's 
defence system against oxidative stress and is known to be protective against 
reperfusion-induced arrhythmias (Woodward and Zakaria, 1985). For these 
reasons, the maintainance of a fully functional glutathione pathway and related 
enzymic systems is critical if a cell and/or organ is to survive an ischaemic insult.
1.3.1 Metabolism.
Reduced glutathione (L- T -glutamyl-L-cysteinylglycine) is a commonly found 
tripeptide that functions directly or indirectly in protein synthesis, enzyme 
activity, cellular metabolism, muscle contraction and the protection of cells 
against potentially damaging oxidising species (Kosower, 1970; Meister and 
Anderson, 1983). It is the predominant intracellular thiol and its structure is shown 
in figure 1. The intracellular synthesis of glutathione occurs by the consecutive 
actions of y -glutamylcysteine synthetase and glutathione synthetase with feedback 
inhibition by glutathione itself. The availability of the precursor amino acids from 
the outside of cells is regulatory in GSH synthesis. The breakdown of glutathione 
is under the control of Y -glutamyl transpeptidase which catalyses the transfer of 
the -glutamyl moiety to acceptors such as cystine, methionine, water and GSH 
itself. This transpeptidase is unusual in the respect that its substrate, GSH, is 
located intracellularly whereas the enzyme is on the cell surface. There is, 
therefore, a GSH transporter to allow the interaction of substrate and enzyme 
(Griffith et al., 1978). V -Glutamyl amino acids formed by this process are then 
transported into cells. The y-glutamyl cycle, which accounts for the synthesis and 
degradation of glutathione, is shown in figure 2. Blaustein et al. (1989) have 
shown that glutathione-depleted hearts can have their GSH content restored to 
control levels by the use of glutathione methyl esters. In addition, Tsan and 
colleagues (1989) have also shown that exogenous GSH can increase GSH levels 
in pulmonary artery endothelial cells as a result of GSH breakdown at the cell 
surface and internal resynthesis. It appears that the time of exposure as well as the 
GSH concentration will have a bearing on the extent of intracellular GSH 
enhancement. In the experiments described in this thesis, it is likely that 
intracellular levels of GSH may be modulated by the perfusion of extracellular 















Figure 1. Structural formula of the tripeptide, reduced glutathione (GSH) 
(y-L-glutamyl-L-cysteinylglycine) highlighting its component amino acid 
residues, glycine, cysteine and glutamate.
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Figure 2. Overall summary of glutathione metabolism: Reaction 1.
y-GLU-CYSH synthetase; Reaction 2: GSH synthetase; Reaction 3 and 3a:
glutamyl transpeptidase; Reaction 4: y-glutamyl cyclotransferase; Reaction 
5: 5-oxoprolinase; Reaction 6 and 6a: dipeptidase; Reaction 7: GSH 
S-transferases; Reaction 8: N-acetylase; Reaction 9: GSH peroxidase; 
Reaction 10: transhydrogenases; Reaction 11: GSSG reductase; Reaction 12: 
oxidation of GSH by O^'; conversion of GSH to GSSG is also mediated by 
free radicals; AA-amino acids.
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the heart or single cell.
1.3.2 Glutathione transport.
The intracellular concentrations of GSH and GSSG are approximately 0.5-10mM 
and l-2pM, respectively. Intracellular glutathione is, under normal conditions 99% 
GSH; levels of GSSG, being very low, only constitute 0.1 to 2% of the total 
glutathione pool. Under conditions of significant oxidative stress or toxicity, 
GSSG increases substantially and there may be a mechanism for its active 
transport out of the cell (Meister and Anderson, 1983). The export of glutathione 
from erythrocytes involves GSSG transport (Beutler, 1983). When the GSSG level 
in such cells is artificially raised by the use of a GSH-oxidising agent, GSSG is 
actively exported. This process requires ATP, and Beutler (1983) suggested that 
this active transport mechanism may represent an emergency mechanism to 
protect cells from the toxic effects of GSSG. In addition, intracellular GSSG is 
reduced to GSH by glutathione reductase and the concomitant use of NADPH. 
The transport of GSH from the intracellular to the extracellular space is found in a 
wide variety of cells {Meister et a l 1980; Meister, 1981) and may function as a 
means of sulphur transport, in the form of cysteine, between cells. The function of 
GSH as a storage and transport form of cysteine has a distinct advantage in that 
the sulphydryl group of GSH is more stable than that of cysteine and GSH is far 
less toxic than cysteine, even at relatively high intracellular concentrations. The 
transport of GSH may also maintain essential -SH groups of proteins in the cell 
membrane during oxidative stress. There is good evidence that extracellular GSH 
functions as a reductant that may prevent the formation of intra- and 
intermolecular disulphides. It is also important in the removal of reactive oxygen 
intermediates and free radicals formed under normal and pathological conditions.
1.3.3 Functions.
Reduced glutathione is well known to toxicologists for its efficacy in the 
conjugation and detoxification of a wide range of xenobiotics and their 
metabolites and this function accounts for approximately 5-10% of GSH 
consumption. Glutathione is also a component of one of the cells main
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endogenous defence systems against ischaemia/reperfusion and free radical- 
mediated oxidative damage. Studies of oxidant stress in a range of cell types have 
indicated that glutathione depletion may be one of the steps in the progression of 
irreversible cell injury. Human lymphoid cells and tumor cells depleted of GSH 
have been shown to be more sensitive to irradiation and cytolysis by reactive 
oxygen intermediates (iGriffith et al., 1978; Arrick et al., 1982). A  reduction of the 
glutathione pool has been related to the progression of lipid peroxidation and the 
alteration of protein-bound thiols and other changes that may alter cell membrane 
integrity (Burton, 1988). GSH is also a co-factor for enzymes such as glyoxylase, 
formaldehyde dehydrogenase and maleyl acetoacetate isomerase. There is evidence 
for its involvement in intracellular calcium homeostasis from its ability to maintain 
thiol groups in a reduced state at the active sites of Ca-ATPases.
1.3.4 Glutathione transhydrogenases.
Thiol-disulphide interchange is involved in several metabolic and physiological 
functions including protein synthesis and degradation, enzyme activation and 
inactivation, the synthesis of deoxyribose intermediates for DNA synthesis, and the 
reduction of cystine. Reduced glutathione has been thought to participate in these 
reactions in view of the fact that it is the major intracellular thiol. There is 
evidence for the existence of enzymes that catalyse thiol-disulphide interchange 
between GSH and low molecular weight disulphides, as well as between GSH and 
protein disulphides (Mannervik and Eriksson, 1974). GSSG reductase does not 
catalyse these reductions; they appear to be mediated by separate 
transhydrogenases. Although glutathione transhydrogenases have important 
functions with regard to the synthesis, structure, degradation, and function of 
proteins and enzymes, there are other systems that affect the thiol-disulphide status 
of cells that are also of considerable importance. These include the thio- and 
glutaredoxin systems which exhibit a high reducing potential.
1.3.5 Protection against myocardial ischaemia and infarction.
A range of pharmacological agents have been shown to be protective in animal 
models of myocardial ischaemia and infarction either by decreasing myocardial 
oxygen demand or by increasing oxygen supply (Maroko et al., 1971). However, 
their clinical significance is limited and as a result the limitation of infarct size has
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been approached by other methods of myocardial cytoprotection.
The ischaemically-induced production of oxygen-derived free radicals is 
accompanied by a loss of protective enzyme and antioxidant mechanisms that are 
normally present in the myocardium (Burton et al., 1984). Among the more 
important protective systems is the glutathione redox pathway, whose role in the 
attenuation of free radical-induced myocardial necrosis has been investigated and 
demonstrated {Forman et al., 1988). In addition, glutathione peroxidase is 
significantly more active than other antioxidant enzyme systems {Fantome and 
Ward, 1982). Therefore, the maintainance of the glutathione pathway and related 
enzymic defence systems against oxidative stress is vital to prevent myocardial 
cell death under such conditions.
A-Acetylcysteine (NAC) is a glutathione precursor which has a longer plasma 
half-life than reduced glutathione. It also undergoes auto-oxidation at a slower rate 
than other sulphydryl compounds {Estrela et al., 1983) and has been used 
effectively to replenish intracellular glutathione stores in several disease processes 
{Olson et al., 1980; Bernard et al., 1984). Alberola et al. (1991) have shown 
NAC limits the extent of irreversible injury in the ischaemic canine heart but does 
not decrease myocardial oxygen demand or influence the regional distribution of 
myocardial blood flow. Therefore, it appears that NAC is protective by other 
mechanisms. The studies of Alberola et al. (1991) showed NAC to attenuate an 
ischaemically-induced reduction in intracellular reduced glutathione (GSH). It is 
unclear, however, whether this represents the protection of existing GSH stores 
from depletion or the replenishment of depleted GSH. NAC is also a free radical 
scavenger and inhibits neutrophil-mediated free radical production {Bernard, et 
al., 1984; Tribble et al., 1987). More recent studies have highlighted the 
beneficial effects of sulphydryl compounds against myocardial infarction which 
supports the theory that these compounds, and related enzymatic systems, are 
essential for myocardial protection against oxidative stress. Although the 
protective mechanism of NAC is unknown, the maintainance of intracellular GSH 
levels may be critical.
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1.4 SODIUM/POTASSIUM ADENOSINE 5’ TRIPHOSPHATASE (Na/K 
ATPase).
The Na/K ATPase is considered to be the biochemical representation of the Na/K 
pump that is critical for the maintainance of cellular ionic homeostasis. The 
modification of its structure, function and activity during periods of ischaemia and 
oxidative stress (Kim and Akera, 1987) may represent a mechanism by which free 
radicals are arrhythmogenic. It may also represent a site where radical scavengers 
and antioxidants, such as reduced glutathione, act, thereby attenuating 
ischaemically-induced potassium loss to the extracellular space and the incidence 
of reperfusion-induced arrhythmias.
1.4.1 The nature of the enzyme.
Na/K ATPase (EC 3.6.1.3) has been extensively purified and characterized, 
especially from cardiac tissue, with little species to species variation. The enzyme 
consists of a catalytic alpha subunit that is a polypeptide of about 95 000 daltons 
to which cardiac glycosides bind, and a glycoprotein, beta subunit with a 
molecular weight of approximately 45 000 daltons. It is thought that the enzyme 
exists as a dimer in vivo with each monomer consisting of a catalytic and 
glycoprotein subunit (figure 3). Hiatt et al. (1984) have suggested that the beta 
subunit may be involved in the insertion of the alpha subunit into the membrane. 
It has been shown that Na/K ATPase is present in the membranes of all animal 
tissues in which a sodium gradient is present. In addition, enzyme activity is 
highest in those tissues, such as the myocardium, which extrude sodium at a 
relatively high rate. In intact cells, the Na/K ATPase is the biochemical 
representation of the sodium pump and is one of the best-studied electrogenic 
transporters. It transports three intracellular sodium ions for two extracellular 
potassium ions resulting in a net outward membrane current with a K^ for 
potassium and sodium of 1.2mM and 18mM, respectively (Gadsby et al., 1989; 
Shattock and Matsuura, 1990). Inhibition of Na/K ATPase results in a decrease in 
sodium extrusion and potassium uptake. Although both sodium and potassium are 
both determinants of sodium pump activity, intracellular sodium has a greater 
influence than extracellular potassium.
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rFigure 3. Diagramatic representation of an oligometric (a-(3) structure for N a/K  
ATPase, highlighting the pore for ion passage between the two a-subunits. 
(Redrawn from Jorgensen, 1982).
pore for ion passage
16
1.4.2 Na/K ATPase activation and inhibition.
1.4.2.1 Sulphydryl groups.
In addition to the well known inhibition of the Na/K pump by cardiac glycosides, 
Na/K ATPase activity is significantly reduced by several other agents. Both 
thallium and rubidium have been reported to have an inhibitory action (Ku et al., 
1975, 1976) which may have bearing on the use widespread use of 86rubidium as 
a marker for potassium movement via sarcolemmal ion transporters. The literature 
also describes the inhibitory action of several sulphydryl blocking agents that 
produce dose-related, positive inotropic effects in isolated heart preparations 
(Jemma et al., 1978). This type of compound, such as N-ethylmaleimide and 
p-chloromercuribenzoate, is thought to act at a different site to the cardiac 
glycosides and monovalent cations. Kawamura and Nagano (1984) have shown 
that there may be a single disulphide bridge in the beta subunit that may lead to 
loss of enzyme activity upon its cleavage with beta-mercaptoethanol. There is also 
thought to be one free sulphydryl group in the beta subunit. There are also several 
classes of sulphydryl groups are present in the alpha subunit that have been 
classified with respect to their rate of reaction with different probes. However, 
reactivity does not correlate with those groups essential for ATPase activity 
(Askari et al., 1979; Schoot et al., 1979; Harris and Stahl, 1980).
Kirley (1990) has shown that ATPase activity and ouabain binding is partly 
decreased by the reduction of a single, specific disulphide bond in the beta 
subunit There are, however, three disulphides in the beta subunit that can be 
protected from reduction by relatively high concentrations of Na+ and K+. The 
presence of these cations also attenuates ouabain binding and increases ATPase 
activity. If there is a relationship between disulphide reduction in the beta subunit 
and the loss of ATPase activity and ouabain binding, it is much more complex 
than the simple one to one relationship postulated previously (Kawamura and 
Nagano, 1984; Kawamura et al., 1985). Kirley (1990) has suggested that the 
reduction of multiple disulphides may cause a change in the folding of the beta 
subunit, resulting in steric interference with extracellular cation binding sites on 
the alpha subunit or a change in the interaction between the subunits which is
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critical for ATPase function. Therefore, the function of the alpha subunit may be 
affected in the absence of any direct effect on the alpha subunit itself. However, 
Kirley (1990) proposed that in the absence of high temperature and organic 
solvents used in the experimental protocol in his investigations, the degree of 
disulphide cleavage in the beta subunit would be insufficient to cause domain 
inactivation. Therefore, this indicates a delocalized protein denaturation 
mechanism rather than a specific bond cleavage is responsible for the reduction in 
Na/K ATPase activity by beta-mercaptoethanol. This work, however, has provided 
useful information on the presence and location of sulphydryl groups and 
disulphides in the alpha and beta subunits. Some workers have reported 12-17 free 
sulphydryl groups per alpha subunit (Esmann, 1962; Gupte and Lane, 1979) 
whilst Kirley (1990) has published data suggesting the presence of three 
disulphide bonds in the alpha subunit that has implications concerning the 
structure and stability of Na/K ATPase. These disulphides are present in the 
hydrophobic, membrane spanning regions of the protein where they contribute to 
the stability of the structural elements involved in sodium and potassium transport 
and their manipulation may prove critical in the regulation of cellular ion 
translocation.
1.4.2.2 Oxygen metabolites.
It is accepted that oxygen-derived free radicals are produced in the reperfused 
myocardium following a period of ischaemia (Zweier, 1988). There are a number 
of avenues whereby these toxic metabolites may be produced under these 
conditions. There may be a role for xanthine oxidase in superoxide production 
(iMcCord, 1985). Hypoxanthine and xanthine are formed and xanthine 
dehydrogenase is converted to xanthine oxidase during ischaemia. On the 
re-introduction of molecular oxygen a burst of superoxide production can occur. 
In addition, leukocytes, macrophages and monocytes which migrate to the 
ischaemic area can contribute to the production of free radicals (Burton, 1988). 
Mitochondrial superoxide production is also increased which, along with the 
autooxidation of catecholamines, may represent sources of free radicals during 
ischaemia/reperfusion (Burton, 1988). It is now thought that these reactive 
metabolites are not only involved in the gross degradation of membrane lipids but 
also in more subtle alterations in intrinsic membrane-bound protein structure and
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function. With regard to this, Kramer et al. (1984) demonstrated the in vitro 
inhibition of sarcolemmal Na/K ATPase in response to oxygen radicals. It is, 
however, difficult to establish if this pump inhibition is the result of relatively 
selective interactions of oxygen radicals with intrinsic proteins, such as the 
sodium pump (Na/K ATPase), or whether it represents more general oxidant- 
induced damage to a multitude of cellular constituents. Undoubtedly, there is a 
certain degree of non-specific damage on exposure to oxidising species and these 
non-specific effects may be dependent on the severity of the insult (eg. the length 
of the ischaemic insult prior to reperfusion). Data from the work of Xie et al. 
(1990) suggests that an oxidant stress induced by the xanthine/xanthine oxidase 
system results in damage to several other sarcolemmal proteins as well as the 
Na/K ATPase, although it seems that damage to the sodium pump is an early 
event in the development of the toxic effects of extracellularly generated oxidants 
in the myocardium. One major problem with such experiments and the 
interpretation of the resulting data is the unknown nature and local concentrations 
of the reactive species. Kim and Akera (1987) indirectly investigated the effects 
of oxygen-derived free radical on sarcolemmal Na/K ATPase using an 
ischaemia/reperfusion model in isolated guinea-pig hearts. A reduction in enzyme 
activity was observed during ischaemia and reperfusion which could be 
attenuated using selected radical scavengers and antioxidants, such as superoxide 
dismutase, catalase, mannitol, vitamin E and dimethylsulphoxide. However, no 
determination of the sites of action of free radical-induced damage to Na/K 
ATPase was made.
1.4.3.3 Fatty acid intermediates.
In addition to the production of various free radical species and changes in 
cellular redox state, long chain acyl carnitines are known to accumulate in 
millimolar concentrations in the ischaemic myocardium (Liedtke et al., 1978). 
These fatty acid intermediates have damaging biochemical, electrophysiological 
and mechanical effects in the myocardium. Despite their well known detrimental 
effects, little is known about the local concentrations of this class of compound 
or the degree of protein binding that occurs in vivo. A reduction in Na/K ATPase 
activity during periods of myocardial ischaemia has been documented, and as a
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result the effect of these compounds on sodium pump activity has been 
investigated using sarcolemmal vesicles. In the majority of these studies relatively 
high concentrations of palmitoyl carnitine have been used which cause myoglobin 
loss and a fall in contracture in the whole heart (Hulsmann et al., 1985). For this 
reason, the data from such investigations should be viewed with caution especially 
when ascribing specific effects of this type of compound.
The therapeutic manipulation of acyl carnitine levels has been approached by the 
inhibition of carnitine acyl transferase 1 which is protective in the ischaemic 
myocardium. At the present time there are two major problems with the currently 
available inhibitors, namely their irreversibility and the fact that they cause 
cardiomyopathy at high doses (Spedding, 1990).
1.5 ACIDOSIS AND MYOCARDIAL FUNCTION.
As previously described, intracellular acidosis, as a result of H+ and lactate 
accumulation, is a hallmark of myocardial ischaemia that results in a depression 
of contractile function. In addition to an increase in intracellular [H+], there is a 
concomitant increase in intracellular sodium and calcium as a result of Na/H and 
Na/Ca exchange. This may affect vascular tone and the degree of ischaemic 
damage following reperfusion.
1.5.1 Background.
There are few reports in the literature on the effects of acidosis on the coronary 
vasculature using the isolated perfused heart model. Some groups have used 
smooth muscle preparations whilst others have concentrated on the mechanical 
response of the heart to an acidotic insult. In vascular smooth muscle preparations, 
such as aortic and coronary artery strips, respiratory acidosis results in a decrease 
in tone whilst alkalosis results in an increase (Rinaldi et al., 1987; Loutzenhiser et 
al., 1990). Although the mechanisms responsible for these effects are, as yet, 
unknown, several proposals have been made. These include the inhibition of 
calcium influx at low pH and the stimulation of this process at high pH. There are
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reports in the literature of the effects of acidosis on both relatively large and fine 
vessels. Steenburgen et al. (1977) reported on the effects of acidosis in the 
constant pressure, isolated rat heart model. Acidosis, which was then synonymous 
with ischaemia, was induced by the use of a perfusate buffered at pH 6.7. A fall 
in coronary flow was noted that is indicative of increased vascular resistance in 
this model. This is in contrast to the vasodilator action of acidosis on the 
pre-contracted rat aorta reported by Loutzenhiser et al. (1990).
Hydrogen ions are not passively distributed, and in order to maintain intracellular 
pH within narrow limits both a proton extrusion mechanism and an intracellular 
buffering system are essential. Three systems have been suggested, namely the 
NaHCOj-Cl, the C1-HC03 and the Na-H exchange mechanisms (Poole-Wilson et 
al., 1984), the latter of which appears to play a major role in the recovery from an 
acid load. In the short term, a significant proportion of acid can be neutralized by 
reversible and rapidly responding mechanisms that serve to buffer acid loads. In 
the long term, intracellular pH homeostasis relies on the cells ability to extrude 
protons or accumulate HCO3 or OH-. In the steady state, the intracellular 
accumulation of H+ is balanced by the energy-requiring extrusion of acid. Siesjo 
and Messeter (1971) first investigated the cells response to an acid load, which 
caused a fall in pHj of rat brain cells and subsequent recovery following washout 
with buffer at pH 7.4. The authors suggested that the initial C 02-induced fall in 
pHj was minimised by biochemical buffering but that the recovery phase was due 
to the active transport of protons or HCO'3 across the cell membrane. Following 
this work there has been increasing evidence for such a H+ extrusion mechanism 
(Roos and Boron, 1981) which is enhanced in rat cardiac muscle by cAMP 
(Fenton et al., 1978). Previous studies in adult guinea-pig, rat, rabbit and ferret 
hearts have also shown that [Ca]j increases in acidosis {Allen and Orchard, 1983; 
Orchard, 1987; Lee et al., 1988; Solaro et al., 1988). The mechanism of this 
accumulation of free cytosolic calcium is unclear although it may be a result of a 
decrease in calcium sequestration by intracellular organelles such as the 
sarcoplasmic reticulum (Orchard, 1987). Also, at low pH values, calcium uptake 
and release from the SR may be decreased (Fabiato and Fabiato, 1978). An 
increased diastolic [Cajj as a result of acidosis may also cause an increased
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calcium-induced calcium release from the SR (Orchard, 1987). In addition, an 
acidosis-induced increase in intracellular [H+] may result in an increase in 
intracellular sodium, via Na/H exchange. Sodium can exchange for calcium via the 
Na/Ca exchange mechanism that may manifest as an increase in free cytosolic 
calcium.
Severe acidosis is often accompanied by a decreased vasoconstrictor response to 
catecholamines (Campbell et al., 1958; Dusting and Rand, 1975). Several 
consequences of a reduction in pH contribute to this effect in smooth muscle, such 
as reduced in Ca2+ influx (van Breemen et al., 1972; Kohlhardt et al., 1976), 
inhibition of myofilament contractility (Portzehl et al., 1969; Fabiato and Fabiato, 
1978) and alteration of cell surface receptors (Flavahan and McGrath, 1981). 
Loutzenhiser et al. (1990) suggested that a small degree of acidification stimulates 
calcium sequestration into intracellular stores that are sensitive to noradrenaline.
The effects of acidosis may be partly mediated by enzyme inhibition due to the pH 
optima of many enzyme systems. The synthesis and degradation of many 
vasoactive compounds are under the control of such systems and therefore may be 
susceptible and sensitive, to varying degrees to changes in extracellular and/or 
intracellular pH depending on the locality of the enzyme. For example, the ability 
of noradrenaline to constrict smooth muscle at lowered intracellular calcium 
concentrations is thought to be due to the activation of protein kinase C 
(Rasmussen and Barrett, 1984; Jiang and Morgan, 1987). Protein kinase C has a 
pH optimum of 7.5-8.0 and could theoretically be inhibited by reduced pH. This is 
in contrast to myosin light chain kinase which is relatively insensitive to pH 
changes between 6.5 and 9.0 (Blumenthal and Stull, 1982).
In addition to changes in vascular tone mediated via ion exchange mechanisms 
such as the Na/Ca, Na/H and Na/K exchange mechanisms, vasoactive substances 
released from the myocardium may be responsible for the response of the coronary 
vasculature to acidosis. There are some reports on the effect of acidosis on the 
release of catecholamines from the isolated rat heart (Dart and Riemersma, 1989) 
although it is not clear whether they are released in sufficient concentrations to 
cause a significant modulation of vascular tone. Neuropeptide Y (NPY) is a 
co-transmitter with noradrenaline and potentiates the action of other vasoactive
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substances such as phenylephrine, histamine, angiotensin II and noradrenaline, at lower 
concentrations than are required for a direct response. Exercise results in extracellular 
acidosis and the release of NPY from the human heart and may contribute to an 
acidosis-induced change in coronary tone either directly or by potentiating the pressor 





2.1 ISOLATED LANGENDORFF PERFUSED RAT HEART PREPARATION.
This preparation was used to investigate the effects of selected thiol compounds on 
ischaemia/reperfusion-induced myocardial noradrenaline release and 86Rb efflux as 
well as the physiological response of the heart to acidosis.
Hearts from male Wistar rats (University of Bath strain, 250-350g), were perfused 
using the Langendorff method at a constant flow rate of lOml/minute at 37°C with 
a modified Krebs-Henseleit solution of the following composition (mM): lactate 
5.0; NaCl 118.0; NaHC03 25.0; KC1 4.7; KH2P04 1.2; CaCl2 1.2; M gS04 1.2, 
which was continuously gassed with 95% 0 2, 5% C02. In all experiments, hearts 
were allowed to stabilize for 15 minutes prior to any interventions. During the final 
5 minutes of the stabilization period hearts were paced at 300 b.p.m (pulses of 7 
volts, rate 5 Hz and a duration of 2.5ms) using a Grass S88 stimulator). Hearts 
were paced in all experiments. Heart rate prior to pacing was 225±55 b.p.m (n=55). 
Perfusion pressure changes were monitored using a Bell and Howell pressure 
transducer connected to a side arm on the perfusion line. Developed tension, under 
a resting tension of 2g, was recorded with a Devices isometric transducer attached 
to the apex of the heart with a length of cotton and a barbless hook; the signal 
from this transducer was used to trigger an instantaneous rate meter. All recordings 
were made on an 8 channel Devices thermal recorder. Any drug injections were 
made in volumes of less than lOOpl via a side-arm situated close to the aortic 
valves. Figure 4 illustrates the perfusion apparatus used in these experiments.
2.2 THE INITIATION OF GLOBAL, LOW-FLOW MYOCARDIAL 
ISCHAEMIA AND SUBSEQUENT REPERFUSION.
This protocol was used to investigate the effect of selected agents on 
ischaemia/reperfusion-induced noradrenaline overflow and contracture.
Following a 15 minute equilibration period, global, low-flow ischaemia was 
induced by reducing the flow rate of the perfusate by 90% to lml/min and 
superfusing the heart with anoxic perfusate (gassed with 95% N2 /  5% CO^ at 
9ml/min. In these experiments the ischaemic period was either 20, 30 or 60
25








Figure 4. Diagram of the apparatus used for the isolated Langendorff 
perfused heart preparation.
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minutes. Reperfusion was initiated, after the appropriate period of ischaemia, by 
restoring the flow to its pre-ischaemic level with oxygenated perfusate. In all 
experiments reperfusion was for 5 minutes after which the experiment was 
terminated and the heart removed from the apparatus, blotted dry and weighed.
2.3 MEASUREMENT OF CORONARY PERFUSATE NORADRENALINE 
LEVELS DURING MYOCARDIAL ISCHAEMIA AND SUBSEQUENT 
REPERFUSION.
This technique was utilized, in conjunction with the isolated perfused rat heart 
preparation, to determine both perfusate and tissue levels of noradrenaline during 
myocardial ischaemia and reperfusion
2.3.1 Collection of perfusate samples.
Hearts were perfused with Krebs-Henseleit solution (containing 5.9mM K+) for a 
control period of 15 minutes. At this point hearts were paced at 300 b.p.m (pulses 
of 7 volts, rate 5 Hz and a duration of 2.5ms) using a Grass S88 stimulator. The 
successful initiation of pacing was confirmed by observation of the heart rate 
meter. Five minutes after the onset of pacing, global low-flow ischaemia was 
induced, as described in section 2.2, for the required period followed by 5 minutes 
reperfusion. Perfusate samples were collected in 1 minute aliquots at 5 minutes 
intervals during the equilibration period. During the ischaemic phase samples were 
collected in 1 minute aliquots at 10 minute intervals whilst during the 5 minutes of 
reperfusion samples were continously collected in 30 second aliquots. Sample 
collection was performed using a Gilson Model 203 automated fraction collector. 
The samples were kept on ice until the end of the experiment when they were all 
immediately assayed for noradrenaline content using HPLC with electrochemical 
detection.
2.3.2 Determination of perfusate noradrenaline levels by HPLC.
2.3.2.1 Preparation of HPLC mobile phase.
The composition of the mobile phase was (mM): 1-octanesulphonic acid (sodium
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salt, HPLC grade) 0.5; sodium acetate (HPLC grade) 100; sodium hydroxide 
(HPLC grade) 60; citric acid (HPLC grade) 40, dissolved in 10% HPLC grade 
methanol: 90% Milli-Q grade water. The mobile phase was filtered through a 2pm 
Millipore™ filter using a Millpore™ vacuum filtration system, gassed to saturation 
with helium and finally degassed by sonication for 20 minutes prior to use.
2.3.2.2 Preparation of activated alumina (aluminium oxide).
Aluminium oxide was activated to obtain the grade recommended by Anton and 
Sayre (1962). 100 grams of aluminium oxide (neutral, Brockman grade 1, BDH) 
was added to 500 ml of 2M HC1 in a Pyrex beaker, covered and heated to 
90-100°C on a hot plate. The aluminium oxide was stirred for 45 minutes under 
these conditions. At the end of this period the aluminium oxide was allowed to 
settle and the yellow supernatant carefully decanted off. The aluminium oxide was 
washed twice with 250 ml aliquots of fresh 2M HC1 at 70°C for 10 minutes, 
discarding the supernatant each time. Subsequently, the precipitate was stirred with 
500 ml of 2M HC1 for 10 minutes at 50°C. The aluminium oxide was then 
repeatedly washed (20-25 times) with 200 ml aliquots of distilled water until the 
supernatant had a pH of 3.4. Finally, the aluminium oxide was transferred to an 
evaporating dish and heated at 120°C for 60 minutes and at 200°C for a further 120 
minutes in an oven. The activated alumina was then stored in a capped glass bottle 
in a dessicator at room temperature until required.
2.3.2.3 Extraction procedure for the assay of perfusate noradrenaline levels.
To a 10ml tube the reagents were added in the following order: 0.3ml perfusate, 
0.05ml 300mM disodium EDTA, 0.05ml 50mM reduced glutathione, 0.05ml 3pM 
3,4-dihydroxybenzylamine (DHBA) as an internal standard and 30mg of activated 
alumina. The reactants were mixed briefly by hand and then 0.15ml 1M Tris (pH 
8.6) was added. The tubes were then stoppered and mixed on a rotary mixer for 20 
minutes at room temperature. The tubes were centrifuged briefly, the supernatant 
decanted off and the alumina, containing absorbed noradrenaline, washed 3 times 
with 5ml of 3mM disodium EDTA pH 7.0. Finally the noradrenaline was eluted off 
the alumina by adding 0.3ml of 0.2M perchloric acid. The elutant was stored at
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-25°C until its noradrenaline content was determined by HPLC.
2.3.2.4 Assay of perfusate extracts for catecholamines by high performance liquid 
chromatography.
The noradrenaline (NA) content of the perchloric acid extracts was determined 
using reversed phase, ion-pair HPLC with electrochemical detection. The liquid 
chromatograph consisted of an LDC Model HI Constametric pump, a Rheodyne 7 
125 injection valve with a lOOpl loop, a 25 cm x 4.6 mm (i.d) stainless steel 
analytical column packed with 5pM diameter Hypersil-ODS (Shandon, U.K) 
particles and a Bioanalytical systems LC-4A amperometric detector. The detector 
was operated at +0.65V with an Ag/AgCl reference electrode (BAS RE-1) and a 
glassy carbon working electrode. The flow rate of the mobile phase (for 
composition, see above) was maintained at 1.0 ml/minute. Chromatograms, of 
which a typical example is shown in figure 5, were recorded on a JJ Instruments 
flat-top recorder. Peak heights and peak height ratios (NA/DHBA) were measured 
and calculated manually.
2.3.2.5 Calibration.
Aliquots of perfusate were spiked with known amounts of noradrenaline. After the 
addition of the internal standard (DHBA), the samples were extracted and assayed 
as previously described. In addition, blank samples of perfusate were assayed to 
allow the correction of the true noradrenaline content of experimental samples. The 
peak height ratios (NA/DHBA) were plotted against perfusate concentration to 
obtain a calibration curve. This curve was used to convert peak height ratios into 
concentration values when analysing perfusate samples.
2.3.2.6 Calculation of recovery.
The recovery of noradrenaline was determined by comparing the peak height ratios 
of spiked samples assayed after alumina extraction and of standards injected 
direcdy into the chromatograph. The recovery of DHBA was calculated by 
comparing the peak height ratios obtained during the construction of the calibration 




Figure 5. Typical high performance liquid chromatogram of the 
quantitative analysis of coronary perfusate for selected 
catecholamines. (Peak identification: I-sample injection, SF-solvent 
front, A-adrenaline, NA-noradrenaline, 
DHBA-3,4-dihydroxybenzylamine.
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Figure 5a. Typical trace of 86rubidium efflux rate coefficient (erc/min) during 30 
minutes 86rubidium washout, 30 minutes global, low flow ischaemia and 5 
minutes subsequent reperfusion. Peak erc/m in during ischaemia and 
reperfusion are represented as PiSCh and Prep, respectively. Mean efflux area 
during ischaemia and reperfusion are represented as A and B, respectively. The 
onset of ischaemia and reperfusion are indicated by the arrows.
recovery of noradrenaline and DHBA were 60% and 65% respectively.
2.3.2.7 Linearity of the extraction procedure and detector response.
The linearity of the extraction procedure was tested by spiking samples of 
perfusate with increasing amounts of noradrenaline and putting them through the 
normal extraction procedure. DHBA was only added with the 0.2M perchloric acid 
used for the final elution. The extracts were analysed and peak height ratios 
determined as before. Results from spiked samples were corrected for endogenous 
noradrenaline using results from blank perfusate samples. In addition, the linearity 
of the detection system was determined by the direct injection of standard 
solutions into the chromatogram. The concentration of DHBA was fixed. Both the 
extraction procedure and detection system were linear within the range 
corresponding to perfusate noradrenaline concentrations of 2.5-80 pmoles/ml.
2.4 DEPLETION OF ENDOGENOUS NORADRENALINE USING 6- 
HYDROXYDOPAMINE.
The effect of endogenous noradrenaline depletion on the onset of an ischaemic 
contracture was determined by reducing myocardial noradrenaline content with a 
single intravenous dose of 6-hyddroxydopamine.
An animal’s endogenous noradrenaline may be depleted over a 24 hour period 
using a single intravenous dose of 50mg/Kg, 6-hydoxydopamine (HQ salt) 
(Kostrzewa and Jacobowitz, 1974) dissolved in 0.1ml of 0.8% (w/v) saline 
immediately prior to use. The animals’ hair standing on end approximately 1 
minute after dosing was used as an indication that the drug had been successfully 
delivered. These animals were sacrificed 17-24 hours later. In all experiments 
involving the use of noradrenaline depleted hearts, two hearts from the same group 
were assayed for tissue noradrenaline levels as were hearts from two untreated 
animals. This allowed calculation of the degree of tissue noradrenaline depletion 
expressed as a percentage of the control untreated hearts.
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2.5 DETERMINATION OF TISSUE LEVELS OF NORADRENALINE.
Hearts were quick-frozen using aluminium tongs pre-cooled in liquid nitrogen. For 
the assay, hearts were ground in an aluminium grinder (pre-cooled in liquid 
nitrogen) to form a fine powder that was then further homogenised in 10ml of 
0.1M perchloric acid containing 4.3mM disodium EDTA and 4.2mM Na2S20 5, 
using a Polytron homogeniser. The homogenate was then centrifuged for 10 
minutes at 400 rpm and 1ml of the resulting supernatant used for the assay. 50pl of 
3pM DHBA, 500pl of 3M Tris (pH8.6) and 30mg of activated alumina were added 
to the supernatant and mixed for 10 minutes. After washing the alumina three 
times with distilled water, the amines were eluted from the alumina with 600pl of 
0.2M perchloric acid (HPLC grade). 0.1 ml of the elutant was run on the column 
as previously described and its noradrenaline content determined.
2.6 86RUBIDIUM EFFLUX EXPERIMENTS.
86Rubidium was used as a marker to monitor the net loss of potassium during 
myocardial ischaemia/reperfusion and the effect of selected compounds on this 
physiological response.
Hearts were perfused with Krebs-Henseleit solution for a control period of 5 
minutes after which 86Rb (0.2pCi/ml; Amersham, U.K) was added and perfused for 
a further 10 minutes. A 30 minute washout period then followed during which the 
heart was paced (same criteria as section 2.3.1). Any drugs were perfused for 10 
minutes immediately after the washout period and during the subsequent period of 
ischaemia and reperfusion. 30 minutes global ischaemia was initiated during which 
the flow was reduced by either 90, 95 or 97.25%. Reperfusion was earned out by 
returning the flow to its pre-ischaemic level of lOml/minute. Perfusate samples 
were collected in 1 minute aliquots during the 30 minute washout period, during 
the addition of drugs prior to the onset of ischaemia and throughout the ischaemic 
phase. During the reperfusion phase, perfusate was continuously collected in 30 
second aliquots. 1ml of each sample was mixed with 8ml of scintillation fluid 
(Optiphase ‘safe’) and counted in an LKB 1215 scintillation counter using an 
external channels ratio method for 10,000 counts or for 10 minutes (Durbin and
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Jenkinson, 1961).
At the end of the experimental period the heart was blotted with tissue paper, 
chopped into small pieces and left to digest in 5mls of 1M NaOH. After 48 hours 
the digested myocardial tissue was neutralized with 5mls of 1M HC1 to prevent 
chemiluminesence (Durbin and Jenkinson, 1961), and the decay during this period 
allowed for. Finally, 1ml of the neutralized material was added to 8mls of 
scintillation fluid and counted as above. 86Rubidium efflux is expressed as efflux 
rate coefficient at time '? (erc/minute) calculated according to equation 1. To 
enable rapid data processing, computer software was utilized that was originally 
written by Dr D.M Coldwell (Smith-Kline Beecham Pharmaceuticals, Harlow, 
Essex) (Appendix 1). In these experiments, peak ere (min-1) and the mean efflux 
area during ischaemia and reperfusion was determined which are diagramatically 
represented in figure 5a.
perfusate count
ere (min ) = - - ; ; —— eauation 1.
total count x collection time (min) H
2.7 RAT ISOLATED PERFUSED MESENTERIC VASCULAR BED 
PREPARATION.
The effect of acidosis on the tone of the pre-contracted mesenteric vascular bed 
was investigated using this preparation.
The superior mesenteric artery was cannulated, the middle colic artery ligated and 
the mesenteric vascular bed removed by careful dissection from male Wistar rats 
(University of Bath strain) weighing between 250-350g. Perfusion of the mesenteric 
vascular bed was performed at a constant flow rate of 4ml/minute with standard 
Krebs-Henseleit solution (see section 2.1) saturated with 95% O2, 5% CO2. 
Changes in perfusion pressure were monitored in a similar way to that described 
for the isolated perfused heart preparation (see section 2.1). The tissue was allowed 
to equilibrate for 30-40 minutes following dissection before any interventions were 
carried out In some experiments the vascular tone was artificially elevated by the 
inclusion of pharmacologically active agents in the perfusion fluid.
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2.8 ISOLATED RAT THORACIC AORTA PREPARATION.
The effect of acidosis on the tone of pre-contracted aortic rings was determined 
using this isolated tissue preparation.
Segments of thoracic aorta, from male Wistar rats (University of Bath, 250-300g), 
of about 0.5cm length were prepared as rings and mounted for isometric tension 
recording, under a resting tension of 2g, in a 10ml tissue bath containing 
Krebs-Henseleit solution saturated with 95% 0 2, 5% C02 at 37°C. Tissues were 
left to equilibrate for 30-45 minutes before starting the experiment. In experiments 
where tissues were pre-contracted with lOpM noradrenaline the tissue was allowed 
to equilibrate for a further 10 minutes after maximal contraction was achieved. In 
all experiments the integrity of the endothelium was tested by the addition of 
acetylcholine (lpM). Endothelial cell damage was assumed to have occured if less 
than 80% relaxation of the aortic strip was observed in response to the prefusion of 
lpM acetylcholine and these preparations were rejected. The tissues were then 
washed and, after a period of recovery, re-contracted with lOpM noradrenaline.
In addition, in some experiments an alternative physiological salt solution was 
used. The composition of this solution was (mM): NaCl 140; KC1 4.6; CaCl2 1.5; 
MgCl2 1.0; D-glucose 10.0; and HEPES 5.0. The perfusate was saturated with 
oxygen and the desired perfusate pH obtained by the addition of 1M HC1.
2.9 GUINEA-PIG TAENIA-COLI PREPARATION.
The guinea-pig taenia-coli preparation was used to determine any calcium- 
antagonist activity of cysteine.
Taenia preparations from the caecum of male guinea-pigs (University of Bath 
strain, 350-450g) were suspended in 10ml organ baths containing Krebs-Henseleit 
solution saturated with 95% 0 2, 5% C 02 at 37°C. Contractions were measured 
using a Devices isometric tension transducer connected to a Lectromed Multitrace 2 
chart recorder. All preparations were mounted under a resting tension of lg  and 
initially left to equilibrate for 30 minutes before changing the bath solution to a 
calcium-free Krebs-Henseleit solution for a further 30 minutes. Following this, 
calcium chloride (0-2700pM) was added cumulatively to the perfusion solution, the
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preparation allowed to recover in solution free of added calcium for 40 minutes 
and the addition of calcium chloride repeated. When assessing the effects of a 
drug on the contractile response to calcium, the drug was included in the 
perfusion solution for 20 minutes prior to the further addition of calcium.
2.10 ISOLATED RAT MYOCYTE PREPARATION.
Isolated ventricular myocytes were used to investigate the effect of selected 
agents on Na/K-activated pump current and free cytosolic calcium levels using 
appropriate electrophysiological and fluorometric techniques described in 
sections .
Isolated rat ventricular myocytes were prepared using an enzymatic procedure 
similar to that described by Powell and Twist (1976). Briefly, hearts from male 
Wistar rats (Bath University strain) weighing 250-300g were perfused at 37°C 
with a HEPES-Tyrode solution of the following composition (mM): NaCl 140; 
KC1 5.4; CaCl2 1.8; MgCl2 0.5; glucose 5.5; HEPES 5.0, adjusted to pH 7.4 with 
the required volume of 1M NaOH and saturated with 0 2. After 5 minutes the 
perfusate was switched to a HEPES-Tyrode solution free from added calcium 
("Ca2+-free" Tyrode) for a further 5 minutes. This Tyrode solution contained an 
undetermined level of contaminant Ca2+ from the water source and the analytical 
reagents used. At this point, 50mls of "Ca2+-free" Tyrode containing 20mg 
collagenase (EC 3.4.24.3, Type 1 from Clostridium histolyticum, Sigma, U.K) and 
lOmg protease (Pronase, Type XIV from Streptomyces griseusy Sigma, U.K) was 
perfused through the coronary circulation in a recycling mode for 15 minutes. A 3 
minute washout period with "Ca2+-free" Tyrode was then performed and the heart 
carefully removed from the cannula and placed in a petri-dish containing 
approximately 20mls "Ca2+-free" Tyrode. Both atria were removed and the 
remaining ventricular tissue cut with scissors into about 10 equal pieces. These 
were then individually teased apart using small tweezers and gently agitated to 
free individual myocytes. Excess tissue fragments were removed from the petri 
dish and discarded. 0.5ml of calcium-containing Tyrode was then added to the 
cell suspension and the cells viewed under low power using a Nikon inverted 
microscope. Cells remained viable for at least 6-8 hours, confirmed by 
trypan-blue exclusion. The proportion of rod-shaped:round cells was within
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50-60:1 immediately prior to and after the addition of calcium. Over the 
experimental time period (2-4 hours) the ratio of rods/round-shaped cells was 
maitained at 40-45:1.
2.11 ISOLATION AND PURIFICATION OF BOVINE VENTRICULAR Na/K 
ATPase.
An isolated Na/K ATPase preparation was utilized to investigate the effect of 
selected compounds on the activity of this intrinsic sarcolemmal protein.
To obtain purified bovine Na/K ATPase, ventricular tissue was processed by the 
method of Pitts and Schwartz (1975) which is described below.
2.11.1 Preparation of fragmented membranes.
Fresh bovine hearts (2.0-2.5 kg) were collected from the local abbatoir and 
transported back to laboratory on ice within 30 minutes. 200g of ventricular 
tissue, trimmed of excess fat, was roughly chopped and blended in a pre-chilled 
Waring blender for 30 seconds at low speed with 300 mis 0.25M sucrose, ImM 
Tris-EDTA (pH 7.0) [Sucrose-EDTA]. A further 300 mis of sucrose-EDTA was 
then added and the suspension homogenised for 45 seconds at high speed. 600 
mis of sucrose-EDTA was then added, mixed briefly, and the homogenate filtered 
through two layers of household muslin. The filtrate was then centrifuged at 12 
000 x g for 10 minutes (MSE High Speed 18 centrifuge). The resulting pellet was 
resuspended in 400 mis of sucrose-EDTA and blended for an additional 60 
seconds at low speed. 50 mis of sucrose-EDTA was used to washout the blender 
and the washings combined. 40 mis of 5% (w/v) sodium deoxycholate was added 
dropwise to the homogenate which was then stirred for 20 minutes and 
subsequently centrifuged at 96 000 x g for 25 minutes (Beckman L8-M 
ultracentrifuge, Ti-60 rotor). The supernatant was removed carefully, diluted to 
840 mis with ImM EDTA (pH 7.0) and centrifuged again at 96 000 x g for 90 
minutes (Beckman L8-M ultracentrifuge, Ti-60 rotor). The resulting pellet was 
then resuspended in 80 mis of ImM EDTA and stored overnight at -20°C. Poor 
sedimentation results in subsequent stages if the enzyme is not frozen at this
36
stage.
2.11.2 Sodium iodide treatment.
Fragmented membrane suspensions from 400g of ventricular tissue obtained from 
stage (i) of the enzyme preparation were pooled and washed with an equal 
volume of ImM EDTA and centrifuged at 40 000 x g for 30 minutes (Beckman 
L8-M ultracentrifuge, Ti-45 rotor). The resulting pellet was resuspended in a final 
volume of 120 mis in ImM EDTA. 30 mis of 6M Nal (containing 15mM EDTA 
and 150mM Tris base, pH 8.4) was added dropwise, stirred for 5 minutes, diluted 
with 240 mis ImM EDTA and centrifuged at 96 000 x g for 25 minutes 
(Beckman L8-M ultracentrifuge, Ti-45 rotor). The relatively soft pellet was 
retained and resuspended in 390 mis of 25mM imidazole-HCl, ImM EDTA (pH 
7.0) [imidazole-EDTA] and centrifuged at 96 000 x g for 20 minutes. The pellet 
(Nal-treated enzyme) was resuspended in 40 mis of imidazole-EDTA and after 
determination of protein content, by the method of Bradford (1976), adjusted to 
lOmg protein/ml.
2.11.3 Deoxycholate-citrate treatment.
To achieve a high yield of pure enzyme the ratio of detergent:protein at this 
preparative stage is critical. From the data of Pitts and Schwartz (1975) the 
optima of this ratio is approximately 0.67 mg deoxycholate/mg protein which was 
subsequently used in all preparations. 30 mis of Nal-treated enzyme (lOmg/ml) 
was added to a suitable tube and imidazole-EDTA added to give a total volume of 
34 mis. 22 mis of 1.5M sodium citrate was then added followed by 4 mis of 5% 
(w/v) deoxycholate, mixing briefly after each addition. The suspension was 
incubated at 0°C for 10 minutes and centrifuged at 150 000 x g for 15 minutes 
(Beckman L8-M ultracentrifuge, Ti-45 rotor). 40 mis of the supernatant was 
transferred to a tube containing 28 mis of imidazole-EDTA and centrifuged at 
150 000 x g for 20 minutes (Beckman L8-M ultracentrifuge, Ti-45 rotor). The 
supernatant from this stage was then transferred to a tube containing 46 mis of 
imidazole-EDTA and centrifuged at 150 000 x g for 60 minutes (Beckman L8-M 
ultracentrifuge, Ti-45 rotor). The pellet was resuspended in 40 mis of
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imidazole-EDTA and stored at 4°C. The specific activity of the preparation was 
determined as described in section 2.12.
2.12 ASSAY FOR Na/K ATPase ACTIVITY.
Na/K ATPase activities of enzyme preparations, prepared as previously described, 
were indirectly determined by continuously monitoring the oxidation of NADH at 
at 340nM and 37°C in a Cecil instruments dual-beam recording spectrophotometer 
using a linked-enzyme system (,Schwartz et al., 1969). Each cuvette contained 
(mM): MgCl2 5; NaCl 100; KC1 10; Tris-HCl (pH 7.4) 25; Tris-ATP 2.5; NADH 
0.5; phosphoenolpyruvic acid 2.5 and 0.02 ml of a combined pyruvate 
kinase-lactate dehydrogenase suspension (Sigma, U.K) in a final volume of 1.9 mis. 
Ouabain octahydrate (Sigma, U.K) was added in aqueous solution in a volume of 
0.02 ml to give a final concentration of 0-100pM. After appropriate temperature 
equilibration the reaction was started by the addition of the Na/K ATPase 
preparation in a volume of lOpl, equivalent to lOOpg of protein. Reaction rate was 
determined by drawing a tangent along the linear portion of the data and expressed 
as change in absorbance units/minute. This data was then converted to determine 
enzyme activity as units/mg protein. When assessing the ouabain-sensitivity of an 
enzyme preparation, a control rate in the absence of ouabain was inititally 
determined. This represents total ATPase activity. Ouabain (0-100pM) was then 
added and the % inhibition determined. Under control conditions (lOOmM Na+, 
lOmM K+), total, ouabain-sensitive and ouabain-insensitive ATPase activity was 
constant for at least 20 minutes. From the data of Schwartz et al. (1969) it is clear 
that substrate levels are not rate-limiting.
To examine the effect of a selected compound on total ATPase activity of a 
sarcolemmal Na/K ATPase preparation, the compound was added directly to the 
cuvette and any change in reaction rate monitored. In a separate group of 
experiments, the effect of the compound on the ouabain-insensitive fraction was 
determined by adding ouabain (final concentration 30pM) followed 3 minutes later 
by the compound in question and any change in reaction rate monitored. In two 
further group of experiments, to determine the effect of a compound on the 
ouabain-sensitive ATPase fraction, the total activity in the presence of the 
compound was determined. The ouabain-insensitive activity, following the 
application of 30pM ouabain, was calculated using a further sample of isolated
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enzyme. The data from each group of experiments (i.e. to determine the effect of a 
compound on total, ouabain-sensitive and ouabain-insensitive ATPase activity) was 
pooled and expressed as a mean value (±s.e.mean).
In all experiments where the effects of reduced glutathione were examined in the 
presence of GSSG, GSH was added following the establishment of a stable rate in 
the presence of GSSG.
Additional experiments were carried out prior to the collection of experimental 
data to validate the specifity of the assay with respect to sensitivity to ouabain, 
temperature, sodium concentration, pH and substrate availability. In view of the 
fact that the assay utilises a linked enzyme system the effect, if any, of any 
compound under investigation was studied on the activity of pyruvate kinase and 
lactate dehydrogenase using appropriate assay systems.
2.13 DEPLETION OF REDUCED GLUTATHIONE in vivo.
The reduction in myocardial reduced glutathione level by this method was utilized 
to investigate the role of cellular glutathione status on the onset of an 
ischaemically-induced contracture.
Diethylmaleate (DEM) is an alpha,beta-unsaturated carbonyl compound and a 
weak electrophile that reacts with reduced glutathione (GSH) in the presence of 
glutathione transferases (Younes and Siegers, 1980). Introduced by Boyland and 
Chausseaud in 1967, DEM is the most widely used depleting agent in this class 
and has been shown to reduce the hepatic GSH of rats by 80-94% at a dose of 
0.8ml/Kg (i.p) within 30 minutes of administration. In this set of experiments male 
Wistar rats (University of Bath strain, 250-350g) were dosed with DEM, 
(0.8ml/Kg, i.p), and sacrificed 30 minutes later. Hearts from these animals were 
then used for experimental purposes. Tissue levels of reduced and oxidised 
glutathione in control and treated hearts were determined spectrophotometrically as 
described in section 2.14.
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2.14 QUANTITATIVE DETERMINATION OF MYOCARDIAL REDUCED 
(GSH) AND OXIDISED (GSSG) GLUTATHIONE CONTENT.
Myocardial glutathione levels were determined using this method to enable the 
correlation of tissue glutathione status with the onset of ischaemic contracture.
Hearts were removed from the perfusion apparatus, blotted dry and weighed. The 
heart was finely chopped in a beaker containing 5 volumes 1% (w/v) picric acid and 
homogenised in a 10 ml Teflon hand-held homogeniser. The homogenate was 
transferred to a 15 ml centrifuge tube and centrifuged at high speed for 5 minutes 
(IEC centra-7 centrifuge). 5pl of the supernatant was assayed for GSH and GSSG 
content. In these experiments it was assumed that total glutathione=[GSH] + 2 x 
[GSSG] (Ferrari et a l, 1989),
For the assay of total tissue glutathione three working solutions were made up in a 
stock buffer of 125mM sodium phosphate and 6.3mM Na-EDTA adjusted to pH 
7.5. These 3 stock solutions were (i) 0.3mM NADPH/buffer, (ii) 6mM
5,5 *-dithiobis-(2-nitrobenzoic acid) (DTNB) and (iii) 50 Units/ml glutathione 
reductase (EC 1.6.4.2; Type ID from Bakers yeast, Sigma, U.K). To assay for total 
glutathione, 700pl of solution (i), lOOpl of solution (ii) and glutathione, sample or 
water to give a final volume of 1.0 ml were mixed in a 1 cm light path cuvette and 
equilibrated to 30°C. To the warmed solution lOpl of solution (iii) was then added 
and the absorbance at 412nM monitored continuously, in a Cecil Instruments 
dual-beam recording spectrophotometer, until it reached a value approaching 2. The 
rate of DNTB reduction was then evaluated from the linear portion of the data. The 
glutathione content of the aliquot was determined by comparison of the rate 
observed to a standard curve generated with known amounts of glutathione (0.1-3.0 
nmoles). The GSSG content of samples was determined by derivatisation of the 
GSH present with 2-vinylpyridine. 2pl of 2-vinylpyridine per lOOpl of protein-free 
supernatant was mixed vigorously for 1 minute and allowed to stand at room 
temperature for 60 minutes. 5pl of this solution was then assayed as above. The 
GSH was then determined by inference using the equation shown above.
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The following experimental techniques were all performed by the author 
under the supervision of Dr M. Shattock and Dr H. Matsuura at the 
Cardiovascular Research Department, The Rayne Institute, S t  Thomas’ 
Hospital, London, SE1 7EH.
2.15 MEASUREMENT OF Na/K PUMP CURRENT IN ISOLATED RAT 
MYOCYTES.
This technique was utilized to determine the effect of the intracellular and 
extracellular application of selected compounds on Na/K pump current in isolated 
rat ventricular myocytes.
2.15.1 cell isolation.
Ventricular cells were obtained from hearts of male Wistar rats (St/Thomas* 
Hospital strain, 250-350g) using an enzymatic procedure similar to that described 
by Powell and Twist (1976) which is described in detail in section 2.10.
2.15.2 Recording arrangements.
Na/K pump currents were recorded in isolated ventricular myocytes using the 
whole-cell voltage-clamp technique originally described by Hammill et al. (1981). 
The recording arrangement used was that already described by Matsuura and 
Shattock (1990a). Briefly, patch electrodes were made from glass capillaries (o.d 
1.5mm, i.d 1.0mm; Clark Electromedical Instruments, Reading, U.K). The 
electrode-puller itself was assumed to fire polish the electrodes sufficiently to 
obtain a high resistance seal between the tip and cell. Tip reistances were typically 
within the range 1-2 Mohm. The formation of a high resistance seal was confirmed 
by the reduction in voltage passing between the tip and cell. This was also 
confirmed by a reduction in an audio signal from the voltage-clamp amplifier. The 
apparatus and technique used for the intracellular dialysis and measurement of 
Na/K pump current in isolated rat ventricular myocytes are shown in figure 6a and 
6b. A hydraulic micromanipulator (MO-102, Narishige Scientific Instruments, 
Tokyo, Japan) was used to position the patch electrode near the cell and a tight 
seal (resistance 10 to 100 Gohm) was established between the electrode tip and the
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cell membrane by applying negative pressure (30 to 60 cmH20). The patch 
membrane was ruptured by a brief period of stronger suction. Current signals were 
recorded using an Axopatch 1-C single electrode voltage-clamp amplifier controlled 
by a microcomputer and pClamp software (Axon Instruments, Foster City, 
California, USA). All current records were filtered with a low-pass 500 Hz Bessel 
filter (cut-off -80 dB/decade) and were digitized at 1 KHz and stored on the 
computer hard disc. Membrane outward holding current was also recorded on 
slow-time base using a Gould two-channel pen recorder. All experiments were 
performed at room temperature (20-22°C).
2.15.3 Solutions used for measurements of Na/K pump currents.
Na/K pump currents were measured according to the method of Gadsby et al. 
(1985). Intracellular (pipette) sodium concentration was elevated to 30mM to 
maximally activate the Na/K pump and pipette solutions were formulated so as to 
block voltage-activated potassium channels and the Na/Ca exchange mechanism. 
The standard pipette soluton contained (mM): NaCl 30; CsOH 100; aspartic acid 
100; tetraethyl ammonium chloride (TEA) 20, MgCl2 2; ethylene-glycol- 
bis-A^V^/’/V’-tetraacetic acid (EGTA) 5; glucose 10, W-2-hydroxy-ethylpiperazine- 
A’-2-ethanesulphonic acid (HEPES) 10; adenosine triphosphate (Mg-salt) 5; 
creatine phosphate (Tris) 5, pH 7.2. The standard Tyrode solution used contained 
(mM): NaCl 140; CsCl 2; KC1 5; MgCl2 1; NiCl2 2; BaCl2 1; glucose 5.5; HEPES 
5, pH 7.4. The Ca-inward current was prevented by using a nominally Ca-free 
Tyrode solution and the possibilty of a Ba current through the voltage-gated Ca 
channel was prevented by the inclusion of 2mM NiCl2 (Shattock, MJ personnal 
communication). The Na current through voltage-gated channels was prevented by 
chosing an appropriate voltage protocol and potassium currents were blocked by 
replacing intracellular (pipette) potassium with Cs (lOOmM) and TEA (20mM). 
Na/Ca exchange current was inhibited by the inclusion of 2mM NiCl2 in the 
Tyrode solution and lOmM EGTA in the pipette solution.
2.15.4 Voltage protocols.
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Figure 6. A: Digramatic representation of the microelectrode set-up 
used for the intracellular dialysis of selected pharmacological 
agents in an isolated rat ventricular myoicyte. B: Diagramatic 
representation of the internal dialysis and measurement of N a/K  
pump cursrent in an isolated rat ventricular myocyte.
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current, a ramp voltage protocol was used which is shown diagramatically below. 
The protocol was sufficiendy slow, at 18mV/second, to give essentially a 
quasi-steady state current-voltage (I-V) relationship (,Shattock and Matsuura, 
1990b). A negative-going ramp (from +50 mV to -120 mV) was used in order to 
prevent activating the voltage-gated Na-channel.
2.15.5 Validation of the technique and characterization of Na/K pump current.
Prior to the use of this method to investigate the effect of various agents on Na/K 
pump current, experiments were undertaken by Dr. M Shattock and Dr. H 
Matsuura to validate the experimental technique. They have demonstrated exact 
similarity between the passive currents recorded in the absence of external 
potassium and those recorded in the presence of lOOpM ouabain suggesting that 
both interventions are eqi-potent in blocking the Na/K-pump current (ip). The Na/K 
pump current is defined, therefore, in these experiments as the K^-sensitive 
fraction of the total current recorded. This is more convienient than using the 
ouabain-sensitive fraction definition as the use of ouabain to block ip is more 
difficult to reverse than exposure to K-free Tyrode {Shattock and Matsuura, 
1990b).
2.15.6 Activation of Na/K pump current by intracellular sodium and extracellular 
potassium.
The relationship between [Na]j, [K]4 and ip was established by Drs. Shattock and 
Matsuura prior to the initiation of this set of experiments. This was performed by 
dialysing different cells with different pipette solutions containing a range of Na+ 
and K+ concentrations between 0 and 50mM and 0 and lOmM respectively. The 
sensitivity of ip to ouabain, extracellular K+ and intracellular Na+ and the similarity 
of these observations to previous studies {Gadsby et al., 1985; Nakao and Gadsby,
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1989; Stimers et al,, 1990) served to validate this experimental approach and, 
therefore, this technique was used to investigate the effect of selected 
sulphydryl-containing and disulphide compounds on Na/K pump current.
In experiments designed to investigate the effect of selected compounds on Na/K 
pump current the compound under investigation was either applied extracellularly 
or intracellularly by its inclusion in the perfusion fluid. Pump current recordings 
were made prior to and throughout the perfusion of the compound and during the 
following washout phase.
2.16 PREPARATION OF ISOLATED VENTRICULAR MYOCYTES FROM 
GSH-DEPLETED ANIMALS.
The effect of endogenous GSH on Na/K pump cuiTent was investigated by 
monitoring the effect of GSH-depletion on Na/K pump current in myocytes from 
control and DEM-treated animals.
In this set of experiments hearts were removed from male Wistar rats treated 30 
minutes previously with diethylmaleate (0.8 ml/Kg, i.p). Isolated ventricular 
myocytes were subsequently prepared from these hearts, as previously described 
in the methods (section 2.10), and the Na/K pump current measured in single 
cells. This was compared to the control Na/K pump current in cells from 
untreated hearts, compensating for cell surface area and cell capacitance.
2.17 THE USE OF HIDDEN METAL-CAPTURE REAGENT FOR THE 
MEASUREMENT OF Na/K ATPase ACTIVITY IN RAT MYOCARDIAL 
TISSUE.
The effect of ischaemia/reperfusion and selected compounds on the activity of 
this cation exchanger, was determined using this cytochemicaltechnique.
In this set of experiments the effect of 30 minutes global, low-flow myocardial 
ischaemia and 5 minutes subsequent reperfusion on rat myocardial Na/K ATPase 
activity in situ in tissue slices, in the presence and absence of reduced glutathione, 
was investigated. In addition control data was obtained from hearts that were not 
subjected to an ischaemic insult. The methodology used for these experiments
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was adapted from the technique described by Chayen et al. (1981).
Prior to the acquisition of experimental data, additional experiments were 
performed to validate the method with regard to sensitivity to ouabain, 
temperature, sodium concentration and substrate (ATP).
Hearts from male Wistar rats (University of Bath strain, 250-350g) were 
quick-frozen in ‘dry-ice7/i-hexane (Fisons, free from aromatic hydrocarbons). The 
tissue was sectioned at lOpM in a Bright’s ciyostat with an automatic cutting 
device to ensure consistency of section thickness. The cabinet temperature was 
maintained between -25 and -30°C and the knife cooled with ‘dry-ice’. Sections 
were picked off the knife and flash-dried onto glass slides. The method used to 
assay for Mg-activated Na/K ATPase activity was derived from Schwartz et al. 
(1969). The final reaction mixture contained the following reactants. A 40% 
solution (w/v) of Polypep 5115 (low viscosity, Sigma, U.K) was prepared in 0.2M 
Tris buffer (pH 7.4 at 37°C) containing ImM sodium acetate. The following 
reactants were then added sequentially: NaCl (24 mg/ml; 410mM); MgCl2 (4 
mg/ml; 20mM); KC1 (2.8 mg/ml; 37.5mM); disodium adenosine 5* triphosphate 
(10 mg/ml; 16.5mM). The lead ammonium citrate acetate complex (Sigma, U.K) 
was dissolved by constant shaking in the smallest volume of dilute ammonia (5 
drops 0.88 ammonia per ml) to give a final concentration of 32 mg/ml. The final 
pH was adjusted to pH 7.5 by the addition of a 10:1 mixture (on a molar basis) of 
sodium and potassium hydroxides or 0.1M HC1. In order to remove free 
phosphate, that would give a strong background colouration, the sections were 
first immersed for 5 minutes in a 40% (w/v) solution of Polypep 5115 (Sigma, 
U.K) in Tris buffer (pH 7.5 at 37°C), containing 0.1M potassium acetate. After 
this time the medium was sucked off and replaced by fresh medium. This was 
then removed and replaced by the full reaction medium to a depth of 2-3 mm. To 
contain the medium over the sample a small Perspex ring was placed around each 
section. The medium, slides and sections were all pre-warmed to 37°C before 
these procedures were commenced. The reaction was then allowed to proceed for 
15 minutes. After this time the sections were rinsed with several changes of 0.2M 
Tris buffer (pH 7.4 at 37°C) in Coplin jars, to remove any remaining Polypep 
media. They were then immersed for 1-2 minutes in water at room temperature 
that had been saturated with hydrogen sulphide. They were then rinsed several 
times with distilled water and allowed to dry. Sections were then mounted in
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glycerol/water (2:1) medium. The density of the lead sulphide reaction product 
was measured using a Vicker M85 microdensitometer with a X40 objective, at 
585nM and a flying spot of 0.5pM diameter in the plane of the section. Two 
succesive sections were fixed on one slide. In one set of sections, total ATPase 
activity was determined. At least 20 sections were cut from each heart. Ten 
readings from at least 10 cells per section were taken and a mean calculated. Data 
is expressed at mean integrated extinction x 100 (MIE x 100).
2.18 INDUCTION OF ACIDOSIS IN THE ISOLATED PERFUSED 
LANGENDORFF HEART MODEL.
The physiological respons of the coronary vasculature was investigated using the 
isolated perfused rat heart model.
Hearts from male Wistar rats (University of Bath strain) weighing 250-300g were 
perfused for a 15 minute equilibration period with a modified Krebs-Henseleit 
solution gassed with 95% 0 2, 5% C 02 at pH 7.4. and perfusion pressure, 
contractility and perfusion pressure continuously monitored as previously 
described in section 2.1. Acidosis was induced by perfusion with an acidotic 
Krebs- Henseleit solution. This had the same composition as the normal Krebs 
apart from the NaHC03 concentration which was reduced to give the desired pH 
within the range pH 7.2-6.8. Perfusion with acidotic Krebs-Henseleit solution was 
performed for 5 minutes and any changes in the criteria described above 
observed. A 10 minute washout period with normal Krebs-Henseleit buffer at pH
7.4 was then carried out. In experiments in which the effect of selected 
compounds on the physiological response of the heart to a reduction in pH were 
investigated, the compound under investigation was first pre-perfused for 5 
minutes at pH 7.4. The compound was then perfused for a further 5 minutes at 
pH 6.8 and the same physiological responses monitored. As in control 
experiments, a 10 minute washout period with Krebs-Henseleit solution was then 
carried out
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2.19 DETERMINATION OF CORONARY PERFUSATE LEVELS OF CYCLIC
GUANYLATE 5’ MONOPHOSPHATE (cGMP) BY RADIOIMMUNOASSAY.
Perfusate levels of cGMP in response to acidosis, in the presence and absence of 
cysteine, was investigated using a specific radioimmunoassay technique.
For these experiments a commercially available cGMP radioimmunoassay kit 
(Amersham International Ltd., Amersham, UK; code TRK.500) was used with 
Amprep™ triethylaminopropyl SAX (strong anion exchange) minicolumns for 
sample preparation (Amersham International Ltd., Amersham, UK; code 
RPN.1918).
The assay is based on the competition between unlabelled cGMP and a fixed 
quantity of tritium-labelled compound for binding to an antiserum which has a 
high specificity and affinity for cGMP. The amount of labelled cGMP bound to 
the antiserum is inversely related to the amount of cGMP present in the assay 
sample. Measurement of the antibody-bound radioactivity enables the amount of 
unlabelled cGMP in the sample to be calculated. Separation of the antibody- 
bound cGMP from the unbound nucleotide is achieved by ammonium sulphate 
precipitaion, followed by centrifugation. The precipitate, which contains the 
antibody-complex, is dissolved in water and its activity determined by beta liquid 
scintillation counting. The concentration of unlabelled cGMP in the sample is 
then determined from a linear standard curve. The detection limit of the assay is 
0.04 pmoles. Coronary perfusate levels of cGMP were determined under control 
conditions and in response to acidosis, in the presence and absence of selected 
compounds. After collection at selected time points, cGMP present in the 
perfusate samples was immediately absorbed onto individual pre-conditioned 
Amprep™ minicolumns which were refrigerated until all samples had been 
collected and the experiment terminated. At this point all samples were eluted off 
the columns and their cGMP content determined simultaneously. Krebs-Henseleit 
buffer was used as a negative control blank.
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2.20 DETERMINATION OF CORONARY PERFUSATE LEVELS OF
THROMBOXANE B2 BY ENZYME-LINKED IMMUNOASSAY (EIA).
The effect of acidosis, in the presence and absence of reduced glutathione, on coronary 
perfusate levels of the satble thromboxane A2 metabolite, thromboxane B2, was 
determined using a specific enzyme-linked immunoassay.
For these experiments a commercially available thromboxane B2 EIA kit was used 
(Cascade Biochem Ltd., Innovation Centre, Philip Lyle Building, University of 
Reading) by Ms. Amanda Taylor (The William Harvey Research Institute, Dept, of 
Biochemical Pharmacology, St.Bartholomew’s Hospital College, Charterhouse Square, 
London, EC1 6BQ) who performed the thromboxane B2 assays of coronary perfusate 
samples. Perfusate samples were prepared prior to assay. 2ml of coronary perfusate was 
mixed with 0.2 ml of IN formic acid resulting in the acidification of the solution to pH 
3. Four mis of ethyl acetate was then added and vortex mixed for 1 minute. The 
aqueous layer was then removed and the resulting organic fraction blown down to 
dryness with a stream of helium. The samples were then stored at -20°C prior to 
dispatch for thromboxane B2 assay.
The assay is based on the competition between free thromboxane B2 and 
acetylcholinesterase-linked thromboxane B2 tracer for limited specific rabbit antiserum 
binding sites. The rabbit antiserum-thromboxane B2 complex (free or tracer) then binds 
to a mouse monoclonal anti-rabbit antibody that is attached to an assay well. The plate 
is washed and Ellman’s reagent (5,5’-Dithio-bis-(2-Nitrobenzoic acid) added to the 
well. The acetylcholinesterase tracer cleaves the Ellman’s reagent to form a yellow 
compound (5-thio-2-nitrobenzoic acid) and the density of this chromophore is 
determined photometrically. The density of colour is proportional to the amount of 
tracer bound to the well, which is inversely proportional to the amount of free 
thromboxane B2 present in the well during the incubation. Samples were collected prior 
to, during the perfusion and the washout of selected interventions and their 
thromboxane B2 content determined. Data is expressed as pg thromboxane B2 
released/minute. The detection limit of the assay is 22.6 pg/ml of perfusate.
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2.21 DETERMINATION OF CYTOSOLIC FREE CALCIUM CONCENTRATION IN 
ISOLATED RAT VENTRICULAR MYOCYTES AND RABBIT PLATELETS.
The cytosolic free calcium concentration of rat ventricular myocytes and washed 
platelets, in response to various pharmacological agents, was measured using a Photon 
Technology International Inc. Deltascan fluorimeter in conjunction with the calcium- 
sensitive dye, fura-2.
2.21.1 Cell preparation and loading with fura-2.
Isolated rat ventricular myocytes, prepared using an enzymic procedure previously 
described (section 2.10), or washed rabbit platelets (section 2.22) were suspended in 4 
mis of HEPES Tyrode free from added calcium ("calcium-free" Tyrode) and incubated 
for 30 minutes at 37°C with 2.5pM fura-2 acetoxymethyl ester (Molecular Probes, 
Eugene, Oregon, U.S.A.). After incubation the cells were washed three times in 15 mis 
of "calcium-free" Tyrode and finally resuspended in 20 mis "calcium-free" HEPES- 
Tyrode.
2.21.2 Measurement of free intracellular calcium ([Ca]*).
2 ml aliquots of cells were dispensed into quartz cuvettes and calcium chloride added 
to give final concentration of ImM. Cuvettes were transferred to a Photon Technology 
Inc. Deltascan fluorimeter fitted with a thermostatted cuvette housing with stirring 
attachment for fluorescence reading at 37°C. Fura-2 is liberated from its methyl ester 
by cytosolic esterases inside the cell. Upon binding Ca2+, fura-2 undergoes both a 
change in fluorescence intensity and spectral shift. Leakage of fura-2 from the loaded 
myocytes was shown to be insignificant as determined by the undetectable change in 
fluorescence signal produced by the addition of ImM Ni+. For our purposes, fura-2 
fluorescence was continuously monitored using monochromator settings of 339nM and 
380nM (excitation) and 410nM and 510nM (emission). The Fmax was determined by 
lysing the cells with 40-50pM digitonin, thereby exposing the fura-2 to total 
intracellular Ca2+. F ^  was determined by adjusting the pH of the cell medium to 8.5 
with 40pl of 2M NaOH followed by the addition of 120pl of lOmM EGTA. No 
correction was made for the background fluorescence of the myocytes. Fluorescence
49
readings were converted by an on-line microcomputer (NEC Powermate 286) with 
dedicated Deltascan software (PTI Instruments Inc., U.S.A) to display real-time [Ca^ 
by use of equation 2 (Grynkiewicz et al., 1985).
where R = [signal Al/signal\2], IQ = dissociation constant for fura-2 = 224nM (Roe et 
al., 1990), V = viscosity coefficient = 1 (for aqueous solutions).
Cells were allowed to equilibrate at 37°C for 2 minutes before compounds or vehicle 
under investigation were added direcdy to the cuvette.
2.22 ISOLATED WASHED PLATELET PREPARATION FROM WHOLE RABBIT 
BLOOD.
Blood was obtained by venepuncture from male New Zealand white rabbits (body 
weight 1.0-1.5 Kg) and mixed with 3.2% (w/v) trisodium citrate (lml/9ml of blood) as 
an anticoagulent. This blood was then centrifuged (1500 r.p.m, 10 minutes, IEC 
centra-7 centrifuge) and the supernatant (platelet-rich plasma, PRP) aspirated into 
plastic tubes. Plasma-free suspensions of platelets were then prepared. 150pl of 112pM 
prostacyclin was added to 20 ml aliquots of PRP and centrifuged (3000 r.p.m, 10 
minutes, IEC centra-7 centrifuge). The purpose of the prostacyclin was to inhibit 
platelet aggregation during cell preparation. The supernatant was discarded and the 
pellet resuspended in 4 mis of HEPES-Tyrode of the following composition (mM): 
NaCl 0.14; HEPES 10; MgCl2 2; NaH2P 04 0.6; KC1 5. BSA (2.5g/L) and D-glucose 
(lg/L) was added immediately prior to use. It was at this stage that the cells were 
loaded with the calcium sensitive dye, fura-2 acetoxymethylester (2.5pM, 30 minutes), 
for the measurement of free cytosolic calcium levels (section 2.21.2). Following fura-2 
loading the cell suspension was centrifuged at 3000 r.p.m and the pellet resuspended in 
3mls of HEPES-Tyrode and 50pl of 112pM prostacyclin. Two further washes with 





Results are expressed as the mean ±  standard error of the mean. Statistical differences 
between means were assessed using a one way analysis of varience followed 




ANTIOXIDANTS ON NORADRENALINE 
RELEASE AND CONTRACTURE IN THE 
ISCHAEMIC/REPERFUSED RAT HEART.
3.1 NORADRENALINE RELEASE FROM THE ISOLATED PERFUSED RAT 
HEART DURING 60 MINUTES, 30 MINUTES AND 20 MINUTES OF 
GLOBAL, LOW-FLOW ISCHAEMIA AND 5 MINUTES SUBSEQUENT 
REPERFUSION.
In view of the arrhythmogenic action of noradrenaline (Daugherty et al., 1986) and 
the corresponding antiarrhvthmic action of reduced glutathione and other free 
radical scavengers and antioxidants {Woodward and Zakaria, 1985), experiments 
were undertaken to investigate whether these compounds exert their antiarrhythmic 
action by attenuating ischaemically-induced noradrenaline release.
There was no significant increase in noradrenaline release from the myocardium 
during the first 20 minutes of an ischaemic insult, whereas 30 and 60 minute 
periods of global, low-flow ischaemia (90% flow reduction from a control rate of 
lOml/minute) resulted in a significant increase in noradrenaline release above 
control levels (figures 7,8,9). Pacing the hearts at 300 beats per minute had no 
significant effect on noradrenaline release during the pre-ischaemic phase or during 
ischaemia and reperfusion. Noradrenaline release upon subsequent reperfusion was 
dependent on the length of the preceding ischaemic period (figure 7,8,9). Typical 
responses of perfusion pressure, developed tension and heart rate during a 60 
minute ischaemic period and 5 minutes subsequent reperfusion are illustrated in 
figure 10. An apparent rapid decline in heart rate is due to a concomitant decrease 
in contractility which fails to trigger the heart rate meter. Following the onset of 
ischaemia there was an increase in resting tension. The time to the onset of this 
ischaemically-induced contracture and the time for this contracture to plateau was 
recorded and this data is shown in table 1.
3.2 THE EFFECT OF REDUCED GLUTATHIONE, VERAPAMIL AND A 
SUPEROXIDE D IS MUT AS E/C AT ALA S E/M ANNITOL COCKTAIL ON 
NORADRENALINE OVERFLOW DURING ISCHAEMIA AND SUBSEQUENT 
REPERFUSION.
In this set of experiments, the concentration of radical scavengers and antioxidants 








Figure 7. Effect of 20 minutes global, low-flow ischaemia and 5 
minutes subsequent reperfusion on noradrenaline release from the 
isolated perfused rat heart. Hearts were paced at 300 b.p.m and the 
ischaemic and reperfusion periods initiated at the points indicated. 
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Figure 8. Effect of 30 minutes global, low-flow ischaemia and 5 
minutes subsequent reperfuison on noradrenaline release from the 
isolated perfused rat heart. Hearts were paced at 300 b.p.m and the 
ischaemic and reperfusion periods initiated at the points indicated. 
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Figure 9. Effect of 60 minutes global, low-flow ischaemia and 
5 minutes subsequent reperfusion on noradrenaline release 
from the isolated perfused rat heart. Hearts were paced at 300 
b.p.m and the ischaemic and reperfusion periods initiated at 
the points indicated. Vertical bars represent +s.e.mean. (n=6,
























Figure 10. Typical trace showing the effect of 60 minutes global, low-flow 
ischaemia and 5 minutes subsequent reperfusion on coronary perfusion 
pressure, cardiac contractility and heart rate in the isolated perfused rat heart. 
The time to the onset and maximal contracture were calculated from the onset 
of ischaemia to the points marked 'onset1 and 'maximal'.
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controls 6 7.6+0.2 15.3+0.2
captopril ImM 4 9.6+0.28* 19.3±2.08*







L-cysteine ImM 4 10.1+0.2* 19.8+0.95*
IOOjiM 4 9.5+0.7* 20.5+0.7*
L-glycine ImM 4 7.4+0.3 15.6+0.5
L-glutamate ImM 4 7.3+0.2 15.5+0.4
L-cystine ImM 3 6.1+0.3* 12.9+0.5*
L-methionine ImM 3 7.1+0.2 15.0+0.2
reduced
dithiothreitol
ImM 3 10.2+ 1.6* 18.6+1.5*
L-penicillamine ImM 4 9.8+0.8* 18.6+2.3*
oxidised
glutathione
ImM 4 6.0+0.2* 13.5±1.0*
reduced
glutathione
ImM 8 10.1+0.3* 18.1+0.5*
verapamil 15nM 6 9.3+0.5* 16.2+0.3*




Table 1. The effect of various pharmacological agents on the time to the onset 
and maximal contracture in the low -flow  (90% flow reduction from a pre- 
ischaemic flow  rate of 10ml/m inute), globally ischaemic, isolated perfused rat 
heart. (n=3-8 hearts/group, * p<0.05 cw  controls)
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perfused rat heart (Woodward & Zakaria, 1985). ImM reduced glutathione 
(GSH) had no significant effect on noradrenaline overflow from the isolated rat 
heart during both the control, ischaemic and reperfusion phase of the 
experiment. In addition, a cocktail of superoxide dismutase/catalase/mannitol 
(10 Units/ml, 300 Units/ml and 50mM respectively) had no significant effect on 
the profile of noradrenaline overflow during 60 minutes ischaemia and 5 
minutes subsequent reperfusion (figure 11). The perfusion of ImM reduced 
glutathione resulted in a significant coronary dilation equivalent to 30±2.5 
mmHg. As a result, the effect of the L-type calcium channel antagonist 
verapamil (15nM), which causes a similar coronary vasodilator response to 
ImM GSH, was investigated in this model. In common with ImM GSH, 15nM 
verapamil had no significant effect on noradrenaline overflow during 60 minutes 
myocardial ischaemia and 5 minutes subsequent reperfusion.
3.3 THE EFFECT OF ENDOGENOUS NORADRENALINE DEPLETION ON 
AN ISCHAEMICALLY-INDUCED CONTRACTURE IN THE ISOLATED 
RAT HEART.
To investigate the possible involvement of noradrenaline release from the rat 
myocardium in the initiation and/or the progression of an ischaemic contracture 
observed in this model, the physiological responses of hearts previously 
chemically-depleted of noradrenaline (section 2.4) to an ischaemic insult were 
studied. The depletion protocol used resulted in a reduction of myocardial levels 
of noradrenaline by 91.4±0.1% (figure 12). Following a 20 minute ischaemic 
period and 5 minutes reperfusion, tissue levels of noradrenaline were reduced by 
a further 7% representing a loss of 800 pmoles of noradrenaline during the 
ischaemia/reperfiision insult (Table2a). Table 2b. shows that the time to the 
onset of contracture in noradrenaline-depleted hearts was significantly increased 
compared to the response of hearts from control, untreated animals.
3.4 THE EFFECTS OF REDUCED GLUTATHIONE, A SUPEROXIDE 
DISMUTASE/ CATALASE/ MANNTTOL COCKTAIL, VERAPAMIL AND 
OTHER SELECTED COMPOUNDS ON AN ISCHAEMICALLY-INDUCED 
CONTRACTURE IN THE ISOLATED PERFUSED RAT HEART.
The effect of the compounds used in the noradrenaline overflow experiments on
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Figurell. Effect of reduced glutathione (ImM), verapamil (15nM) 
and a superoxide dismutase (SOD) (10 units/ml)/catalase (CAT) 
(300 units/ml)/mannitol (MAN) (50mM) cocktail on noradrenaline 
release from the isolated perfused rat heart during 60 minutes 
global, low-flow ischaemia and 5 minutes subsequent reperfusion. 
Vertical bars represent +s.e.mean. (n=6, *pAO-05!)
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GROUP n non-ischaemic 20 minutes ischaem ia/5
minutes reperfusion
Tissue noradrenaline (nm oles/g wet weight tissue).
control, untreated 6 11.4+0.2 10.45+0.3*
hearts







control untreated 6 7.6+0.2 15.3+0.2
hearts
6-hydroxydopamine 5 9.0+0.1* 16.2+0.3*
treated hearts
Table 2. A: Tissue noradrenaline levels in control and 6-hydroxydopamine 
treated animals under control conditions and following 20 minutes global, 
low-flow ischaemia and 5 minutes subsequent reperfusion. (n=5-6, *p<0.05 
cw  respective controls). B: Effect of myocardial noradrenaline depletion with  
6-hydroxydopamine (50m g/kg, i.v 17-24 hours pre-sacrifice) on the time to 
the onset and maximal ischaemically-induced contracture in the isolated 
perfused rat heart. (n=5-6, *p<0.05 cw  respective controls).
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an ischaemically-induced contracture are shown in table 1. Reduced glutathione 
(ImM), a superoxide dismutase/catalase/mannitol cocktail (lOUnits/ml, 300Units/ 
ml and 50mM respectively) and verapamil (15nM) all significantly delayed the 
onset and time to maximal contracture in this model. The concentrations of free 
radical scavengers and antioxidants used were those previously shown to attenuate 
the incidence of reperfusion-induced arrhythmias in the isolated rat heart model 
(Woodward and Zakaria, 1985). The effect of compounds related to GSH 
(L-cysteine, L-glycine, L-glutamate, L-cystine, reduced dithiothreitol, L- 
penicillamine, captopril, L-methionine and oxidised glutathione (GSSG)) on an 
ischaemic contracture were also investigated and the data from these experiments 
are shown in table 1. The sulphur-containing, non-sulphydryl amino acid, 
L-methionine, had no significant effect on the time to onset or maximal 
contracture. However, all the compounds containing a free sulphydryl group 
significantly delayed the onset and the time to maximal contracture. This is in 
contrast to the effects of oxidised glutathione and cystine which both significantly 
reduced the time to the onset of the contracture.
3.5 THE EFFECT OF ENDOGENOUS GLUTATHIONE DEPLETION ON AN 
ISCHAEMICALLY-INDUCED CONTRACTURE IN THE ISOLATED RAT 
HEART.
In view of the ability of exogenous reduced glutathione to significantly delay the 
onset and time to maximal contracture in the ischaemic rat heart, the role of 
endogenous glutathione in the protection against ischaemic contracture was 
investigated. This was approached by the chemical depletion of endogenous 
glutathione using diethylmaleate (section 2.13) and comparison of the physiological 
response of these hearts to ischaemia with the response of hearts from untreated 
animals. Time-matched controls to assess changes in basal myocardial glutathione 
levels in response to perfusion in the presence and absence of an ischaemic insult 
were also used. Data from these experiments are shown in table 3a The protocol 
used for the depletion of endogenous glutathione (section 2.13) resulted in 
reduction of total and reduced glutathione with no recordable change in tissue 
content of oxidised glutathione (table 3b). The inability to determine a change in 
GSSG levels may be due to the insensitivity of the assay system. This resulted in a 





(|im ol/g  wet weight tissue)
untreated
controls
1.6±0.09 0.013±0.009 1.55+0.07 125.6
30 mins post 
DEM
0.36±0.06* 0.014+0.007 0.34+0.05* 27
60 mins post 
DEM
0.32+0.05* 0.015+0.005 0.29±0.04* 23
20 min non 
ischaemic 
perfusion
0.52±0.02+ 0.014+0.002 0.4+0.03+ 28
20 min 
ischaem ic/5  
min 
reperfusion
0.40±0.03+ 0.010±0.01 0.23+0.02+ 10
Table 3a,b. Effect of diethylmaleate (0.864 g /k g  i.p 30 or 60 minutes pre-sacrifice) 
or 20 minutes global low-flow ischaemia and 5 minutes subsequent reperfusion 






control untreated 6 7.6+0.3 15.5+0.4
hearts
glutathione- 5 6.2+0.2* 13.1+0.2*
depleted hearts.
Table 4. Effect of endogenous myocardial glutathione depletion, using 
diethylmaleate (0.8ml/kg i.p, 30 minutes pre-sacrifice), on the time to the 
onset and maximal contracture in the isolated perfused rat heart. (n=5-6 
hearts/group, *p<0.05 cw controls).
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seen following an ischaemic insult {Ferrari et al., 1989). The depletion of 
endogenous glutathione using this protocol also resulted in a significant shortening 
of the time to the onset and maximal contracture following the onset of ischaemia 
(table 4).
3.6 THE EFFECT OF SUPEROXIDE PRODUCTION USING THE XANTHINE/ 
XANTHINE OXIDASE SYSTEM ON AN ISCHAEMICALLY-INDUCED 
CONTRACTURE IN THE ISOLATED RAT HEART.
The effect of free radicals on the ischaemically-induced contracture seen in this 
model was investigated using the xanthine/xanthine oxidase system that results 
primarily in the production of the superoxide radical (0 2-‘). Superoxide production 
in this set of experiments was confirmed by the detection of uric acid throughout 
the entire length of the experimental time course {Xie et al., 1990). In addition, the 
effect of exogenous superoxide dismutase or GSH on the effects of 0 2-  in this 
model was investigated. Neither xanthine, xanthine oxidase nor the ammonium 
sulphate vehicle in which the xanthine oxidase was suspended had any significant 
effect on the time to the onset of the ischaemic contracture. However, a bolus 
injection of 0.65 units of xanthine oxidase in the presence of ImM xanthine, 5 
minutes prior to the onset of the ischaemic insult, resulted in a significant 
shortening of the time to the onset of contracture. The perfusion of either 50 
units/ml of superoxide dismutase or ImM reduced glutathione throughout the 
experimental time course resulted in a significant attenuation of the combined
3.7 EFFECT OF REDUCED GLUTATHIONE ON 86RUBIDIUM EFFLUX 
DURING MYOCARDIAL ISCHAEMIA AND SUBSEQUENT REPERFUSION.
To investigate a possible mechanism by which reduced glutathione is 
antiaiThythmic (Woodward and Zakaria, 1985) and delays the onset of an 
ischaemically-induced contracture, its effect on the efflux of radiolabelled rubidium 
(86Rb), as a marker for potassium, from pre-labelled hearts during 30 minutes 
ischaemia and 5 minutes subsequent reperfusion was examined. Data is expressed 
as efflux rate coefficient against time (erc/minute) (see section 2.6). During the 











Im M  xanthine 
controls
4 8.0+0.3 15.9±0.4















xan th in e/0.65 
units xanthine 
oxidase/50  
u n its/m l SOD
5 7.6+0.4 15.3+0.4
Table 5. Effect' o f xanthine/xanthine oxidase (ImM and 0.65 units, respectively), 
in the presence and absence of reduced glutathione (GSH) (ImM) or superoxide 
dismutase (SOD) (50 units/m l), on the time to the onset and maximal 
contracture in the low -flow , globally ischaemic isolated rat heart. (n=4-5 
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Figure 13. Effect of reduced glutathione (GSH) (ImM) and flow rate on the 
peak 86rubidium efflux coefficient during 30 minutes global, low-flow 
ischaemia in the isolated perfused rat heart Vertical bars represent ±s.e.mean. 
(n=4. *p<0.05 cw controls).
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Figure 14. Effect of reduced glutathione (GSH) (ImM) and flow rate during 30 
minutes global, low-flow myocardial ischaemia on the peak 86rubidium efflux 
rate coefficient (erc/minute) upon subsequent reperfusion in the isolated 
perfused rat heart Vertical bars represent ±s.e.mean. (n=4, *p<0.05 cw 
controls).
from a pre-ischaemic value of 10 ml/minute. There was no correlation between the 
degree of flow reduction and the maximum efflux coefficient during the ischaemic 
period (figure 13). However, the maximum erc/minute value achieved upon 
reperfusion was dependent on the degree of flow reduction during the preceding 
ischaemic phase (figure 14). The addition of ImM reduced glutathione to the 
perfusate during ischaemia had no effect on the maximum erc/minute achieved 
(figure 13) whereas it reduced the peak erc/minute value upon reperfusion when the 
flow rate in the preceding ischaemic insult was reduced by 90 or 95% (figure 14). 
The effects of reduced glutathione on the mean efflux area during ischaemia and 
subsequent reperfusion were also assessed and this data is shown in figures 15 and 
16. ImM GSH reduced the mean efflux area only when the flow rate was reduced 
by 95% during the ischaemic period and during reperfusion when the flow was 
reduced by either 90 or 95% during the preceding ischaemic period. This data 
suggests a potassium sparing action of reduced glutathione in this model. (N.B 
peak erc/minute and mean efflux area were determined as outlined digrammically 
in figure 5a. Mean efflux area is expressed in arbitary units).
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Figure 15. Effect of reduced glutathione (GSH) (ImM) and flow rate on the 
mean 86rubidium efflux area during 30 minutes global, low-flow ischaemia in 
the isolated perfused rat heart Vertical bars repesent ±s.e.mean. (n=4, *p<0.05 
cw controls). Mean efflux area corresponds to the mean area under the plots 
of erc/minute during the ischaemic period (see figure 5b).
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Figure 16. Effect of reduced glutathione (GSH) (ImM) and flow rate 
during 30 minutes global, low-flow ischaemia on the mean 86rubidium 
efflux area during 5 minutes subsequent reperfusion in the isolated 






With a view to studying how free radical scavengers attenuate the incidence of 
reperfusion-induced arrhythmias (Woodward and Zakaria, 1985), the effect of 
reduced glutathione, selected free radical scavengers and the L-type calcium 
antagonist, verapamil, on noradrenaline overflow from the ischaemic myocardium 
was examined. None of the free radical scavengers or verapamil significantly 
reduced noradrenaline release during ischaemia or reperfusion at previously 
determined antiarrhythmic concentrations {Woodward and Zakaria, 1985). 
However, the contracture which occurred in response to an ischaemic insult was 
attenuated by several of the compounds studied. In light of these results, further 
experiments were undertaken to investigate how these compounds delay the onset 
of this ischaemic contracture, while 86Rubidium efflux experiments were used to 
investigate whether GSH exerts an antiarrhythmic, potassium-sparing action during 
ischaemia and reperfusion. Reduced glutathione significantly attenuated 86Rb efflux 
during ischaemia and reperfusion raising the possibility that the Na/K pump or 
other sarcolemmal potassium channels (eg ATP-dependent K+ channels) are 
modulated by reduced glutathione and related compounds that may contribute to its 
potassium-sparing, antiarrhythmic action.
During the early phases of an ischaemic period, there is a reduction in the ability of 
the myocardium to maintain ionic homeostasis. Intracellular [Na+], [H+] and [Ca2+] 
rise simultaneously within the first 5 minutes of ischaemia, whilst K+ is lost from 
the cell in a biphasic manner (Weishaar et al., 1979; Cobbe and Poole-Wilson, 
1980; Hirche et al., 1980). In addition, there is a reduction in cellular ATP 
([Jennings et al., 1981) and an accumulation of cAMP (Lubbe et al., 1981; Opie,
1982) which correlate with an increase in [Ca]j and the onset of contracture. There 
is also evidence for the mobilization of endogenous noradrenaline during ischaemia 
(Mathes and Gudbjarnason, 1971; Holmgren et al., 1981; Muntz et al., 1984), 
while on reperfusion and re-oxygenation of a previously ischaemic myocardium, 
cardiac reserves of noradrenaline are further depleted (Riemersma and Forfar, 
1982; Abrahamsson et al., 1983) and the noradrenaline content of the coronary 
circulation is raised (Abrahamsson et al., 1983; Nayler and Sturrock, 1983). 
Noradrenaline has several effects on the myocardium including stimulation of 
oxygen consumption (Rolett, 1974), constriction of the coronary vasculature (Pace,
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1977; Borda et al., 1980), production of oxygen free radicals via autoxidation 
(Del Maestro, 1980) and the generation of arrhythmias (Opie and Thandroyen,
1983). The mechanisms implicated in the genesis of reperfusion-induced 
arrhythmias are all mediated by the establishment of chemical and electrical 
gradients caused by the accumulation of metabolites in the ischaemic myocardium 
(Surawicz, 1971). Arrhythmogenic mechanisms, which are outlined in figure 17, 
include an increase in [cAMP]j (Podzuweit et al., 1978), lysophosphatide 
formation (Corr and Sobel, 1982), free radical production (Manning and Hearse, 
1984; Woodward and Zakaria, 1985; Bernier et al., 1986), alpha- and 
beta-adrenoceptor stimulation (Sheridan et al., 1980; Bralet et al., 1985; Bartel et 
al., 1986) and disturbances in sodium (Kleber and Wilde, 1986), calcium (Clusin 
et al., 1982) and potassium homeostasis (Curtis et al., 1986; Lubbe et al., 1986). 
There is also evidence to suggest that adrenergic activation increases the size of 
the ischaemic area (Waldenstrom et al., 1978). The arrhythmogenic action of 
catecholamines during myocardial reperfusion suggests that adrenergic receptor 
stimulation may be involved in this action. Catecholamine autoxidation and the 
resulting production of free radicals and adrenochrome, a metabolite of 
noradrenaline, may also contribute to the damaging effects of noradrenaline 
release during reperfusion (Yates et al., 1981). It is, therefore, undesirable if 
noradrenaline reserves are mobilized, particularly if this occurs during ischaemic 
acidosis (Cobbe arid Poole-Wilson, 1980) and reduced coronary flow which will 
reduce its rate of removal from the myocardium.
The protective role of reduced glutathione, a superoxide dismutase/catalase/ 
mannitol cocktail and verapamil during ischaemia was investigated with respect 
to their effect on myocardial noradrenaline release and uptake. Noradrenaline 
release during 60 minutes of global, low-flow ischaemia and 5 minutes 
subsequent reperfusion was unaffected by GSH and, therefore, it seems unlikely 
that GSH exerts its antiarrhythmic effect by directly attenuating ischaemically- 
induced noradrenaline overflow. In the light of these investigations, it would also 
seem that GSH has no effect on the neuronal uptake mechanism for noradrenaline 
that is inhibited during ischaemia (Schdmig et al., 1982). Stimulation of this 























Figure 17. Diagramatic representation of factors involved in myocardial 
ischaemia/reperfusion-induced arrhythmogenesis, intracellular calcium overload and 
loss of cellular function.
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noradrenaline during ischaemia. There is the further possibility that GSH and the 
other compounds studied may scavenge oxygen free radicals derived from 
catecholamines released under these conditions in the absence of any direct effect 
on noradrenaline release itself. If this is true then the production of adrenochrome 
would be reduced in the presence of free radical scavengers. At the present time 
there is no evidence to support this hypothesis. In addition, the contribution of this 
source of free radicals to the initiation of reperfusion-induced arrhythmias is 
unclear. In agreement with other groups (Gauduel et al., 1979; Nayler and Scott, 
1982), cellular catecholamine depletion with 6-hydroxydopamine was found to be 
protective in that it significantly delayed the onset of an ischaemically-induced 
contracture. However, the amount of noradrenaline released from depleted hearts 
was not significantly different from that of the control, untreated hearts. In view of 
the fact that the protocol used for noradrenaline depletion resulted in only 
91.4±0.1% depletion, the remaining 10% must be sufficient to account for 
ischaemically-induced noradrenaline overflow.
In view of the negative data from this set of experiments, it is likely that GSH 
exerts its antiarrhythmic action via another mechanism. The present investigations 
suggest a potassium-sparing action of GSH, which may be antiarrhythmic in view 
of the pro-arrhythmic effect of an elevated potassium concentration upon 
reperfusion of a previously ischaemic myocardium. 86Rubidium efflux was 
dependent on the length of the ischaemic insult and the degree of flow reduction 
during this phase which may represent a correlation between the severity of an 
ischaemic insult and the degree of specific and non-specific cell damage to the cell 
membrane, intracellular organelles and membrane-bound ion pumps. However, this 
experimental data does not indicate whether the 86Rb loss during reperfusion 
represents the washout of 86Rb accumulated during the ischaemic phase or that 
released as a result of the restoration of flow. It is also impossible to determine 
whether the net 86Rb loss represents a reduced uptake or an increase in actual 
efflux. There is no indication as to whether GSH attenuates 86Rb loss due to the 
reperfusion phase itself or if it simply attenuates 86Rb efflux during ischaemia. 
One experimental approach that may help resolve this anomaly would be to 
monitor myocardial lactate release during ischaemia and reperfusion. Lactate and
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potassium are both released during myocardial ischaemia. Lactate is not released 
as a direct result of reperfusion and, therefore, lactate detected in the perfusate 
during reperfusion will represent washout of lactate accumulated during the 
preceding ischaemic phase. Differences in the profile of lactate and 86Rb efflux 
may help to determine if 86Rb, and therefore potassium, is released as a result of 
reperfusion or whether it is simply washout of 86Rb released during ischaemia. 
Although the Na/K pump was targetted as a potential site for the action of GSH 
and related compounds, there is the possibility that potassium loss from the 
ischaemic myocardium may also occur as a result of changes in the activity of one 
or more of the various potassium channels in the heart, such as the ATP-sensitive 
K+ channels (Noma et al., 1983). The sensitivity of the ischaemic/reperfusion- 
induced 86Rb efflux to ouabain and TEA, for example, would be an experimental 
approach by which potassium loss via alternative potassium channels could be 
investigated.
The initiation of global, low-flow myocardial ischaemia resulted in a reduction in 
cardiac contractility and an ischaemically-induced contracture of the myocardium. 
It is clear from the results that reduced glutathione significantly delayed the onset 
of this contracture and so investigations were extended to include other compounds 
containing a free sulphydryl group. Cysteine, captopril, reduced dithiothreitol 
(DTTred,) and penicillamine (PSH) all significantly delayed the onset of contracture 
in response to ischaemia. This is in contrast to the effect of the sulphur-containing, 
non-sulphydryl amino acid, L-methionine, which had no significant effect. The 
pre-prefusion of ImM reduced glutathione, cysteine, DTTred or PSH resulted in a 
significant reduction in perfusion pressure of 30±2.5, 25.5±2.2, 28±3.5 and 20±2.2 
mmHg, respectively, that is indicative of coronary vasodilation in this model. The 
concentration of verapamil that caused the same degree of coronary dilation 
(15nM) was, therefore, used as a non-sulphydryl control. Verapamil was also 
found to have no significant effect on noradrenaline overflow during ischaemia or 
reperfusion, yet it also significantly delayed the onset of myocardial contracture 
during the ischaemic phase. The presence of a free sulphydryl group is, therefore, 
not a requirement for a compound to attenuate an ischaemic contracture. Nayler 
and Sturrock (1985) showed that dihydropyridine-type calcium antagonists
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attenuated the loss of cardiac noradrenaline during reperfusion following relatively 
short periods of ischaemia. However, Nayler and Sturrock (1985) and other groups 
(Bourdillon and Poole-Wilson, 1982\ Higgins and Blackburn, 1984) failed to show 
an attenuation of ischaemia-reperfusion induced loss of noradrenaline with 
verapamil and diltiazem which is in agreement with the data presented here. In fact, 
when added just at the time of reperfusion, verapamil and diltiazem potentiated 
noradrenaline loss (Nayler and Sturrock, 1985). Recently, Richardt et al., (1991) 
have reported on the ability of the L-type calcium channel antagonists verapamil, 
gallopamil, nifedipine and felodipine to attenuate the loss of noradrenaline from rat 
myocardium during reperfusion following a 20 minute period of global, no-flow 
ischaemia. The methodology used by this group differs from that used in the 
experiments described here with respect to the relatively low perfusate flow rate 
and that no-flow ischaemia was used. Because of this, coronary effluent was not 
collected or analysed during the ischaemic phase. In addition, the concentration of 
verapamil used by this group was O.Ol-lOOpM, with an IC50 of lpM, in contrast to 
15nM used in the experiments described here. In view of this data, a verapamil 
concentration of 15nM would not be expected to attenuate ischaemically-induced 
noradrenaline loss from the myocardium.
Ischaemic contracture has also been reported to be dependent on cellular ATP 
content such that contracture is initiated at concentrations below approximately 12 
pmoles/g dry weight (Hearse et al., 1977). GSH may attenuate a fall in tissue ATP 
content preventing the activation of ATP-dependent K+ channels that would 
attenuate potassium loss during ischaemia. Talesnik and Tsoporis (1984) have 
shown that GSH protects against oxidant-induced damage to ATP-dependent 
microsomal Ca2+ sequestration in the guinea-pig and rat heart, which may represent 
an alternative method by which GSH delays the onset of ischaemic contracture. 
From the present investigations, the site of action of GSH is uncertain.
These experiments were negative in the respect that all of the interventions chosen 
failed to significantly attenuate noradrenaline release from the isolated rat heart 
during ischaemia and subsequent reperfusion. However, they provided evidence for 
the protective role of reduced glutathione and other sulphydryl compounds against 
ischaemically-induced myocardial injury. In light of the results, further work was
79
initiated to investigate potential mechanisms by which these compounds attenuate 
an ischaemically-induced contracture that is assumed to be ultimately due to 
calcium overload or an altered sensitivity of intracellular proteins and organelles to 
calcium. Examples of ion translocating systems involved either directly or 
indirectly in intracellular calcium homeostasis include the Na-pump (driven by the 
Na/K ATPase), the Na/Ca exchange mechanism, the sarcoplasmic reticulum 
Ca-ATPase and the Na/H exchange mechanism. As a starting point, the Na/K 
ATPase was chosen as a target for investigation as the activity of this enzyme has 
been shown to be significantly reduced during myocardial ischaemia (Kim and 
Akera, 1987) which would result in a rise in [Najj favouring calcium influx via the 
Na/Ca exchange mechanism. This may represent a mechanism by which [Ca], rises 
during ischaemia. The prophylactic modulation of the activity of this enzyme, 
resulting in its activation or the prevention of ischaemically-induced reduction in 
Na/K ATPase activity, would elicit a reduction in intracellular sodium, an increase 
in intracellular potassium and could contribute to the delaying effect of GSH on the 
onset of ischaemic contracture.
The data from this group of experiments has shown that although GSH has no 
effect on noradrenaline release during myocardial ischaemia and reperfusion, it 
delays the onset of ischaemic contracture and attenuates ischaemia/reperfusion- 
induced 86Rb efflux , which may explain its antiarrhythmic action in the heart. In 
view of the data available regarding an ischaemically-induced reduction in Na/K 
ATPase activity that can be attenuated by selected free radical scavengers (Kim and 
Akera, 1987), the effect of GSH on this ion translocating system was investigated 
as this could also affect 86Rb efflux.
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CHAPTER 5.
SULPHYDRYL COMPOUNDS AND 
SELECTED AGENTS ON THE ACTIVITY 
OF ISOLATED BOVINE VENTRICULAR 
AND RAT MYOCARDIAL SODIUM/ 
POTASSIUM ATPase AND SODIUM PUMP 
CURRENT IN ISOLATED RAT 
VENTRICULAR MYOCYTES.
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5.1 THE EFFECT OF SULPHYDRYL COMPOUNDS AND SELECTED 
AGENTS ON ISOLATED BOVINE Na/K ATPase ACTIVITY.
The previously described effects of reduced glutathione (GSH) on an ischaemic 
contracture and ischaemia/reperfusion-induced 86rubidium could be due to a 
stimulatory effect of the Na/K ATPase, that is the biochemical representation of 
the Na/K pump. For this reason, the effect of GSH, and related compounds, on 
the activity of Na/K ATPase was investigated using an isolated bovine ventricular 
preparation.
5.1.1 Validation and characterization of the Na/K ATPase preparation.
Before the examination of the effects of glutathione and other selected 
compounds on the activity of purified Na/K ATPase, preliminary studies were 
performed to characterize its activity with respect to stimulation by sodium and 
potassium, and sensitivity to cardiac glycosides, temperature and pH. The assay of 
Na/K ATPase activity relies on a linked-enzyme system and, therefore, it was also 
important to determine any stimulatory or inhibitory effect of the selected 
pharmacological interventions on the pyruvate kinase and lactate dehydrogenase 
preparations used in the assay, in addition to any regulatory effects on the Na/K 
ATPase preparation itself.
5.1.1.1 Ouabain inhibition of isolated bovine Na/K ATPase.
Schwartz et al. (1969) reported a dependence of the time of exposure and 
temperature of incubation on the affinity of ouabain for a bovine Na/K ATPase 
preparation. For this reason the time of exposure and temperature were kept 
constant at 10 minutes and 37°C, respectively. Because the inhibition of bovine 
Na/K ATPase by ouabain is curvilinear, enzyme activity at varying ouabain 
concentrations was determined during the initial linear phase (figure 18). At 37°C 
the Na/K ATPase preparation was ouabain-sensitive, within the range 0-100pM, 
with an IC50 value of approximately 25pM, which is in agreement with Schwartz 
et al. (1969). At ouabain concentrations greater than 30pM no further enzyme 
inhibition was observed (figure 19). As a result, a ouabain concentration of 30pM 
was used in all subsequent investigations to reveal the activity of the
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Figure 18. Diagramatic representation of the determination of ouabain 
sensitivity (0-100pM) of an isolated bovine Na/K ATPase activity. 


























0 20 40 60 80 100 120
[ouabain] uM
Figure 19. Effect of ouabain (0-50jiM) on the activity of isolated bovine 
Na/K ATPase, expressed as % maximum activity. (Highest total activity 
measured in a single enzyme preparation = 32.2±2.2 units/mg protein).
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ouabain-sensitive and insensitive fractions of the enzyme preparation (Total Na/K 
ATPase activity = activity of ouabain sensitive fraction + activity of 
ouabain-insensitive fraction).
To examine the effect of a selected compound on total activity, the compound 
was added directly to the cuvette and any change in reaction rate monitored. In a 
separate group of experiments, the effect of the compound on the ouabain- 
insensitive fraction was determined by adding ouabain (final concentration 30pM) 
followed 3 minutes later by the compound in question and any change in reaction 
rate monitored. In two further groups of experiments, to determine the effect of a 
compound on the ouabain-sensitive fraction the total activity in the presence of 
the compound was determined, as was the ouabain-insensitive activity following 
the application of ouabain. The data from each group was pooled and expressed 
as a mean value (±s.e.mean). The ouabain-insensitive fraction accounted for 
18±5% of the total activity (n=5 preparations). The relative ouabain-sensitivity 
(and therefore the purity of the enzyme preparation) is probably a reflection of 
variability in the efficiency of the enzyme preparation and different sensitivities 
of the preparations to detergent solublization. The ouabain-insensitive ATPase 
activity is assumed to be due to calcium and magnesium-dependent ATPase.
5.1.1.2. Temperature sensitivity of bovine Na/K ATPase activity.
The effect of temperature on the activity of the total, ouabain-sensitive and 
insensitive fractions of bovine Na/K ATPase activity was determined at 25 and 
45°C and the data are shown in figure 20. In response to a 20°C rise in incubation 
temperature (from 25 to 45°C), total enzyme activity rose significantly by 
22.1±3.2 units/mg (basal activity at 25°C = 15.1±2.5 units/mg). The activity of 
the ouabain-sensitive fraction was also temperature dependent over the same 
range. The same temperature rise resulted in a concomitant increase in activity of 
18±2.0 units/mg (basal activity at 25°C = 3.5±0.3 units/mg). Finally, the 
temperature sensitivity of the ouabain insensitive fraction was also determined. In 
this fraction, a 20°C rise in temperature significantly increased activity by 18±2.2 
units/mg (basal activity at 25°C = 11.5±1.5 units/mg).
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Figure 20. Effect of incubation temperature on the total, 
ouabain-sensitive and ouabain-insensitive ATPase activity of an 
isolated bovine sarcolemmal preparation. Vertical bars represent 
+s.e.mean. (n=6,*, +, +  p<0.05 cw respective control group). Highest 
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Figure 21. A: Effect of potassium concentration (0-10mM) on the total 
activity of an isolated bovine Na/K ATPase preparation expressed as % 
of highest measured total ATPase activity. B: Effect of sodium 
concentration (O-lOOmM) on the total activity of an isolated bovine Na/K 
ATPase preparation expressed as % of highest measured total ATPase 
activity. In both figures, vertical bars represent ±s.e.mean. (Highest total 
activity measured in a single enzyme preparation = 30.2±2.3 units/mg 
protein. [Na]=10mM, [K]=10mM, [ATP]=2.5mM). (n=4, *p<0.05 cw 
controls).
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5.1.1.3 Activation of Na/K ATPase by potassium and sodium.
Figure 21a shows the potassium sensitivity (in the presence of a constant sodium 
concentration and temperature of lOOmM and 37°C, respectively) of the total 
ATPase activity of an isolated bovine Na/K ATPase preparation. The total activity 
of the Na/K ATPase preparation was also dependent on the sodium concentration 
of the buffer (in the presence of a constant potassium concentration of lOmM) 
(figure 21b).
5.1.1.4 Effect of pH on Na/K ATPase activity.
The effect of acidosis, with respect to the optimal pH of 7.4 suggested {Schwartz et 
al., 1969), on the activity of the Na/K ATPase preparation was also investigated. 
Data from these experiments are shown in figure 22 and reveal the pH-dependency 
of the activity of the total, and ouabain-sensitive fractions of the enzyme within the 
pH range 6.8-7.4. The activity of the ouabain-insensitive fraction was unaffected by 
changes in pH within the same pH range.
The experiments described thus far were designed to validate and characterize the 
isolated enzyme preparation and the experimental technique used to quantify 
enzyme activity. The ouabain, temperature and pH sensitivity as well as its 
dependence on sodium and potassium concentration are similar to the data 
described by Pitts and Schwartz (1975) for an isolated bovine Na/K ATPase 
preparation and were assumed to validate the suitability of the enzyme preparation. 
This technique was, therefore, used to investigate the effect of glutathione and other 
selected compounds on the activity of the total, ouabain-sensitive and ouabain- 
insensitive fractions of bovine ventricular Na/K ATPase.
5.1.2 Effect of reduced glutathione on Na/K ATPase activity.
Figure 23 shows that the addition of reduced glutathione significantly increased the 
total activity and the activity of the ouabain-sensitive and insensitive fractions of 
the Na/K ATPase preparation in a concentration-dependent manner (0.25-1.0 mM). 
This activation was maintained for the duration of the experiment and did not 













■  total  ac t i v i t y .  
ES3 o u a b a i n - s e n s i t i v e  
o u a b a i n - i n s e n s i t i v e
7.4 7.2 7.0 6.8
pH
Figure 22. Effect of pH (7.4-6.8) on the activity of the total, 
ouabain-sensitive and ouabain-insensitive fractions of an isolated bovine 
Na/K ATPase preparation. Highest total activity measured in a single 
enzyme preparation = 32.2±2.3 units/mg protein. Vertical bars represent 





£  c ■>-> o  U ofO
CDO’ > 
CO —ro *-»
& -  
< £






















Figure 23. Effect of reduced glutathione (GSH) (0.25-1.0mM) on the 
activity of the total, ouabain-sensitive and ouabain-insensitive fractions of 
an isolated bovine Na/K ATPase preparation. Highest total activity 
measured in a single enzyme preparation = 32.2±2.3 units/mg protein. 
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Figure 24. Effect of reduced glutathione (GSH) (ImM), oxidised glutathione (GSSG) 
(0.25-1.OmM), reduced dithiothreitol (DTT) (ImM), DL-penicillamine (PSH)s (ImM), 
cysteine (ImM), cystine (ImM), captopril (ImM), glycine (ImM) and glutamate (ImM) on 
the total, ouabain-sensitive and ouabain-insensitive ATPase activity of an isolated bovine 
N a/K  ATPase preparation. Vertical bars represent +s.e.mean. (100% total ATPase 
activity=30.2+2.3 units/mg; 100% ouabain-sensitive ATPase activity=24.2+2.1 units/mg; 
100% ouabain-insensitive ATPase=6+1.2units). n=6, *p<0.05 cw untreated control group.
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5.1.3 Effect of glutamate, glycine and cysteine on Na/K ATPase activity.
In view of the fact that glutathione is a tripeptide composed of glutamate, glycine 
and cysteine, the effect of these individual amino acids on the activity of the 
isolated Na/K ATPase preparation was investigated. At a concentration of ImM, 
neither glutamate nor glycine had a significant effect on the total activity or the 
activity of the ouabain-sensitive and ouabain-insensitive fractions of the Na/K 
ATPase preparation. This is in contrast to the effect of cysteine (ImM final 
concentration) which significantly increased the activity of all three enzyme 
fractions (figure 24).
5.1.4 Effect of cystine and oxidised glutathione on Na/K ATPase activity.
Oxidised glutathione and cystine are the disulphide forms of reduced glutathione 
and cysteine respectively and, therefore, the effect of their exogenous application 
on the activity of bovine Na/K ATPase activity was investigated. Total Na/K 
ATPase activity, in addition to the ouabain-sensitive and insensitive fractions of 
the enzyme preparation were inhibited in a concentration-dependent manner 
(0.25-1.0mM) by oxidised glutathione (figure 24). Cystine (ImM final 
concentration) had no significant effect on the activity of either the total, 
ouabain-sensitive or ouabain-insensitive fractions of the enzyme preparation 
(figure 24).
5.1.5 Effect of other selected sulphydryl compounds on Na/K ATPase activity.
In addition to reduced glutathione, the effects of the sulphydiyl-containing 
compounds DL-penicillamine, reduced dithiothreitol and the angiotensin- 
converting-enzyme inhibitor, captopril on the activity of bovine ventricular Na/K 
ATPase were investigated. In common with reduced glutathione, all of these 
sulphydryl-containing compounds, at a concentration of ImM, significantly 
increased the activity of the total, ouabain-sensitive and insensitive fractions of 
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Figure 25. Effect of oxidised glutathione (GSSG) (ImM), in the 
presence of reduced glutathione (GSH) (0.25-1.OmM), on the total, 
ouabain-sensitive and ouabain-insensitive ATPase activity of an 
isolated bovine sarcolemmal preparation. Vertical bars represent 
+s.e.mean. (n=6 hearts/group, *, +p<0.05 cw respective controls).
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5.1.6 Effect of reduced glutathione on the oxidised glutathione-induced inhibition 
of Na/K ATPase.
When applied alone, reduced glutathione (GSH) and oxidised glutathione (GGSG) 
had opposing effects on the activity of the total, ouabain-sensitive and insensitive 
fractions of the isolated Na/K ATPase preparation. Therefore, the effect of reduced 
glutathione (0.25-1.0mM) on the inhibition of Na/K ATPase activity caused by 
ImM oxidised glutathione was examined.
Figure 25 shows that reduced glutathione can overcome, in a concentration- 
dependent manner, the GSSG-induced inhibition of the activity of the total and 
ouabain-sensitive fractions of the Na/K ATPase preparation. A GSSG-induced 
inhibition of ouabain-insensitive activity was not significantly affected by the 
addition of GSH (0.25-1.0mM). ImM GSSG caused a mean inhibition of total 
activity of 63.1±1.3%. This was reduced to 40%, 19.4% and 4.7% by 0.25, 0.5 and 
0.75mM GSH, respectively. In the presence of ImM reduced glutathione and ImM 
oxidised glutathione there was a 7.3% increase in total enzyme activity which was 
not statistically significant.
5.1.7 Effect of selected pharmacological interventions on pyruvate kinase and 
lactate dehydrogenase.
As already mentioned, the assay of Na/K ATPase activity is based on a linked- 
enzyme system and it was, therefore, important to determine any effects of the 
compounds used on the activity of the pyruvate kinase and lactate dehydrogenase 
preparations. None of the interventions at the concentrations used had a significant 
effect on the activity of the enzyme preparations, confirming that the effects on 
enzyme activity of the exogenous application of these agents is due to an 
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Figure 26. A: Effect of potassium concentration (0-10mM), in the presence 
of reduced glutathione (GSH) (ImM) on the total activity of an isolated 
bovine Na/K ATPase preparation expressed as % of highest measured total 
ATPase activity (n=4, *p<0.05 cw controls). B: Effect of sodium 
concentration (1-lOOmM), in the presence of reduced glutathione (GSH) 
(ImM) on the total activity of an isolated bovine Na/K ATPase preparation 
expressed as % of highest measured total ATPase activity. (Highest total 
activity measured in a single enzyme preparation= 30.2±2.3 units/mg 
protein. [Na]=100mM, [k]=10mM, [ATP]=2.5mM). (n=4, *p<0.05 cw 
controls). In both figures, vertical bars represent ±s.e.mean.
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5.1.8 The effect of sodium and potassium concentration on the effects of reduced 
glutathione on bovine Na/K ATPase activity.
Figures 26a and 26b show that a [GSH]-dependent increase in the total activity of 
an isolated bovine Na/K ATPase preparation is [K+] and [Na+]-dependent 
(O.l-lOmM and 1-lOOmM, respectively).
5.2 HISTOCHEMICAL ANALYSIS OF Na/K ATPase ACTIVITY IN RAT 
HEART SLICES.
5.2.1 Validation and characterization of the technique.
As with the assay of bovine Na/K ATPase activity, a clarification of the 
specificity of the histochemical Na/K ATPase assay was carried out with respect 
to ouabain and temperature sensitivity, in addition to ATP and sodium 
dependence.
5.2.1.1 Ouabain inhibition of rat myocardial Na/K ATPase.
Rat myocardial Na/K ATPase was relatively less sensitive to ouabain-induced 
inhibition than the isolated bovine Na/K ATPase preparation, with an IC50 of total 
activity of 0.75mM (figure 27). This is as expected in view of previous reports of 
the relative insensitivity of rat myocardial Na/K ATPase to inhibition by cardiac 
glycosides. At ouabain concentrations greater than ImM no further enzyme 
inhibition was seen. A ouabain concentration of ImM was used in all subsequent 
investigations to determine the activity of the ouabain-sensitive and insensitive 
fractions of the Na/K ATPase present in rat myocardial sections. In common with 
the methodology used in the isolated enzyme studies, the effect of selected 
compounds on cellular ATPase activity was approached by investigating the effect 
of each agent on each enzyme fragment individually. In one set of ventricular 
sections total ATPase activity was monitored. Ouabain-insensitive activity was 
monitored by prior exposure of sections to ImM ouabain followed by the addition 
of the compound in question. Activity was measured pre- and post compound 
addition. Ouabain-sensitive activity was determined by the use of a separate group 
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Figure 27. Effect of ouabain (0.0-2.0mM) on rat myocardial Na/K ATPase 
activity, expressed as % highest total activity. (Highest total activity = 
25.2±2.1 mean integrated extinction x 100). Total activity was determined in 
a set of sections from each heart Ouabain-sensitivity was determined in 
sequential fractions from the same hearts. The reason for this is that the 
assay does not allow measurement of total and ouabain-insensitive ATPase 
activity in the same section.
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Figure 28. Effect of incubation temperature on the total, ouabain 
sensitive and ouabain-insensitive ATPase activity of rat 
myocardial slices. Vertical bars represent +s.e.mean. (n=4, 
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Figure 29. Effect of sodium concentration (0-41 OmM) on the total ATpase 
activity of rat myocardial slices. Vertical bars represent+s.e.mean. (n=4 




Figure 30. Effect of adenosine 5' triphosphate (ATP) (10 m g/m l) and 
guanosine 5' triphosphate (GTP) (10 m g/m l) on the total ATPase activity of 
rat myocardial slices. Vertical bars represent+s.e.mean. (n=4 hearts/group, 
***p<0.001 cw control group).
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under investigation. Ouabain-sensitive activiity was then determined by subtraction. 
The data from each group (ie total, ouabain-sensitive and ouabain-insensitive 
activity) was pooled and expressed as a mean value (±s.e.mean).
5.2.1.2 Temperature sensitivity of rat myocardial Na/K ATPase.
Rat myocardial Na/K ATPase activity was temperature dependent within the range 
25-37°C (figure 28). At 37°C, total activity was 20.9±0.1 MIE x 100; 
ouabain-sensitive and insensitive activity was 12.5±0.2 and 7.9±0.3 MIE x 100, 
respectively. At 25°C, the activity of the total, ouabain-sensitive and insensitive 
fractions were significantly reduced to 15.2±0.2, 9.5±0.6 and 6.5±0.5, respectively.
5.2.1.3 Effect of sodium concentration on rat myocardial Na/K ATPase activity.
Figure 29 shows that the total activity of rat myocardial Na/K ATPase activity was 
sodium-dependent within the range 0-410mM. The large residual activity observed 
in the absence of added sodium may be due to the use of sodium/potassium 
hydroxide used to establish the final pH of the media, sodium present in the 
Polypep media itself or endogenous sodium within the section.
5.2.1.4 Assay dependence and specificity for adenosine 5* triphosphate (ATP) as a 
substrate.
The total ATPase activity of the enzyme preparation was determined in serial 
sections of rat myocardium in the presence of either adenosine 5* triphosphate 
(ATP) (lOmg/ml) or guanosine 5* triphosphate (GTP) (lOmg/ml). Figure 30 shows 
that relatively low specific Na/K ATPase activity was found when ATP was 
replaced by GTP in the reaction media and highlights its substrate specificity.
The experiments described thus far were designed to clarify the specificity of the 
histochemical assay. In common with the assay of isolated bovine Na/K ATPase 
activity, the ouabain and temperature sensitivity, as well the dependence on sodium 
and ATP were assumed to validate the suitability of the histochemical assay. This 
technique was, therefore, used to investigate the effects of global, low-flow 
myocardial ischaemia and subsequent reperfusion, in the presence and absence of
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Figure 31. Effect of 30 minutes global, low-flow ischaemia and 5 
minutes subsequent reperfusion, in the presence and absence of reduced 
glutathione (GSH) (ImM), on the activity of the total, ouabain-sensitive 
and ouabain-insensitive fractions of rat myocardial Na/K ATPase. 
Vertical bars represent ±s.e.mean. (n=4, *p<0.05 cw controls).
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reduced glutathione, on the activity of rat myocardial Na/K ATPase.
5.2.2 Effect of global, low-flow myocardial ischaemia/reperfusion in the presence 
and absence of reduced glutathione.
5.2.2.1 Effect of global, low-flow ischaemia and subsequent reperfusion on rat 
myocardial ATPase activity.
A 30 minute ischaemic period and 5 minutes reperfusion resulted in a significant 
loss of activity of the total, ouabain-sensitive and insensitive fractions of rat 
myocardial Na/K ATPase activity (figure 31).
5.2.2.2 Effect of reduced glutathione on basal Na/K ATPase activity.
The perfusion of ImM reduced glutathione for 35 minutes under control conditions 
had no significant effect on activity of the total, ouabain-sensitive or insensitive 
fractions of rat myocardial Na/K ATPase (figure 31).
5.2.2.3 Effect of reduced glutathione on a loss of Na/K ATPase activity associated 
with global, low-flow myocardial ischaemia and reperfusion.
Figure 31 shows that ImM reduced glutathione significantly attenuated the loss of 
total and ouabain-sensitive Na/K ATPase activity associated with a 30 minute 
ischaemic insult and 5 minutes reperfusion. Analaysis of variance and Bonferroni’s 
f-test showed that there was no significant effect of GSH during ischaemia on total 
ATPase activity compared to the contol, non-ischaemic group.
The following electrophysiological studies were all performed by the author under the 
supervision of Dr M. Shattock and Dr H. Matsuura at the Cardiovascular Research 
Department, The Rayne Institute, St Thomas' Hospital, London, SE17EH.
5.3 EFFECT OF EXOGENOUS THIOL COMPOUNDS ON SODIUM PUMP 
CURRENT IN ISOLATED RAT VENTRICULAR MYOCYTES.
Figure 32 shows the voltage protocol used in these studies and current traces 
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Figure 32. The ramp-voltage protocol used in this set of experiments (upper 
panel) and examples of currents recorded durin the ramp from +50 to -120mV 
under control conditions or in a K-free Tyrode solution (lower panel). The 
voltage protocol was imposed in the direction of the arrow from a holding  
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Figure 33. Ko-sensitive fractions of the currents recorded in figure 32. The 
current records shown here were obtained by subtracting the digitised potassium- 
free current trace from those recorded under control conditions. This reflects ip 
uncontaminated by the currents through the passive membrane resistance. 
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Figure 34. Activation of N a /K  pum p current by intracellular sodium  and 
extracellular potassium. A: Relationship between intracellular sodium  and 
Ko-sensitive N a/K  pump current. This relationship w as obtained by dialysing 
different cells with different pipette solustions containing a range of sodium  
concentrations between 0 and 50mM. The Ko-sensitive pum p current was 
measured at OmV and was expressed as a percentage of the maximally activated 
current. The N a /K  pump current was half-maximally activated at a [Na] of 
18.4mM. The values shown represent the mean+s.e.mean for at least 6 different 
cells for each Na concentration. B: Relationship between intracellular potassium  
and Ko-sensitive N a /K  pum p current. This relationship w as obtained by dialysing 
different cells with different pipette solustions containing a range of potassium  
concentrations between 0 and lOmM. The Ko-sensitive pum p current was 
measured at OmV and was expressed as a percentage of the maximally activated 
current. The N a /K  pump current was half-maximally activated at a [K] of 1.24mM. 
The values shown represent the mean+s.e.mean for at least 6 different cells for each 
N a concentration. (Reproduced by kind permission of Shattock and Matsuura, 1990).
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and Tyrode solutions (previously described in 2.15.2 - 2.15.3), the cuirent-voltage 
(I-V) relationship obtained consists of a Na-pump current component (ip) and the 
current through the passive membrane resistance (Rceii). This component is 
revealed when the Na-pump current is inhibited by the removal of extracellular 
potassium.
The record in figure 33 was determined by the subtraction of the digitized K-free 
current trace from those recorded in the presence of extracellular potassium and 
represent ip uncontaminated by the current through the passive membrane 
resistance.
5.3.1 Validation and characterisation of technique.
Due to the constraints of available time, the sodium and potassium dependence of 
Na-pump current (ip) were not determined during the course of this set of 
experiments. However, data for this was obtained by Dr M. Shattock and Dr H. 
Matsuura prior to the initiation of this work using the same protocol and 
equipment. The relationship between Nai and ip was determined by dialysing 
different cells with a range of sodium concentrations. The K0-sensitive pump 
current was measured at OmV and expressed as a percentage of the maximally 
activated current. The relationship between ip and sodium concentration was 
sigmoidal and ip was half maximally activated at a sodium concentration of 
approximately 18mM (figure 34a). A similar protocol was used to investigate 
potassium dependence by superfusing cells with a range of potassium 
concentrations. Ip was half maximally activated at a potassium concentration of 
approximately 1.2 mM (figure 34b).
The prior characterization of this model using an identical experimental set-up in 
the laboratories of Dr M. Shattock and Dr H. Matsuura was assumed to be 
adequate to demonstrate the validity and suitability of this experimental approach 
to investigate the effects of exogenous thiol compounds on Na-pump current (ip).
5.3.2 Effect of reduced glutathione on Na-pump current.
5.3.2.1 Extracellular superfusion.
Figure 35(i) shows that the extracellular superfusion of ImM reduced glutathione
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Figure 35. Chart recordings showing changes in holding current, recorded 
on a slow time-base, in the presence and absence of (i) extracellular 
reduced glutathione (GSH) (ImM), (ii) oxidised glutathione (GSSG) (ImM) 
or (iii) reduced dithiothreitol (DTTred). The timing of the changes in 
Tyrode potassium concentration are indicated and marked Ramp 
voltage protocols (as shown in figure 31) were imposed at the start of the 
trace and during potassium-free exposure and potassium-repletion (in the 
presence and absence of the compound under investigation). 
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Figure 36. Influence of the extracellular superfusion of reduced 
glutathione (GSH) (ImM) on the current-voltage relationships for the 
N a/K  pump current in a an isolated rat ventricular myocyte, using a 














Figure 37. Chardt recordings showing changes in holding 
current, recorded on a slow time-base, in the presence and 
absence of (i) intracellular reduced glutathione (GSH) (ImM) or 
(ii) oxidised glutathione (GSSG) (ImM). The timing of the 
changes in Tyrode potassium concentration are indicated and 
marked Ramp voltage protocols (as shown in figure 31) 
were imposed at the start of the trace and during potassium-free 
exposure and potassium-repletion (in the presence and absence 
of the compound under investigation). (Abbreviations: K+ - 
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Figure 38. Influence of intracellular dialysis of reduced 
glutathione (GSH) (ImM) on the current-voltage relationships 
for the N a/K  pump current in an isolated rat ventricular 
myocyte, using a ramp-pulse protocol stepping at 18m V /s  
between +50 and -120m V.
I l l
significantly increased the outward membrane holding-current recorded in an 
isolated rat ventricular myocyte. The extracellular superfusion of ImM reduced 
glutathione (GSH) resulted in a significant increase in Na-pump current at all 
voltages (figure 36). Na-pump current returned to control values, at all voltages, on 
the removal of extracellular GSH. The re-admission of potassium after the 
potassium-free period (marked 'o' ) resulted in an overshoot of pump current that 
presumably reflects a reactivation of the Na/K pump in the presence of an elevated 
sodium concentration. This protocol of GSH addition and removal could be 
repeated three times on the same cell and similar results obtained.
5.3.2.2 Intracellular dialysis.
Current-voltage relationships were obtained prior, during and following the 
intracellular dialysis of ImM reduced glutathione in isolated rat ventricular 
myocytes. The intracellular dialysis of ImM GSH significantly increased the 
outward holding current (figure 37(i)) and Na-pump current at all voltages (figure 
38). This effect was not significantly different to the effect of the extracellular 
superfusion of GSH.
Therefore, ImM reduced glutathione significantly increased Na-pump current in 
isolated rat ventricular myocytes when applied either intra- or extracellularly.
5.3.3. Effect of oxidised glutathione on Na-pump current.
5.3.3.1 Extracellular superfusion.
The extracellular superfusion of ImM oxidised glutathione (GSSG) significantly 
decreased the outward membrane holding-current (figure 35 (ii)) and significantly 
attenuated Na-pump current at all voltages, in isolated rat ventricular myocytes 
(figure 39). As with reduced glutathione, this effect was readily reversible and 







-1 0 0  J
Figure 39. Influence of extracellular superfusion of oxidised  
glutathione (GSSG) (ImM) on the current-voltage relationships for 
the N a /K  pump current in an isolated rat ventricular myocyte, 
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Figure 40. Influence of intracellular dialysis of oxidised  
glutathione (GSSG) (ImM) on the current -voltage relationships 
for the N a/K  pump current in an isolated ventricular myocyte, 
using a ramp-pulse protocol stepping at 18m V /s between +50 
and -120mV.
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Figure 41. Influence of extracellular superfusion of reduced 
dithiothreitol (DTTred) (ImM) on the current-voltage 
relationships for the N a/K  pump current in an isolated rat 
ventricular myocyte, using a ramp-pulse protocol stepping at 
18m V/s between +50 and -120mV.
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5.33.2  Intracellular dialysis.
In common with its extracellular superfusion, the intracellular dialysis of ImM 
GSSG resulted in a reduction in outward membrane holding current (figure 37(h)). 
In addition, Na-pump current was significantly attenuated at all voltages following 
the intracellular dialysis of ImM GSSG (figure 40).
ImM oxidised glutathione, therefore, significantly attenuated Na-pump current at all 
voltages, in a reversible manner, whether applied intra- or extracellularly.
5.3.4 Influence of reduced dithiothreitol on Na-pump current.
5.3.4.1 Extracellular superfusion.
The superfusion of ImM reduced dithiothreitol resulted in an increase in outward 
membrane holding current (figure 35(iii)). Na-pump current was also significantly 
increased at all voltages (figure 41).
No determination of the effects of the intracellular dialysis of DTTred was 
performed due to problems with the formation of a brown precipitate upon the 
addition of ImM DTTred to the intracellular buffer.
5.3.5 Influence of intracellular glutathione depletion on Na-pump current.
Isolated rat ventricular myocytes were prepared from animals previously depleted of 
endogenous glutathione (as decribed in section 2.16) which was confirmed by 
enzymatic analysis. Na-pump current was compared in myocytes prepared from 
untreated and GSH-depleted animals. Whole cell capacitance (Ccell) was estimated 
using a ramp voltage protocol according to the method described by Shattock and 
Matsuura (1990). Na-pump current was normalised to cell capacitance by the 
method described by Isenberg et al. (1987). The rapid current deflection (A  I) 
observed on switching from a negative-going to a positive-going ramp was 
measured and Ccell= A 1/(2 x dV/dt). Cell surface area was estimated assuming a 
specific membrane capacitance of 1.0 pF/cm2 (Hille, 1984). At OmV, in control 
myocytes from untreated animals, capacitance-normalised Na-pump current was
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CONTROL CELLS.
AT OmV, CAPACITANCE NORMALISED N a/K  PUMP 
CURRENT = 0.015±0.002 pA /pm 2.
GSH-DEPLETED CELLS.
AT OmV, CAPACITANCE NORMALISED N a/K  PUMP 
__________CURRENT = 0.007+0.002* pA /pm 2 __________
Table 6. Comaprison of the effect of reduced glutathione (GSH) on  
capacitance normalised N a/K  pump current, at OmV, in isolated rat ventricular 
myocytes prepared from hearts from control, untreated animals with isolated rat 
ventricular myocytes prepared from hearts from glutathione-depleted animals 
using diethylmaleate (0.864 g /k g , i.p, 30 minutes pre-sacrifice). (n=3, *p<0.05 cw
control group).
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0.015±0.002 pA/pm2 (n=3). This was significantly decreased in myocytes prepared 
from GSH-depleted hearts. In these cells, capacitance normalised Na-pump current was 
significantly reduced to 0.007±0.002 pA/pm2 (n=3, *p<0.05). Therefore, endogenous 
glutathione depletion significandy attenuated Na-pump current in isolated rat 





The investigations described above have shown that the activity of both a bovine 
ventricular and rat myocardial Na/K ATPase preparation can be modulated by the 
exogenous application of selected reductants and oxidants, such as reduced (GSH) 
and oxidised (GSSG) glutathione. These experiments were undertaken in an attempt 
to explain how reduced glutathione exerts its antiarrhythmic effect (Woodward and 
Zakaria, 1985), delays the onset of an ischaemically-induced contracture, as 
described in the present investigations, and attenuates 86rubidium efflux from the 
rat myocardium (Blackwell et al., 1986). Modulation of Na-pump activity was also 
investigated in isolated rat myocytes. In this set of experiments the ability of GSH 
to increase and GSSG to decrease Na-pump activity was independent of whether 
they were applied intra- or extracellularly. A reduction in Na-pump activity was 
also observed in cells depleted of endogenous glutathione, using diethylmaleate, 
which may point to GSH being a component in the regulation of ion translocating 
systems such as Na/K ATPase.
The breakage and formation of intra- and intermolecular disulphide bridges has 
been shown to be crucial in the regulation of insulin-mediated hexose transport, 
phosphofructokinase, glutathione reductase, guanylate cyclase and fatty acid 
synthase (Brigelius, 1985; Zeigler, 1985; Miller et al., 1990) and may have a role 
to play in the modulation of Na/K ATPase activity observed in the investigations 
described above. The involvement of GSH and/or GSSG in such interactions would 
result in a change in cellular redox state, having a knock-on effect on the structure 
and activity of other enzymes and ion translocating proteins that may be susceptible 
to varying degrees of oxidant/reductant stress. Hence, the oxidation of protein thiols 
may be responsible for alterations in the activity and function of key enzyme 
systems, such as the Na/K pump, that may result in a reduction in the ability of the 
ischaemic myocardium to maintain ionic homeostasis, contractile function and 
rhythm. Ischaemia and subsequent reperfusion results in a significant loss of Na/K 
ATPase activity in guinea-pig hearts, an effect which can be attenuated by selected 
free radical scavengers and antioxidants (such as superoxide dismutase, catalase, 
dimethylsulphoxide, vitamin E and allopurinol) (Kim and Akera, 1987). In view of 
these results obtained by Kim and Akera (1987), the effect of reduced glutathione 
on the activity of Na/K ATPase was investigated as another example of a
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compound involved in cellular defence against oxidative stress. The data from 
these experiments, described previously, is in agreement with Kim and Akera 
(1987) with respect to the ability of GSH as an antioxidant to attenuate an 
ischaemically-induced loss of Na/K ATPase activity. Klim and Akera, however, did 
not distinguish between the free radical scavenging and antioxidant activity of 
these compounds and the possibility of other direct or indirect effects on the Na/K 
pump itself.
In the past many authors have stressed the importance of free radical-induced lipid 
peroxidation as the central event in oxidative damage to the myocardium during 
ischaemia and reperfusion. This damage is likely to be dependent on many factors 
such as the severity of the ischaemic insult, the location of cell subtypes within a 
tissue and the efficiency of endogenous defence systems against oxidative stress. 
However, it is highly likely that ischaemia/reperfusion-induced oxidative stress 
may also affect the primary, secondary and tertiary structure of many 
membrane-bound proteins, such as the enzymes and ion translocating proteins 
involved in intracellular ionic homeostasis. Kim et al. (1989) investigated the 
effects of myocardial ischaemia on sarcolemmal Na/K ATPase activity with 
respect to the degree of lipid peroxidation and interactions with non-esterified fatty 
acids (NEFA) and their ester derivatives (acyl carnitines) that accumulate in the 
ischaemic myocardium (Liedtke et al., 1978). This group failed to show a 
correlation between the level of ischaemically-induced lipid peroxidation and an 
associated reduction in Na/K ATPase activity which lessens the significance of 
lipid peroxidation in the early stages of ischaemic damage to the myocardium and 
implies that there are other mechanisms by which the activity of membrane-bound 
proteins and enzymes are affected during this phase. It would be of interest to 
investigate the effect of reduced and oxidised glutathione on the accumulation of 
NEFA and acyl carnitines with a view to investigating the mode of action by 
which reduced and oxidised glutathione modulate Na/K ATPase activity during 
myocardial ischaemia and reperfusion.
From the work described here, it is unclear as to whether the ability of selected 
thiol compounds, such as reduced glutathione, to modulate the activity of Na/K 
ATPase results from direct interactions with the alpha and/or beta subunits of the
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enzyme or by the involvement of these compounds in the removal of reactive 
oxygen species that cause oxidant/reductant stress. There is little doubt that 
glutathione, glutathione reductase and glutathione peroxidase are key components 
in the cells defence against highly reactive and potentially damaging reactive 
oxygen species (Halliwell and Gutteridge, 1989). During oxidative stress there is a 
reduction of total cellular glutathione and GSH during the removal of lipid 
peroxides and hydrogen peroxide, which also curtails a rise in intracellular GSSG 
levels. Ferrari et al. (1985) have documented such a change in the ratio of 
GSH/GSSG in response to an ischaemic insult. Under normal conditions, free 
sulphydryl (-SH) groups on proteins are maintained in the reduced state by a high 
intracellular GSH/GSSG ratio with only low concentrations of mixed thiols 
(Brigelius, 1985). However, in pathological conditions an associated fall in the 
GSH/GSSG ratio may result in a decrease in free -SH groups. Their oxidation and 
the formation of mixed thiols may be responsible for a loss of enzyme and ion 
channel activity. Therefore, the free radical scavenging action of GSH and related 
systems, that help protect against oxidative stress, may have an indirect effect on 
cellular redox state and enzyme activity. In view of this, it is reasonable to 
postulate that under conditions of oxidative stress, a change in the GSH/GSSG 
status of the heart could be an important factor in the regulation of Na/K ATPase, 
such that a fall in the GSH/GSSG ratio would lead to a net loss of potassium from 
the cell and a concomitant accumulation of intracellular sodium, both of which 
occur during ischaemia. These conditions would in turn result in a shift in 
sodium/calcium exchange favouring calcium influx, manifesting itself as 
contracture in this experimental model.
It is thought that the beta subunit of the Na/K ATPase dimer may be involved in 
the insertion of the alpha subunit into the lipid bilayer of the plasma membrane 
and, therefore, may be relatively more exposed and/or susceptible to oxidant/ 
reductant stress. Indeed, Kirley (1990) suggests that one of the three disulphide 
bonds found in the beta subunit may be more susceptible to cleavage by a reductant 
such as dithiothreitol. Subsequent cleavage of this bond renders the remaining two 
disulphide bonds liable to similar attack resulting in a loss of Na/K ATPase 
activity. Since GSH and dithiothreitol increased Na/K ATPase activity in the
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present investigations, it would seem that either these compounds do not act at this 
site or that they cause other conformational changes that mask these disulphides 
from attack. An alteration in the structure of the beta unit may have a "knock-on" 
effect on the alpha unit resulting in an altered insertion of the alpha subunit into the 
membrane. This may modulate the activity of the enzyme in the absence of a direct 
effect on the alpha subunit. No correlation between enzyme inactivation and 
reduction of disulphide bonds exists, suggesting a requirement for multiple or 
sustained reductant attack to inactivate the enzyme. The ability of GSH to activate 
Na/K ATPase in the present investigations may be representative of a species or 
tissue difference between the two sources of enzyme. Using isolated Na/K ATPase 
from lamb kidney, Kirley (1990) reported an inhibitory effect of 50-100mM 
dithiothreitol which is in contrast to the stimulatory effect of ImM dithiothreitol 
observed in experiments with bovine ventricular Na/K ATPase described here. It is 
not uncommon for drugs to have varying effects at relatively high and/or low 
concentrations and, therefore, it would be unwise to directly compare the two sets 
of data.
Reports on the number of cysteine residues in the alpha subunit of Na/K ATPase 
range between 9 and 14, whilst the concensus is that the beta subunit contains two 
(Perrone et al., 1975; Peters et al., 1981). Schoot et al. (1981) classified the 
sulphydryl groups of Na/K ATPase in terms of reactivity with N-ethylmaleimide 
(NEM) and dinitrobenzoic acid (DNTB). There are 12 Class A -SH groups per 
dimer that react with both NEM and DTNB; at least one of these -SH groups is 
essential for enzyme activity. There are 14 groups in Class B that only react with 
NEM. The remainder are in Class C and can only be alkylated after unfolding of 
the protein with a detergent, such as SDS. There is thought to be at least one thiol 
group in or near the catalytic centre. It is not possible to determine which groups, if 
any, are affected by GSH and GSSG from the experiments described in this thesis. 
Even though the extracellular application of GSH may enhance the intracellular 
[GSH], in the time course of these experiments it is more likely that GSH and/or 
GSSG may act in the short term at the thiol groups located on the extracellular side 
of the cell membrane in the histochemical studies of Na/K ATPase activity 
previously described. In ischaemically-induced oxidative stress in isolated hearts,
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thiol groups located both intra- and extracellularly, are just as likely to be affected 
by free radical-induced oxidant stress. In the isolated enzyme preparation, the 
conformation of the enzyme is unknown and should not be assumed to be identical 
to that found in vivo. In this situation, GSH and/or GSSG may have access to a 
greater proportion of thiol groups required for enzyme activity. This may explain 
the ability of GSH to increase the activity of the isolated enzyme whereas it has no 
effect on basal Na/K ATPase activity in isolated heart preparations. Therefore, the 
location and relative susceptibility of free -SH groups and disulphides in an enzyme 
or protein to oxidative and reductive attack, respectively, may be important. With 
regard to Na/K ATPase, the location and relative vunerability to reductant attack of 
disulphides on the beta subunit may be critical.
Temma et al. (1978) investigated the relationship between the inotropic action of 
sulphydryl blocking agents and membrane sodium pump activity. These agents (of 
w h i c h  N - e t h y  l m a l e i m i d e ,  p - c h l o r o - m e r c u r i b e n z o a t e ,  p - 
chloromercuribenzenesulphonic acid and digitoxin are examples) are known Na/K 
ATPase inhibitors (Skou and Hilberg, 1965) but may affect membrane functions 
and properties other than Na-pump activity (Rothstein, 1970). The inotropic action 
of N-ethylmaleimide was partially reduced in the presence of the beta-adrenoceptor 
antagonist, propranolol or by reserpine pretreatment which suggests a role for 
catecholamine release in its mode of action. The functionally-related sulphydryl 
groups on the Na-pump are located at the inner surface of the cell membrane 
(Rothstein, 1970) and, therefore, these essential groups for Na-pump activity should 
be affected first by blocking agents that penetrate the cell membrane. This group, 
however, was unable to determine the site of action of these agents. Such blocking 
agents produce a biphasic effect with a relatively brief positive inotropic action 
followed by a negative inotropic effect. This is in common with the opposing 
effects of relatively high and low concentrations of dithiothreitol reported earlier. 
The latter effect of sulphydryl blockers may be due to a longer access time to 
subcellular organelles that may be responsible for this observation. The data from 
these experiments underlines, however, the potential involvement of -SH groups in 
the modulation of Na-pump activity. It would be of interest to study Na/K ATPase 
activity in response to ischaemia in hearts and isolated myocytes from animals
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previously depleted of catecholamines, using reserpine or 6-hydroxydopamine, and 
the effect of the subsequent exogenous application of reduced and oxidised 
glutathione. As described earlier, the time to the onset of an ischaemically-induced 
contracture was significantly increased in hearts from animals previously depleted 
of endogenous catecholamines. However, in a separate set of experiments, reduced 
glutathione was shown to have no significant effect on noradrenaline release. 
Therefore, the role of GSH and catecholamines in ischaemic contracture and the 
modulation of Na/K pump activity remains unclear.
The exposure of myocytes to extracellularly generated oxidants results in 
alterations in membrane function and in cell viability CBarrington et al., 1985; 
Sato et al., 1989; Shattock amd Matsuura, 1990). Hydrogen peroxide and the 
superoxide radical may pass readily through the plasma membrane where they may 
react with metal ions bound to the plasma membrane or the membranes of 
intracellular organelles to produce the highly reactive hydroxyl radical {Fridovich,
1989). This may result in self propagating reactions and the amplification of the 
effects of the superoxide anion. Xie et al. (1990) reported on the effects of such 
oxidants on the function of selected membrane bound ion translocating proteins 
and suggested that, although their experimental approach resulted in some 
non-specific damage to the cell, there was some specificity in the interactions of 
superoxide and hydrogen peroxide-derived free radicals with sarcolemmal transport 
proteins, such as the Na/K ATPase. Both in vivo and in vitro, the long-term 
presence of such species may result in a time-dependent depression in activity and 
function of the cells’ defence systems against oxidative stress, such as the 
glutathione/glutathione reductase/glutathione peroxidase system and a concomitant 
change in cellular redox state. Therefore, the direct effects of reactive oxygen 
species on membrane-bound proteins may represent irreversible damage whereas 
the modulation of enzyme activity via a change in cellular redox state (eg. the ratio 
of GSH/GSSG), due to a depression in the activity of cellular defence systems 
against oxidative stress, may be reversible. The effect of the exogenous application 
of oxidised glutathione on the activity of an isolated bovine Na/K ATPase 
preparation, described in the present investigations, may be synonymous with this 
situation. The depression of Na/K ATPase activity in response to GSSG was
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readily reversible by the addition of GSH. The activity of this Na/K ATPase 
preparation may, therefore, be controlled by cellular redox state and may represent 
a mode of enzyme regulation that is downstream from the effects of free radicals 
themselves. In vivo, there is the possibility that oxidant-induced damage of this 
enzyme may render it more susceptible to subsequent redox regulation following 
the free radical-induced oxidation and/or reduction of free -SH groups and 
disulphides. In the experiments described earlier, using both isolated Na/K ATPase 
and rat Na/K ATPase in tissue slices, oxidant and reductant stress was mimicked 
using GSH and GSSG as opposed to the use of a free radical generating system, 
such as the xanthine/xanthine oxidase system that results, primarily, in the 
production of superoxide radicals. These experiments show that the activity of this 
enzyme can be modulated by changes in redox state as opposed to more permanant 
damage to membranes and proteins that results from the direct action of free 
radicals.
In the present investigations, reduced and oxidised glutathione were also used to 
study reductant and oxidant stress in isolated myocytes and their effect on 
Na-pump current investigated. These experiments were performed to confirm the 
data obtained using an isolated Na/K ATPase preparation and histochemical studies 
in isolated hearts. In rat ventricular myocytes, the intracellular dialysis and 
extracellular superfusion of reduced and oxidised glutathione resulted in a 
significant potentiation and attenuation of Na-pump current at all voltages, 
respectively. This suggests that there are free thiols and disulphides located both 
intra- and extracellularly that may be oxidised and reduced resulting in the 
modulation of Na-pump activity. The observation that the intracellular depletion of 
glutathione resulted in a depression of Na-pump activity suggests the involvement 
of cellular redox state in the modulation of this ion translocating system. However, 
other non-specific effects of diethylmaleate, used to deplete cellular glutathione, 
may be responsible for this effect. Therefore, it is important to repeat these 
experiments using alternative methods of intracellular glutathione depletion, such as 
buthionine sulphoximine or phorone (Meister and Anderson, 1983). The re-addition 
of glutathione by intracellular dialysis to cells previously depleted of glutathione 
would be of interest to investigate any reversibility of the effects of diethylmaleate.
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The preliminary results obtained with isolated ventricular myocytes reflect the 
experimental observations using isolated Na/K ATPase and whole hearts with 
regard to the effect of the exogenous application of reduced and oxidised 
glutathione and may explain how an ischaemically-induced reduction in the ratio of 
GSH/GSSG results in contracture.
In globally ischaemic hearts extracellular potassium concentration increases in a 
biphasic manner with a brief plateau phase 5 minutes after the onset of ischaemia 
and rising further to appoximately 20-30mM within 30 minutes {Knopf et al.,
1990). Inhibition of Na/K ATPase with cardiac glycosides abolishes this plateau 
phase {Weiss and Shine, 1982). It has been proposed that this phase is due to the 
stimulation of Na/K ATPase by catecholamines that are released from the 
ischaemic myocardium in concentrations that may maximally activate the Na-pump 
(Schdmig et al., 1987; Knopf et al., 1990). Na/K ATPase is also stimulated by a 
decrease in resting membrane potential (Gadsby et al., 1985) and by an increase in 
intracellular sodium {Glitsch et al., 1981). Therefore, there are several mechanisms 
that may be responsible for this brief activation of Na/K ATPase activity during 
ischaemia: (i). noradrenaline release, (ii). increase in intracellular [Na+] and/or [H+] 
and (iii). membrane depolarisation due to an increase in extracellular [K+]. In view 
of this, reduced glutathione may increase Na/K ATPase activity by stimulating 
catecholamine release under resting and/or ischaemic conditions. However, in view 
of the potentially pro-arrhythmic effect of catecholamines under ischaemic 
conditions {Pallandi et al., 1987; Daugherty et al., 1986) and the antiarrhythmic 
action of GSH (Woodward and Zakaria, 1985), this seems unlikely. In experiments 
described earlier it was also shown that GSH attenuated 86Rb efflux and, by 
inference, K+ efflux during ischaemia and reperfusion which suggests an alternative 
mode of action in this model by which GSH influences Na/K ATPase activity. The 
second phase of an ischaemically-induced rise in extracellular [K+] is thought to 
represent irreversible damage to ischaemic myocytes (Kleber, 1984). Fiolet et al. 
(1984) suggested that as this second phase of the increase in extracellular potassium 
coincides with a decline in cellular ATP and that Na/K ATPase activity is markedly 
reduced after 30 minutes of ischaemia {Bersohn et al., 1982), a fall in ATP 
availability may contribute to this rise in extracellular potassium. The data obtained
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from the investigations described here have shown that GSH stimulates isolated 
Na/K ATPase and prevents an ischaemically-induced loss of myocardial Na/K 
ATPase activity. However, no studies of cellular ATP levels, in the presence and 
absence of GSH, during an ischaemic insult in isolated hearts were undertaken. It 
remains unclear whether cellular ATP levels and/or changes in specific ATP pools 
are important in the loss of Na/K ATPase associated with myocardial ischaemia 
and reperfusion. Reduced glutathione may attenuate this rise in extracellular 
potassium during ischaemia via an ATP-sparing action, or by stimulating ATP 
synthesis, in addition to a stimulatory action on Na/K ATPase. Xie et al. (1990) 
found that free radical-induced oxidative stress reduced Na/K ATPase activity prior 
to any significant reduction in cellular ATP content and loss of cell viability. In 
addition, Jennings et al. (1985) showed that myocardial reperfusion, following an 
ischaemic period, resulted in a recovery of tissue ATP but also an enhanced 
decrease in Na/K ATPase activity. Therefore, it seems unlikely that a fall in 
cellular ATP content is responsible for any significant loss of Na/K ATPase 
activity during ischaemia and reperfusion.
Cysteine, dithiothreitol, penicillamine and captopril all have a free sulphydryl group 
and, in common with reduced glutathione, they all significantly increased the 
activity of isolated bovine Na/K ATPase in the present investigations. Relatively 
high concentrations of captopril (0.37mM) have been shown to attenuate 
reperfusion-induced arrhythmias (Van Gilst et al., 1986a) and this may be related 
to its ability to potentiate and attenuate reperfusion-induced prostacyclin and 
catecholamine release, respectively (Van Gilst et al., 1986b). A stimulatory action 
on Na/K ATPase reported in the investigations described here, however, may also 
contribute to the antiarrhythmic action of captopril during reperfusion. However, at 
plasma concentrations well above those found therapeutically (approximately 
lOOpM), captopril has no effect on the action potential in guinea-pig ventricular or 
S-A node cells (Helmsworth, 1989). Stimulation of an electrogenic Na/K pump 
would be expected to cause hyperpolarization and therefore it appears unlikely that 
captopril stimulates the Na/K ATPase at concentrations of approximately lOOpM. 
However, there is no data on the electrophysiologcal effects of captopril during 
reperfusion and yet it is during this phase when oxidant stress is at its greatest, 
indicated by a fall in the GSH/GSSG ratio (Ferrari et al., 1989). If the fall in this 
ratio of reductants and oxidants inhibits Na/K ATPase during reperfusion then the
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possibility remains that captopril may stimulate the inhibited enzyme during 
reperfusion but have no effect on the unstressed enzyme.
The role of cellular redox state in the control of systems involved in ion 
translocation in vivo is unclear. It would seem likely that if changes in redox state 
have a potentially profound effect on intracellular ion homeostasis that the 
processes controlling redox state would in turn be subject to tight regulation. In 
some respects this is true. Oxidised glutathione produced under oxidative stress is 
transported out of the cell where it is metabolized. In addition glutathione reductase 
re-synthesises reduced gluathione intracellularly from GSSG and NADPH, to 
maintain a low intracellular GSSG concentration. It would be logical to assume that 
the enzymes involved in glutathione homeostasis are liable to activation/ 
inactivation by reductant and/or oxidant stress. Both intra- and intermolecular 
disulphide bridges are critical in the regulation of glutathione reductase (Brigelius, 
7985; Zeigler, 1985; Miller et al., 1990). Therefore, it is possible that the activity 
of this enzyme may be modulated during oxidative stress to cope with an increased 
intracellular GSSG concentration. The GSSG transporter mechanism may also be 
activated under severe or prolonged oxidative stress during which time glutathione 
reductase may be inactivated.
The relationship between myocardial ischaemia and a reduction in the ability of the 
heart to maintain ionic homeostasis is a complex situation. There are several 
alterations in the status of the myocardium that may have both a direct and indirect 
effect on the function of ion translocating systems, such as the Na/K ATPase. It is 
fairly certain that free radical-induced oxidative stress has a direct effect on such 
proteins. However, the potential to modulate the activity of these systems via 
pharmacological interventions that alter the cellular redox state is unclear. The 
selectivity of such an approach is a problem in view of the contrasting effects of 
sulphydryl oxidation and reduction on the activity of varying enzymes and ion 
translocating systems, as outlined above. Potential approaches may be to 
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7.1 FREE CYTOSOLIC CALCIUM LEVELS IN ISOLATED RAT MYOCYTES 




Under extracellular calcium-free conditions, basal free cytosolic calcium in 
isolated rat myocytes was 147.5±13.1nM (n=4). Upon adjustment of the external 
calcium concentration to ImM, free cytosolic calcium rose slightly and plateaued 
at 196.2±16.2nM (n=4) (figure 43). Following equilibration for 2 minutes, in the 
presence of ImM extracellular calcium, the effect of various pharmacological 
agents on [Cajj was investigated.
7.1.1.2 Effect of reduced glutathione on extracellular calcium ([Ca]0)-induced 
increase in free intracellular calcium ([Cajj) in isolated rat myocytes.
In the absence of added extracellular calcium, the addition of reduced glutathione 
(final concentration ofl.OmM) had no significant effect on free cytosolic calcium 
levels (figure 42). The subsequent addition of calcium (final concentration ImM) 
resulted in no significant change in [Ca]v In a separate group of experiments, the 
addition of extracellular calcium (final concentration ImM) resulted in a rise in 
[Ca]j. The subsequent addition of reduced glutathione (final concentration l  .OmM) 
resulted in a rapid and significant fall in [Ca]j from 150±23nM (n=3) to 55±21nM 
(n=4) (figure 43).
7.1.1.3 Effect of oxidised glutathione (GSSG) on free cytosolic calcium in rat 
myocytes.
The effect of the extracellular addition of oxidised glutathione (GSSG) on [Ca]j in 
rat myocytes is shown in figure 44. GSSG significantly increased [Ca]j at a final 
concentration of 0.75-1.0mM. This effect was partly attenuated by the subsequent 
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Figure 42. Typical trace of the effect of reduced glutathione (GSH) (ImM)
on an increase in free intracellular calcium associated with adjusting
extracellular calcium to ImM (final concentration) in a suspension of
isolated rat ventricular myocytes. The reduction in [CaJ following the
addition of ImM calcium in the cells pre-treated with 0.5mM GSH may
represent inadequate stirring or an increase in intracellular calcium
sequestration rendering it fura-2 insensitive. The traces overlap and 


















Figure 43. Typical trace of the effect of reduced glutathione (GSH) 
(0.5mM) on free intracellular calcium in a suspension of isolated rat 
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Figure 44. Typical trace of the effect of oxidised glutathione (GSSG) 
(0.1-1.0mM) and the subsequent addition of reduced glutathione (GSH) 
(0.5mM) on free intracellular calcium in a suspension of isolated rat 
ventricular myocytes.
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7.1.1.4 Effect of U44619, GR 3219IB and reduced glutathione on free cytosolic 
calcium in rat myocytes.
The potential role of thromboxane A2 in changes in [Ca]i} that may be modulated 
by reduced glutathione during ischaemia/oxidative stress, was investigated by the 
use of a thromboxane A2 mimetic, U44619.
The addition U44619 (lpM final concentration), to rat myocytes in the presence 
of ImM extracellular calcium, resulted in a sustained rise in [Ca]j of 115±55nM 
(n=3) from a resting value of 140±30nM (n=3) (figure 45). In a separate group of 
cells, the addition of a selective thromboxane A2 receptor antagonist, GR 3219IB 
(lOpM final concentration), resulted in no significant change in [Ca]j. There was a 
small, significant rise in [Ca]j of 15±6nM (n=3) in response to the subsequent 
addition of U44619 (lpM final concentration); this rise was significantly less than 
the rise in [Ca^ in response to lpM U44619 alone confirming its effect is 
thromboxane A2-receptor mediated. The increase in [Ca]j in the myocytes 
exposed to lpM U44619 alone was reversed and sustained by the addition of 
reduced glutathione (final concentration 0.5mM). From a resting concentration of 
2S<Q:30nM (n=5), [Ca^ fell to *121 ‘±l^nM (n-S’) following the addition of GSH 
(final concentration 0.5mM); 0.5mM GSH slightly but significantly reduced [Ca]* 
in the cells exposed to both lOpM GR 32191B and lpM U44619 (figure 45).
7.1.2 Platelets.
In addition to the experiments with isolated rat myocytes, a similar group of 
experiments were performed using isolated rabbit platelets.
7.1.2.1 Effect of oxidised and reduced glutathione.
The addition of exogenous calcium to the cell suspension resulted in a sustained 
rise in intracellular calcium, reaching a plateau of 115±25 nM (n=3) within 2 
minutes (figure 48). The subsequent addition of reduced glutathione (ImM) 
resulted in a rapid, significant and sustained fall in [Ca]j plateauing at 60+18 nM 
(figure 48). In a separate group of cells, the addition of oxidised glutathione 
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Figure 45. Typical traces of the effect of reduced glutathione (GSH) 
(0.5mM) on a rise in free intracellular calcium associated with the addition 
of the thromboxane A2 mimetic, U44619 (lpM) to a suspension of isolated 
rat ventricular myocytes.
(Multiple copies of typical traces of this set of experiments 
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Figure 45. Typical traces of the effect of reduced glutathione (GSH) 
(0.5mM) on a rise in free intracellular calcium associated with the addition 
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Figure 45. Typical traces of the effect of reduced glutathione (GSH) 
(0.5mM) on a rise in free intracellular calcium associated with the addition 
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Figure 45. Typical traces of the effect of reduced glutathione (GSH) 
(0.5mM) on a rise in free intracellular calcium associated with the addition 
of the thromboxane A2 mimetic, U44619 (lpM) and on the effect of GR 
32191B (lOpM) to a suspension of isolated rat ventricular myocytes.
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7.1.2.2 Effect of U44619 and GR 32191B.
Following equilibration of washed platelets with extracellular calcium (final 
concentration ImM), the addition of U44619 (final concentation lpM) resulted in a 
sustained rise in [CaJj of 575±190M (n=4) from a resting value of 37.5±4.7nM 
(figure 50). The subsequent addition of reduced glutathione (final concentration 
0.5mM) resulted in a rapid and significant fall in [Ca]j to 35±7.9nM (n=5). In 
another group of cells left to equilibrate with extracellular calcium (final 
concentration ImM), the addition of GR 3219IB (final concentration lOpM) 
resulted in no significant change in [Ca]  ^ The subsequent addition of U44619 
(final concentration lpM) resulted in a significantly depressed increase in [Ca]j 
compared to the cells exposed to the thromboxane A2 mimetic alone. The 
subsequent addition of GSH (final concentration 0.5mM) resulted in a small but 
insignificant change of [Ca]j (figure 50).
The results obtained with both these cell types in response to selected 
pharmacological agents are both quantitatively and qualitatively similar, possibly 
indicating common methods by which free intracellular calcium is regulated and 
























Figure 48. Effect of reduced glutathione (GSH) (ImM) on free intracellular 
calcium in isolated rabbit washed platelets. Extracellular calcium was increased 
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Figure 49. Effect of oxidised glutathione (GSSG) (0.1-1.OmM) on free intracellular calcium 
in isolated rabbit washed platelets. Extracellular calcium was increased to ImM at the 
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Figure 50. Typical trace of the effect of reduced glutathione (GSH) 
(0.5mM) on a rise in free intracellular calcium associated with the 
addition of the thromboxane A2 mimetic, U44619 (lpM) to a suspension 
of isolated rabbit washed platelets.
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Figure 50. Typical trace of the effect of reduced glutathione (GSH) 
(0.5mM) on a rise in free intracellular calcium associated with the 
addition of the thromboxane A2 mimetic, U44619 (lpM) to a suspension 
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Figure 50. Typical trace of the effect of reduced glutathione (GSH) 
(0.5mM) on a rise in free intracellular calcium associated with the 
addition of the thromboxane A2 mimetic, U44619 (lpM) to a suspension 
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Figure 50. Typical trace of the effect of reduced glutathione (GSH) 
(0.5mM) on a rise in free intracellular calcium associated with the 
addition of the thromboxane A2 mimetic, U44619 (lpM) to a suspension 
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Figure 50a. Effect of GR 32191B (lOpM), U44619 (lpM) and reduced glutathione 





In the afore-mentioned experiments, reduced glutathione has been shown to delay 
the onset of an ischaemic contracture, reduce reperfusion-induced 86rubidium 
efflux, attenuate the ischaemically-induced loss of Na/K ATPase activity in the rat 
heart, increase the activity of an isolated bovine Na/K ATPase preparation and 
increase Na-pump current in isolated rat ventricular myocytes. In this set of 
experiments, the change in free intracellular calcium concentration ([Ca]j) in 
isolated rat ventricular myocytes was measured in response to reduced glutathione 
and related compounds using a fluorometric method and the calcium-sensitive 
probe, fura-2. The data from these experiments shows that GSH reduces and GSSG 
increases free intracellular calcium, respectively, adding weight to the hypothesis 
that the intracellular ratio of GSH/GSSG may be an important factor in the 
regulation of ion translocating systems involved in calcium homeostasis.
It is assumed that an ischaemically-induced contracture is a consequence of 
intracellular calcium overload (Hearse et al., 1977). This contracture is caused by 
an inadequate supply of ATP which cannot dissociate the actin-myosin cross 
bridges, or enable the restoration of basal cytosolic calcium levels to below the 
micromolar range (Grossman and Barry, 1980). An ischaemically-induced rise in 
intracellular calcium has been suggested to activate a variety of catabolic enzymes 
which may be partly responsible for cell injury under such conditions (Katz and 
Reuter, 1979; Nayler et al., 1979; Poole-Wilson et al., 1984). Several groups have 
measured free intracellular calcium in both isolated ischaemic tissues and cells 
using fluorescent calcium-sensitive dyes. A very rapid increase in systolic and 
diastolic [Ca]j following the onset of ischaemia has been shown in rabbit hearts 
loaded with the calcium-sensitive dye, indo-1 (Lee et al., 1988). In isolated 
myocytes, an increase in [Ca]j following metabolic inhibition preceded cell death 
(Cobbold and Bourne, 1984). However, there is evidence from this group that in an 
individual myocyte a rise in [Cajj occurs after the cell exhibits extreme contracture.
In view of the stimulatory and inhibitory action of reduced and oxidised 
glutathione, respectively, on isolated bovine ventricular Na/K ATPase and the 
ability of reduced glutathione and other sulphydryl compounds to attenuate an 
ischaemic contracture in the isolated rat heart, the effect of these compounds on 
free cytosolic calcium in isolated rat myocytes was investigated. The effect of
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sulphydryl blocking agents was also studied to assess the possible involvement of 
sulphydryl groups in intracellular calcium homeostasis. The exogenous 
application of reduced and oxidised glutathione, and other selected sulphydryl 
compounds, to a suspension of isolated myocytes may be analogous to the change 
in redox state observed during ischaemia (Ferrari et al., 1989) although other 
physiological parameters, such as intra- and/or extracellular [Na+], [K+] and 
[Ca2+] are also altered in the pathological situation (Knopf et al., 1990). These 
experiments were undertaken in an attempt to extrapolate the effects of GSH and 
GSSG on an ischaemic contracture in the isolated rat heart and on the activity of 
bovine Na/K ATPase, to their effects on [Ca]j levels in rat myocytes. A 
stimulatory action of GSH on Na/K ATPase may indirectly reduce [Ca]j via an 
effect on Na/Ca exchange and this could be responsible for the ability of GSH to 
delay the onset of an ischaemically-induced contracture.
Under resting conditions, ImM reduced glutathione significantly reduced [Ca]j in 
a suspension of isolated rat ventricular myocytes. In a separate group of cells in 
which the [Ca^ was artificially raised by the addition of a thromboxane Aj 
mimetic U44619, (final concentration 30pM), 0.5mM GSH reduced [Ca]  ^ GSH 
does not readily cross the cell membrane although its prolonged extracellular 
application may significantly increase intracellular GSH levels (Martensson e t  Jil, 1989) 
and in a suspension of isolated cells this effect may be potentiated. Therefore, 
during the time scale of these experiments, it would appear that GSH acts 
primarily at sites located on the extracellular surface but may ultimately influence 
the intracellular redox state/glutathione status by increasing intracellular GSH.
There is no indication from these experiments as to whether GSH acts directly to 
sequest [Ca]j or whether it acts through a second messenger system. In contrast to 
the effects of GSH, GSSG increased [CaJj in a concentration-dependent manner.
GSSG would not be expected to enter the cell and, therefore, it would also appear 
to act primarily at extracellular sites. From the work of Ferrari et al. (1989), the 
concentration of GSSG in the coronary perfusate immediately after reperfusion is 
approximately 30nM. This is significantly lower than the concentrations of GSSG 
used in the experiments described here. However, there is the possibility that 
significantly higher concentrations of GSSG may occur in localized areas. The
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concentration of GSSG in the perfusate is inevitably a mean of the concentration of 
GSSG in all localities. ImM reduced glutathione partially reversed the 
GSSG-induced increase in [Ca]*. It is possible, therefore, that the reversible 
oxidation and reduction of disulphide bonds is responsible for the cells response to 
GSH and GSSG. If the Na/K pump is involved in calcium homeostasis in this 
experimental situation, GSH may reduce disulphides located extracellularly 
resulting in an increase in pump activity, leading to a net loss of calcium from the 
cell. The converse may be true for GSSG. However, the sulphydryl groups essential 
for Na-pump activity are located on the intracellular surface (Rothstein, 1970). This 
raises the possibility that GSH and GSSG affect the structure and function of the 
beta subunit of the Na-pump, thereby altering the insertion and activity of the 
catalytic alpha subunit. Alternatively, in the whole cell situation GSH and GSSG 
may affect the activity of other ion translocating systems involved in [CaJj 
homeostasis such as the Na/Ca and Na/H exchange mechanisms. Although these 
experiments have only examined the extracellular application of GSH and GSSG, 
the data from the electrophysiological investigations of GSH and GSSG on 
Na-pump current described earlier in this thesis, show that this pump can be 
modulated by changes in intracellular redox state. Therefore, the intracellular 
presence of oxidants and reductants during ischaemia may modulate Na-pump 
activity and [CaJj. In a separate group of experiments, the effect of all the 
compounds used in this set of experiments, on the calcium binding of fura-2 was 
investigated. The free acid of fura-2 was used in these experiments. The fluorimeter 
was calibrated using ImM calcium and excess EGTA. The
fluorescence signal resulting from the binding of Ca2+ to fura-2 was monitored any 
any change following the addition of the compound in question determined. This 
data showed that neither GSHofGSSG, affected the calcium
handling of fura-2, indicating that these compounds affect [Ca]j levels and not 
calcium/fura-2 binding.
The Na/Ca exchange mechanism may be involved in the rise of [Ca^ during 
ischaemia. After approximately 10 minutes of myocardial ischaemia there is a 
significant increase in [Na]j (Pike et al., 1988) which is secondary to an 
intracellular acidosis-stimulated increase in Na/H exchange. The time course of the
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ischaemically-induced rise in [Na]j is similar to that of [Ca]j and therefore Na/Ca 
exchange may be responsible for an increase in [Ca]j. If the Na/H exchange 
mechanism is blocked with amiloride or its derivatives, such as 
ethylisopropylamiloride (EIPA), the increase in [Na]j is prevented (Cala et al., 
1988) as is the rise in [Ca]j (Murphy et al., 1987). Interaction of GSH and GSSG 
with these proteins should be investigated via the use of amiloride and its 
derivatives to further elucidate the mechanism by which GSH and GSSG modulate 
[Ca]j under physiological conditions.
Unlike reduced glutathione, glutathione mono-isopropyl esters pass readily through 
the cell membrane where they are de-esterified. This causes an increase in 
intracellular glutathione concentration significantly above basal levels and this may 
represent an experimental approach by which the effect of [GSH^ on [Cajj may be 
studied with more relevance to the in vivo situation (Martensson et al., 1989). 
There is the possibility that this type of compound and experimental strategy may 
be useful agents in the investigation of the relative contribution of cardioprotective 
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9.1 THE EFFECT OF ACIDOSIS IN ISOLATED VASCULAR  
PREPARATIONS.
9.1.1 THE CORONARY VASCULATURE.
In common with the Na/K pump, the Na/H exchange mechanisim is an intrinsic, 
membrane protein involved in intracellular ion homeostasis. In order to investigate 
whether GSH and other thiols could affect Na/H exchange, the physiological 
response of the heart to a change in pH and the modulation of the response by 
reduced glutathione and related compounds was investigated as this may be 
indicative of an effect on Na/H exchange. This was approached by perfusing the 
rat coronary vasculature with an acidotic perfusate and monitoring the 
physiological and mechanical responses.
9.1.1.1 Effects of acidosis in control hearts.
During myocardial ischaemia, intracellular pH is known to fall relatively rapidly to 
a minimum of approximately pH 6.8 (Knopf et al., 1990). For this reason a 
bicarbonate-buffered perfusate (NaHC03 final concentration 25.0mM) at pH 6.8 
was used to induce acidosis in preliminary experiments. Figure 51 shows typical 
responses of cardiac contractility, perfusion pressure and heart rate in response to 
extracelluar acidosis. The reduction of extracellular pH to pH 6.8 resulted in a 
concomitant reduction in heart rate, developed tension and rise in perfusion 
pressure, that is indicative of coronary vasoconstriction in this model. In control 
hearts, perfusion pressure rose in response to acidosis at a rate of 23.6±0.7 
mmHg/minute (n=6). The effects of acidosis on coronary tone and cardiac 
contractility were completely reversible by switching between perfusates buffered 
at pH 7.4 and 6.8, and this could be repeated at least 10 times in the same heart 
(data not shown).
9.1.1.2 Effect of a reduction in extracellular sodium concentration ([Na]0) and the 
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Figure 51. Typical trace of the effects of extracellular acidosis (pH 6.8) on 
coronary perfusion pressure, cardiac contractility and heart rate in the 
isolated perfused rat heart The pH of the Krebs-Henseleit buffer is 
indicated by the arrows.
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As described above, the pH of the Krebs-Henseleit solution was adjusted by 
lowering the NaHC03 concentration, which inevitably results in a reduction in 
sodium concentration (as well as bicarbonate concentration) which would be 
expected to alter Na/Ca exchange. Therefore, the effect of reducing the sodium 
concentration of the buffer on coronary tone, without affecting the HCO'3 
concentration, was investigated. This was achieved by reducing the NaCl content 
to give the same reduction in sodium concentration ([Na]) as in the acidotic 
perfusate prepared by NaHC03 reduction. This represented a 5mM reduction in 
[Na]. The effect of reducing the [Na] was a slight but insignificant rise in cardiac 
contractility but no effect on coronary perfusion pressure (data not shown). It is 
unlikely that the decrease in bicarbonate concentration had any significant effect 
on ionised calcium concentration in the perfusate (Schaer, 1974).
To investigate the effect of the method of pH reduction of the Krebs-Henseleit 
buffer on the physiological response of the heart to acidosis, the pH of the 
solution was reduced to pH 6.8 by the addition of 1M HC1. There was no 
significant difference in the physiological response of hearts subjected to acidosis 
by perfusion with acidotic perfusate prepared by either of the two methods 
described, with respect to changes in perfusion pressure, cardiac contractility and 
heart rate (data not shown).
9.1.1.3 Effect of extracellular pH on coronary tone in the isolated perfused rat 
heart.
The relationship between coronary tone and extracellular pH was investigated by 
perfusion with Krebs-Henseleit solutions buffered at pH values betwen 7.4 and 
6.8 and the rate of rise of perfusion pressure per minute recorded. Figure 52 
shows that coronary tone was significantly increased, with respect to controls, at 
all pH values investigated. For the purposes of simplicity, cost and available time, 
all subsequent experiments were performed at pH 6.8.
9.1.1.4 Effect of adrenoceptor agonism.
To investigation any involvement of catecholamines, that are released in response
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Figure 52. Effect of perfusate-pH (pH 6.8-7.4) on perfusion 
pressure in the isolated perfused rat heart. Vertical bars 
represent+s.e.mean. (n=8-5 hearts/group, *p<0.05, **p<0.01, 
***p<0.001 cw controls at pH  7.4.
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to myocardial acidosis (Dart and Riemersma, 1989), in the progression of the pH 
dependent coronary vasoconstriction, alpha-adrenoceptors were blocked under 
acidotic conditions with lpM phentolamine and the pressor response to acidosis 
monitored. Figure 53 shows the effect of the alpha-adrenoceptor antagonist, 
phentolamine, on the coronary vasoconstrictor response to perfusion with an 
acidotic perfusate at pH 6.8. At pH 7.4 and a concentration of lpM, the perfusion 
of phentolamine resulted in a significant transient fall in perfusion pressure of 
15.2±2.2 mmHg, that is indicative of coronary vasodilation. At pH 6.8, the same 
concentration of phentolamine significandy reduced the acidosis-induced coronary 
constriction which indicates the involvement of catecholamines or some other 
non-specific effect of phentolamine in the pressor response to acidosis (figure 53).
9.1.1.5 Effect of cyclooxygenase inhibitors.
The cyclooxygenase pathway is responsible for the synthesis of several vasoactive 
compounds (Figure 54) that may play a part in the pH-dependent yasoconstriction 
of the coronary vasculature in this model (thromboxane A2, PGF2 and several of 
the leukotrienes cause coronary constriction, while prostacyclin causes coronary 
dilation). To investigate this hypothesis, the effect of inhibiting this pathway with 
several selective cyclooxygenase inhibitors on the hearts physiological response to 
acidosis was studied. All compounds were perfused at previously determined 
concentrations that give complete cyclooxygenase inhibition (Flower, 1974).
lOpM flurbiprofen perfused at pH 7.4 resulted in a transient and significant fall in 
perfusion pressure of 24.5±5.2 mmHg, from a resting pressure of 42.5±5.5 mmHg, 
that is indicative of coronary vasodilation in this model. The subsequent perfusion 
of the same concentration of flurbiprofen at pH 6.8 resulted in a significant 
reduction in the rate of rise of coronary perfusion pressure associated with 
acidosis. Under these conditions perfusion pressure rose at 12.3±2.8 mmHg/minute 
compared to the response in control hearts (in the absence of flurbiprofen), in 
which perfusion pressure rose at 26.2±2.1 mmHg/minute (figure 55).
A comparison was made of the effects of flurbiprofen with another cyclooxygenase 
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Figure 53. Effect of phentolamine (phent) (lpM) on a pH-dependent 
coronary constriction in the isolated, perfused rat heart Vertical bars 
represent dts.e.mean. (n=4, *p<0.05)cw controls.
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Figure 55. Effect of BW 755C (lOOpM), GR 32191B (lOpM), 
indomethacin (28pM), flurbiprofen (lOpM) and aspirin (ImM) on the 
rate of rise of perfusion pressure at pH 6.8 in the isolated perfused rat 
heart. Vertical bars represent ±s.e.mean. (n=4, **p<0.01 cw controls).
at pH 7.4 resulted in a transient and significant fall in coronary perfusion pressure 
of 22.5±4.6 mmHg that was not significantly different to the effect of 
indomethacin on resting pressure at pH 7.4. The subsequent perfusion of lOpg/ml 
indomethacin at pH 6.8 resulted in a rise in perfusion pressure at a rate of 4.3±1.6 
mmHg/minute, which represented a significant reduction in the rate of coronary 
constriction compared to control responses in the absence of indomethacin (figure 
55).
In contrast to flurbiprofen and indomethacin, acetylsalicylic acid (aspirin) is a 
non-reversible cyclooxygenase inhibitor. The effect of aspirin on the pH-dependent 
vasoconstriction was studied using the same protocol as for the studies with 
flurbiprofen and indomethacin. Unlike the two reversible cyclooxygenase inhibitors 
studied, the perfusion of ImM aspirin at pH 7.4 resulted in a sustained rise in 
perfusion pressure of 11.7±1.1 mmHg. The perfusion of ImM aspirin at pH 6.8 
resulted in a potentiation of the vasoconstrictor response such that in response to 
acidosis the perfusion pressure rose at 57.5±3.2 mmHg/minute (figure 55).
9.1.1.6 Effects of dual cyclooxygenase/lipoxygenase inhibition.
The effect of the dual cyclooxygenase/lipoxygenase inhibitor BW 755C on the 
physiological response of the coronary vasculature to a reduction in pH was also 
investigated. Perfusion of lOOpM BW 755C at pH 7.4 resulted in a significant 
transient vasodilation of 21.3±2.4 mmHg from a basal resting pressure of 49.8±1.9 
mmHg which was not significantly different to the vasodilation at pH 7.4 reported 
above with lOpM flurbiprofen and 28pM indomethacin. The subsequent perfusion 
of lOOpM BW 755C at pH 6.8 resulted in a significant attenuation of the 
pH-dependent vasoconstriction. Compared to a rise in perfusion pressure in 
response to acidosis of 25.75±2.2 mmHg/minute in control hearts, lOOpM BW 
755C significantly reduced this effect such that prefusion pressure rose at 5.25±1.1 
mmHg/minute (figure 55).
9.1.1.7 Effects of thromboxane A2 receptor antagonism.
In view of the observation that flurbiprofen and indomethacin both significantly
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attenuated the rise in coronary perfusion pressure in response to acidosis, the 
potential involvement of thromboxane A2 in this response was investigated. This 
was approached by the use of GR 3219IB, a potent and selective thromboxane A2 
receptor antagonist (Ritter et al., 1990). Perfusion of lOpM GR 32191B at pH 7.4 
resulted in a transient but significant fall in coronary perfusion pressure of 
13.5±5.1 mmHg from a resting pressure of 48.5±5.6 mmHg. The subsequent 
perfusion of lOpM GR 32191B at pH 6.8 resulted in a significant attenuation of 
the pH dependent vasoconstriction such that in response to acidosis the perfusion 
pressure rose at 8.25±1.18 mmHg/minute (figure 55).
9.1.1.8 Effects of reduced glutathione and related compounds.
The physiological response of the heart to acidosis in the presence of reduced 
glutathione and related compounds was investigated and compared to the responses 
observed in control hearts to see if GSH might affect Na/H exchange which is 
involved in the physiological response of the heart to acidosis.
9.1.1.9 Reduced glutathione.
As previously described, the perfusion of ImM reduced glutathione (GSH) at pH
7.4 resulted in a sustained and significant fall in perfusion pressure of 32.8±3.4 
mmHg from a resting pressure of 55.5±2.9 mmHg. The subsequent perfusion of 
ImM GSH at pH 6.8 resulted in a significant potentiation of the constrictor 
response to acidosis (figure 56). In the presence of ImM GSH at pH 6.8, the 
coronary perfusion pressure rose at 90.0±7.07 mmHg/minute. Figure 57 shows that 
the efficacy of reduced glutathione to potentiate the pH-dependent vasoconstriction 
was concentration-dependent within the range 0.25-1.0 mM.
9.1.1.10 Glycine, cysteine and glutamate.
Reduced glutathione is a tripeptide consisting of the amino acid residues glycine, 
cysteine and glutamate (figure 1). For this reason, the effect of these individual 
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Figure 56. Typical trace of the effect of the perfusion of reduced 
glutathione (ImM) at pH 7.4 and pH 6.8 on coronary perfusion pressure, 
cardiac contractility and heart rate in the isolated perfused rat heart
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[GSH] mM
Figure 57. Effect of reduced glutathione (GSH) (0.25-1.0 mM), at pH 6.8, 
on the rate of rise of perfusion pressure in the isolated perfused rat heart 
Vertical bars represent ±s.e.mean. (n=6, *p<0.05, **p<0.01, ***p<0.001 cw  
controls).
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The perfusion of ImM glycine at pH 7.4 resulted in no detectable change in basal 
coronary perfusion pressure. The subsequent perfusion of 1 mM glycine at pH 6.8 
resulted in a constrictor response during which the perfusion pressure rose at 
21.8±0.5 mmHg/minute. This was not significantly different to control responses to 
acidosis in the absence of glycine. In common with glycine, the perfusion of ImM 
glutamate at pH 7.4 had no detectable effect on basal coronary perfusion pressure. 
The perfusion of glutamate under acidotic conditions resulted in a rise in perfusion 
pressure of 32.0±2.0 mmHg/minute representing a significant potentiation of the 
constrictor effect in response to acidosis (figure 58).
The pre-perfusion of ImM cysteine at pH 7.4 resulted in a significant fall in 
perfusion pressure of 34.2±3.5 mmHg, from a resting pressure of 53.2±4.2 mmHg, 
that was not significantly different to the effect of the pre-perfusion of ImM 
reduced glutathione at pH 7.4. The subsequent perfusion of ImM cysteine at pH
6.8 resulted in no recordable change in coronary perfusion pressure in contrast to 
the pressor effect seen in response to acidosis in the absence of cysteine (figure 
58).
In view of the observation that ImM cysteine completely abolished the 
pH-dependent coronary vasoconstriction, concentration-effect studies were carried 
out within the range 0.25-1.0 mM. Figure 59 shows the results from these 
experiments. At a concentration of 0.25mM, cysteine still significantly attenuated 
the pH-dependent vasoconstriction. The minimum concentration of cysteine that 
could significantly attenuate the constrictor response to acidosis was approximately 
0.07mM.
9.2 THROMBOXANE B2 RELEASE IN RESPONSE TO MYOCARDIAL 
ACIDOSIS.
9.2.1 Control responses.
Figure 60 shows the release of thromboxane B2, the relatively stable metabolite of 
thromboxane A2, in response to two acidotic insults of 5 minutes duration at pH 
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Figure 58. Effect of reduced glutathione (GSH) (ImM), glycine (gly) 
(ImM), glutamate (Glu) (ImM), cysteine (ImM), and cystine (ImM) on 
the rate of rise of perfusion pressure at pH 6.8 in the isolated perfused rat 
heart Vertical bars represent ±s.e.mean. (n=4-6, *p<0.05, ***p<0.001 cw 
controls).
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Figure 59. Effect of cysteine (0.25-1 .OmM) on the rate of rise 
of perfusion pressure at pH  6.8 in the isolated perfused rat 
heart. Vertical bars represent+s.e.mean. (n=4 hearts/group, 
*p<0.05, **p<0.01, ***p<0.001 cw OmM cysteine controls).
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Figure 60. Effect of acidosis (pH 6.8), in the presence and absence of 
ImM cysteine (cys), on thromboxane B2 efflux from the isolated 
perfused rat heart Vertical bars represent ±s.e.mean. (n=3, *p<0.05, 
**p<0.01 cw controls).
thromboxane B2 was detected in coronary perfusate samples in response to 
acidosis, induced by perfusion of a crystalloid buffer at pH 6.8, compared to 
samples collected during control periods of perfusion at pH 7.4. Thromboxane B2 
release and, by inference, thromboxane A2 release peaked 3 minutes after the onset 
of the acidotic insult and was not maintained; during the remainder of the acidotic 
insult, thromboxane A2 synthesis decayed and returned to control levels upon 
switching to a perfusate at pH 7.4. There was no significant difference between the 
total thromboxane B2 detected during the first acidotic insult and the second 
subsequent insult (figure 60).
9.2.2 Effect of cysteine on thromboxane B2 perfusate levels in response to acidosis.
Figure 60 shows control levels of thromboxane B2 detected in coronary perfusate 
samples during the perfusion of normal and acidotic buffer. The perfusion of ImM 
cysteine at pH 7.4 had no significant effect on the peak level of thromboxane B2 
detected. However, at pH 6.8 the perfusion of ImM cysteine significantly 
attenuated the peak level of thromboxane B2 detected, as well as the total 
thromboxane B2 released during the 5 minute acidotic insult. The peak level of 
thromboxane B2 detected during acidosis in the presence of ImM cysteine was still 
significantly greater than under conditions of normal pH.
9.1.1.11 INVESTIGATIONS INTO THE POSSIBLE MODES OF ACTION OF 
REDUCED GLUTATHIONE AND CYSTEINE UNDER ACIDOTIC 
CONDITIONS IN THE RAT CORONARY VASCULATURE.
9.1.1.11.1 Reduced glutathione.
In view of the observations that the cyclooxygenase inhibitors flurbiprofen and 
indomethacin both attenuated a pressor effect in response to acidosis in the 
coronary vasculature, their effect on the potentiation of the constriction by reduced 
glutathione was investigated. The rationale behind these experiments was that 
reduced gluathione may attenuate basal prostacyclin synthesis and release, or 
preferentially favour the synthesis of the vasoconstrictor compound, thromboxane 
A2 (figure 54).
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The perfusion of lOpM flurbiprofen at pH 7.4 resulted in a significant fall in 
perfusion pressure of 21.0±6.5 mmHg, as previously described. The addition of 
ImM reduced glutathione resulted in a further dilation of 7.5±3.2 mmHg from a 
resting pressure of 40.2±5.2 mmHg. The subsequent and simultaneous perfusion of 
lOpM flurbiprofen and ImM GSH at pH 6.8 resulted in a rise of perfusion 
pressure of 15.0±2.4 mmHg/minute (figure 61). This represents a significant 
reduction in the rate of constriction compared to the response to acidosis in the 
presence of ImM reduced glutathione alone.
The perfusion of lOpg/ml indomethacin at pH 7.4 resulted in a significant fall in 
perfusion pressure of 25.2±3.4 mmHg. The addition of ImM reduced glutathione 
resulted in no further detectable change in perfusion pressure. The subsequent 
perfusion of 28pM indomethacin and ImM GSH at pH 6.8 resulted in a rise in 
perfusion pressure at 17.5±4.2 mmHg/minute (figure 61). This represents a 
significant reduction in the rate of constriction compared to the response to 
acidosis in the presence of ImM reduced glutathione alone.
p
The perfusion of the dual cyclooxygenase/lioxygenase inhibitor BW 755C (100 
pM) at pH 7.4 resulted in a significant fall in perfusion pressure of 23.5±3.5 
mmHg from a resting pressure of 55.2±6.2 mmHg. The subsequent addition of 
ImM reduced glutathione resulted in a further dilation of 5.5±2.2 mmHg. The 
subsequent and simultaneous perfusion of lOOpM BW 755C and 1 mM GSH at pH
6.8 resulted in a rise in perfusion pressure at 19.3±2.2 mmHg/minute (figure 61). 
This represents a significant reduction in the rate of coronary constriction 
compared to the response to acidosis in the presence of ImM GSH alone.
The effect of a selective thromboxane A2 antagonist, GR 3219IB, on the 
potentiation of the pH-dependent vasoconstriction was also investigated. The 
perfusion of lOpM GR 32191B at pH 7.4 resulted in a significant fall in perfusion 
pressure of 10.6±3.5 mmHg from a resting pressure of 50.1±5.2 mmHg. The 
addition of ImM reduced glutathione resulted in no further recordable change in 
perfusion pressure. The subsequent, simultaneous perfusion lOpM GR 32191B and 
ImM GSH at pH 6.8 resulted in a rise in perfusion pressure of 16.2±2.6 
mmHg/minute (figure 61). This represents a significant attenuation of the rate of 
constriction compared to the response to acidosis in the presence of ImM GSH
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Figure 61. Effect of flurbiprofen (lOmM), indomethacin 
(28mM), GR 32191B (lOmM) and BW 755C (lOOmM) on the 
potentiation of the rate of rise of perfusion pressure by 
reduced glutathione (GSH) (ImM) at pH 6.8 in the isolated 
perfused rat heart. Vertical bars represent mean+s.e.mean. 
(n=4 hearts/group, ***p<0.001 cw control pH 6.8 perfusions, 




There was no significant difference between the ability of flurbiprofen, 
indomethacin, BW 755C and GR 32191B, at the concentrations used, to attenuate 
the potentiation of the pH dependent vasoconstriction by ImM GSH.
In view of the abiltity of the alpha-adrenoceptor antagaonist, phentolamine, to 
attenuate the physiological response of the coronary vasculature to an acidotic 
insult, its effect on the potentiation of this response by ImM reduced glutathione 
was investigated. The perfusion of lpM phentolamine at pH 7.4 resulted in a 
significant fall in perfusion pressure of 15.9±3.1 mmHg. Following the addition of 
ImM reduced glutathione there was no further change in basal perfusion pressure. 
Under acidotic conditions the simultaneous perfusion of lpM phentolamine and 
ImM reduced glutathione resulted in a rise in perfusion pressure of 75.2±5.3 
mmHg/minute that represents a significant attenuation of the rate of constriction 




As previously described, cysteine significantly attenuated the coronary 
vasoconstriction in response to acidosis in a concentration-dependent manner 
(0.25-1.OmM). Experiments were undertaken to investigate mechanisms by which 
cysteine may exert this effect. The possible involvement of endothelium-derived 
relaxant factor (EDRF) in the ability of cysteine to attenuate the pH dependent 
vasoconstriction was investigated by the use of L-NG-nitro-arginine, a selective 
and potent inhibitor of EDRF synthesis {Moore et al., 1990). In this set of 
experiments an intermediate concentration of cysteine (O.lmM) was used so that 
any effect of L-NG-nitro-arginine on the ability of cysteine to attenuate the pressor 
effect in response to acidosis could be observed.
The perfusion of O.lmM cysteine at pH 7.4 resulted in a significant fall in 
perfusion pressure of 21.8±1.2 mmHg. The subsequent perfusion of the same 
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Figure 62. Effect of phentolamine (lpM) on the potentiation of an 
acidosis-induced coronary constriction by reduced glutathione (GSH) 
(ImM), in the isolated perfused rat heart Vertical bars represent ±s.e.mean. 
(n=4, *p<0.05 cw controls).
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Figure 63. Effect of L-N^-mtro-arginine (L-NOARG) 
(lOOmM), in the presence and absence of cysteine (O.lmM), 
on the rate of rise of perfusion pressure at pH 6.8 in the 
isolated perfused rat heart. Vertical bars represent 
+s.e.mean. (n=4 hearts/group, *p<0.05 cw control pH  6.8 
perfusion group).
17.5±1.4 mmHg/minute, which was significantly less than in the absence of 
O.lmM cysteine (figure 63). The perfusion of lOOpM L-NG-nitro-arginine at pH
7.4 resulted in a significant rise in perfusion pressure of 23.8±1.3 mmHg. Perfusion 
of the same concentration of L-NG-nitro-arginine at pH 6.8 resulted in a rise in 
perfusion pressure at 23.3±1.3 mmHg/minute. This was not significantly different 
to the response of coronary perfusion pressure to acidosis in the absence of 
L-NG-nitro-arginine. In hearts in which the coronary tone had been artifically 
raised by 23.8±1.3 mmHg by the perfusion of lOOpM L-NG_nitro-arginine at pH 
7.4, the perfusion of O.lmM cysteine resulted in a significant fall in perfusion 
pressure of 22.5±1.4 mmHg. The subsequent and simultaneous perfusion of lOOpM 
L-NG-nitro-arginine and O.lmM cysteine at pH 6.8 resulted in a rise in perfusion 
pressure of 17.4±1.1 mmHg/minute. This was not significantly different from the 
effect of O.lmM cysteine alone at pH 6.8 (figure 63). Therefore it appears unlikely 
that EDRF is involved in the ability of cysteine to significantly attenuate a 
pH-dependent vasoconstriction in the isolated coronary vascular bed of the rat
Experiments were also undertaken in order to assess whether cysteine exerts its 
ability to attenuate a pH-dependent coronary constriction by acting as a calcium 
channel antagonist. The isolated guinea-pig taenia-coli preparation was used for 
these studies described below.
9.1.1.11.2.1 Effects of cysteine on calcium-induced contraction.
The isolated guinea-pig taenia-coli was used to assess whether cysteine exerts an 
antagonistic effect on contractile responses of this preparation to calcium. 
Cumulative concentration-response curves were constructed to calcium (0.1- 
2.7mM) in potassium-depolarised (llOmM K+) preparations. Following the 
washout of the calcium, the effect of cysteine on calcium-induced contraction was 
investigated by suspending the tissue in ImM cysteine and repeating the 
cumulative addition of calcium in the presence of cysteine. ImM cysteine had no 











Figure 64. Comparison of the effects of cysteine (ImM) on the contractile 
response of isolated guinea-pig taenia coli with that of time-matched 
controls. Vertical bars represent ±s.e.mean. (n=4, *p<0.05 cw controls).
9.1.1.11.3 EFFECT OF CYSTEINE ON THE POTENTIATION OF A pH- 
DEPENDENT VASOCONSTRICTION BY REDUCED GLUTATHIONE IN THE 
CORONARY VASCULATURE.
In view of the observation that reduced glutathione potentiated while cysteine 
attenuated the vasoconstriction of the coronary vasculature in response to acidosis, 
the effect of cysteine on the potentiation of the pressor response to acidosis by 
reduced glutathione was investigated. The rat coronary vasculature was perfused at 
pH 7.4 with varying concentrations of cysteine (0.25-1.OmM) and any changes in 
perfusion pressure recorded. Further perfusion pressure changes following the 
addition of ImM reduced glutathione were also recorded. Subsequently, varying 
concentrations of cysteine (0.25-1.OmM) and ImM reduced glutathione were 
perfused simultaneously at pH 6.8 and the rate of rise of perfusion pressure 
determined.
Figure 65 shows that cysteine attenuated, in a concentration-dependent manner 
(0.25-1.OmM), the potentiation of the constrictor response to acidosis by ImM 
reduced glutathione; ImM cysteine completely abolished the pressor effect of 
ImM GSH.
9.1.1.12 EFFECT OF REDUCED DITHIOTHREITOL, DL-PENICILLAMINE, 
CAPTOPRIL, OXIDISED GLUTATHIONE, CYSTINE AND OXIDISED 
DITHIOTHREITOL ON THE PHYSIOLOGICAL REPONSE OF THE 
CORONARY VASCULATURE TO ACIDOSIS.
In common with reduced glutathione, DL-penicillamine, reduced dithiothreitol and 
captopril all contain a free sulphydryl group. Oxidised glutathione 
[dithiobis[l-[(carboxymethyl)carbamoyl]ethylene]]diglutamine), oxidised 
dithiothreitol (trans-4,5-dihydroxy-1,2-dithiane) and cystine are the oxidised, 
disulphide forms of reduced glutathione, reduced dithiothreitol and cysteine, 
respectively. With the above in mind, the effects of these compounds on the 
physiological response of the coronary vasculature to acidosis was investigated.
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Figure 65. Effect of cysteine (0.25-l.OmM) on the potentiation of an 
acidosis-induced coronary constriction by reduced glutathione (ImM) 
(GSH). Vertical bars represent ±s.e.mean. (n=4, °p<0.05, °°p<0.01, 
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Figure 66. Effect of DL-penidllamine (PSH) (ImM), reduced 
dithiothreitol (DTTred) (ImM) and captopril (ImM) on the 
rate of rise of perfusion pressure in the isolated perfused rat 
heart at pH 6.8. Vertical bars represent+s.e.mean. (n=6 
hearts/group, *p<0.05 cw  control group).
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9.1.1.12.1 DL-penicillamine, reduced dithiothreitol and captopril.
The perfusion of ImM DL-penicillamine (DL-PSH) at pH 7.4 resulted in a 
significant fall in perfusion pressure of 7.5±2.5 mmHg, indicative of coronary 
vasodilation. In this set of experiments the basal perfusion pressure was 45.2±5.2 
mmHg. Perfusion pressure rose at 8.5±2.3 mmHg/minute following the subsequent 
perfusion of ImM DL-PSH at pH 6.8 (figure 66). In a separate group of hearts, a 
fall in perfusion pressure of 21.5±2.2 mmHg followed the perfusion of ImM 
reduced dithiothreitol (DTTred) at pH 7.4. The perfusion of the same concentration 
of DTTred, at pH 6.8, resulted in a rise in perfusion pressure of 10.0±1.5 
mmHg/minute (figure 66). In another group of hearts, the perfusion of ImM 
captopril, at pH 7.4, caused a significant fall in perfusion pressure of 15.2±4.2 
mmHg. The subsequent perfusion of ImM captopril at pH 6.8 resulted in a rise of 
perfusion pressure of 12.2±0.8 mmHg/minute that was significantly less than the 
response to acidosis in control hearts in the absence of captopril (figure 66).
This data shows that in contrast to the effects of the free sulphydryl containing 
compound reduced glutathione, DL-penicillamine, reduced dithiothreitol and 
captopril all significantly attenuated the rise in coronary perfusion pressure in 
response to acidosis.
9.1.12.2 Oxidised dithiothreitol, cystine and oxidised glutathione.
The perfusion of ImM oxidised dithiothreitol (DTToxid) at pH 7.4 had no 
significant effect on basal perfusion pressure. Perfusion of the same concentration 
of DTToxid at pH 6.8 resulted in a rise in perfusion pressure of 28.0±1.7 
mmHg/minute (figure 67). At pH 7.4, the perfusion of ImM cystine resulted in no 
significant change in perfusion pressure. The perfusion pressure rose at a rate of 
22.6±4.3 mmHg/minute following the subsequent perfusion of the same 
concentration of cystine at pH 6.8. (figure 67). The perfusion of ImM oxidised 
glutathione (GSSG) at pH 7.4 had no significant effect on perfusion pressure. At 
pH 6.8, the perfusion of ImM GSSG resulted in a rise in perfusion pressure of 
25.6±5.1 mmHg/minute (figure 67). The effects of DTToxid, cystine and GSSG at 
pH 6.8 were not significantly different to the changes in coronary perfusion
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Figure 67. Effect of oxidised dithiothreitol (DTToxid) (ImM), 
cystine (ImM) and oxidised glutathione (GSSG) (ImM) on the 
rate of rise of perfusion pressure at pH 6.8 in the isolated 
perfused rat heart. VErtical bars represent+s.e.mean. (n=6 
hearts/group).
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pressure during acidosis in the absence of these compounds.
9.1.2 ISOLATED RAT MESENTERIC VASCULAR BED.
9.1.2.1 Control responses to acidosis.
In addition to the physiological response of the rat coronary vasculature to acidosis, 
the response of the isolated rat mesenteric bed to an acidotic insult, in the presence 
and absence of reduced glutathione was investigated.
From figure 68 it can be seen that upon changing the perfusate from pH 7.4 to 6.8 
there was no significant change in perfusion pressure. The viability of each 
preparation was confirmed in control and experimental tissues both prior to and 
after the acidotic insult by the perfusion of lOpM phenylephrine which resulted in 
submaximal vasoconstriction. In addition, acidosis had no effect upon the perfusion 
pressure of tissues pre-contracted with lOpM phenylephrine (figure 68).
9.1.2.2 Effect of reduced glutathione.
The perfusion of ImM reduced glutathione at pH 7.4 had no significant effect on 
basal perfusion pressure in both control tissues and tissues pre-contracted with 
lOpM phenylephrine. The perfusion of ImM reduced glutathione at pH 6.8 resulted 
in no detectable change in perfusion pressure in control tissues. In preparations 
pre-contracted with phenylephrine (lOpM), the addition of ImM reduced 
glutathione under acidotic conditions resulted in a further significant constriction, 
indicated by a rise in perfusion pressure of 18.2±3.2 mmHg (figure 68).
9.1.3 ISOLATED RAT THORACIC AORTA PREPARATION.
Acidosis has been recently reported in the literature to cause vasodilation of the 
isolated rat aorta using a HEPES-buffered physiological salt solution (PSS), the 
compostion of which is described in the methods (section 2.8) (Loutzenhiser et al„ 
1990), Experiments were undertaken to investigate the effect of acidosis, in the 
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Figure 68. Effect of acidosis, in the presence and absence of 
reduced glutathione (GSH) (ImM), on perfusion pressure in
untreated and pre-contracted (phenylephrine, IOjiM) isolated 
rat mesenteric beds. Vertical bars represent +s.e.mean. (n=4, 
*p<0.05 cw respective controls).
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Krebs-Henseleit buffer used in the acidosis experiments in the isolated rat heart 
and the alternative HEPES-buffered PSS described in the literature (Loutzenhiser 
et al., 1990). The aim was to determine if a feature of the buffer was responsible 
for the contrasting responses of acidosis in the coronary vasculature and larger 
vessels, such as the aorta.
Figure 69 shows the effects of lowering the pH from 7.4 to 6.8 on the tone of 
aortic rings pre-contracted with lOpM noradrenaline, using both perfusates 
described in the methods (section 2.1 & 2.8). In pre-contracted rings, acidification 
resulted in a transient reduction in tension of 28.0±2% (basal tension, +5.1±0.3g) 
using Krebs-Henseleit buffer and 26.0±2% using the HEPES-buffered PSS (basal 
tension, +5.2±0.3g). There was no significant difference between these two 
responses, which are in agreement with Loutzenhiser et al. (1990). At pH 7.4, 
ImM reduced glutathione caused a significant increased relaxation of preparations 
pre-contracted with lOpM noradrenaline using both types of buffer. Using normal 
Krebs buffer this relaxation was 36.0±3% (100% = 5.1±0.2g) and with the 
HEPES-buffered PPS, 38±2% (100% = 5.6±0.3g). Acidosis, in the presence and 
absence of ImM GSH using both types of buffer, had no effect on the tone of 
aortic rings that had not been previously pre-contracted with lOpM noradrenaline.
9.2 RADIOIMMUNOASSAY OF CORONARY PERFUSATE LEVELS OF 
CYCLIC GMP (cGMP) IN RESPONSE TO ACIDOSIS IN THE PRESENCE 
AND ABSENCE OF CYSTEINE.
Figure 70 shows that under resting conditions there was a relatively low detectable 
level of cGMP in coronary perfusate samples. The perfusion of ImM cysteine, at 
pH 7.4, resulted in a significant rise in perfusate cGMP levels. During acidosis, in 
the presence of ImM cysteine, the amount of cGMP detected in perfusate samples 
was significantly raised in comparison to levels during acidosis in the absence of 
cysteine. The subsequent washout with buffer at normal pH resulted in a return of 
perfusate cGMP levels to within control values.
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Figure 69. Effect of Krebs-Henseleit buffer (K-H) and HEPES-buffered 
physiological salt solution (HEPES-PPS), in the presence and absence 
of reduced glutathione (GSH) (ImM), at pH 6.8 on the tone of 
pre-contracted (lOpM noradrenaline (NA)) isolated rat thoracic aortae. 
The composition of the buffers is described in the methods (sections
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Figure 70. Effect of cysteine (ImM), under normal and acidotic 
conditions, on coronary perfusate cyclic GMP (cGMP) levels in the 
isolated perfused rat heart. Vertival bars represent +s.e.mean. (n=3, 





The ability of reduced glutathione and related compounds to modulate Na/K 
ATPase activity has been demonstrated. The physiological response of the 
coronary vasculature to acidosis, in the presence and absence of reduced 
glutathione and related compounds, was studied to investigate the effect of these 
compounds on the Na/H exchange mechanism as another example of an intrinsic, 
membrane-bound protein that is essential for the maintainance of cellular function 
and ionic homeostasis under normal and/or ischaemic conditions (Lazdunski et al., 
1985; Tani, 1990). The present investigations have shown that acidosis causes a 
pH-dependent rise in perfusion pressure that is indicative of coronary 
vasoconstriction in the constant flow Langendorff rat heart model. This is in 
contrast to a vasodilator response to acidosis in the isolated, pre-contracted rat 
thoracic aorta and the absence of any change in tone in response to acidosis in the 
isolated rat mesenteric bed. Of all the compounds investigated containing a free 
sulphydryl group, only GSH potentiated, in a concentration-dependent manner, the 
acidosis-induced rise in perfusion pressure, whilst cysteine, reduced dithiothreitol, 
penicillamine and captopril all attenuated this response. The role of 
cyclooxygenase products and catecholamines in the response of the coronary 
vasculature to acidosis in the presence and absence of GSH was investigated. With 
respect to the effect of cysteine under acidotic conditions, the involvement of 
endothelium-dependent relaxant factor (EDRF) and the release of cGMP and 
thromboxane A2 were studied. In addition, the guinea-pig taenia coli preparation 
was used to quantify any calcium-antagonist activity of cysteine.
It is well documented that decreased oxygen delivery and the accumulation of 
metabolic end products are components of an ischaemic insult. However, the 
relative contribution of acidosis to ischaemically-induced myocardial damage is 
unclear. Acidosis has been reported to cause coronary vasodilation (Jerusalem and 
Starling, 1910; Patterson, 1914; Gremels and Starling, 1926), whereas 
Steenburgen et al. (1977) observed a decline in coronary flow following acidosis 
that is indicative of increased vascular resistance in the constant pressure 
Langendorff model. The data presented in the present investigations, using a 
constant flow model, is in agreement with this observation. There are, however, a 
diverse array of reports on the effects of acidosis on other isolated vessels and
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tissues. Rinaldi et al. (1987) and Rooke and Sparks (1981) have used isolated dog 
coronary arteries to investigate the effects of both acidosis and alkalosis on 
contactile tension; acidosis relaxed depolarised tissues whereas alkalosis increased 
coronary tone. Therefore, in a whole organ, such as the heart that contains both 
relatively large and fine resistance vessels, there is a danger of extrapolating results 
obtained with isolated vessels to isolated perfused organs. This is because in the 
coronary vascular bed the reponse to selected conditions or agents is recorded as a 
net change in perfusion pressure a result of the net 'tone' of the vasculature as a 
whole. The tone of selected areas of coronary vasculature cannot be determined 
using this preparation.
In the experiments, described here using a constant flow Langendorff heart 
preparation, acidosis (over the range pH 7.2-6.8) resulted in a rise in perfusion 
pressure that is indicative of coronary vasoconstriction in this model. This is in 
contrast to the vasodilator effect of acidosis in other vessels, such as the rat aorta 
{Loutzenhiser et al., 1990) and the absence of any effect in the rat mesenteric bed 
observed in the present investigations. This difference in response is thought to be 
due to the tissue type and not to differences between experimental protocols and 
buffers described by other groups.
Kwan et al. (1990) recently reported the effects of simulated ischaemia on the tone 
of isolated sheep circumflex coronary artery rings. The conditions chosen to mimic 
ischaemia were hypoxia, a raised potassium and lactate concentration (lOmM and 
ImM respectively), a reduced glucose concentration (4mM) and a reduction of 
extracellular pH (pH 6.85±0.05). These conditions resulted in a transient relaxation 
of the preparations lasting 5 minutes followed by a sustained contraction. The 
authors concluded that the ‘ischaemic contraction* was mediated by substances 
released from the endothelium, including a product of the lipoxygenase pathway 
(figure 54). Furthermore, they provided evidence that simulated ischaemia causes 
the release of noradrenaline and 5-hydroxytryptamine, both of which cause 
coronary constriction. These observations may be significant in view of the ability 
of selected cyclooxygenase and lipoxygenase inhibitors and a thromboxane A2 
receptor antagonist to attenute a pH-dependent coronary constriction in the present 
investigations. Kwan et al. (1990) did not investigate the role of catecholamines in
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the two phases of the response to acidosis, whereas the efficacy of alpha- 
adrenoceptor antagonism in attenuating a pH-dependent constriction in the 
experiments described here suggests that catecholamine release may have a role in 
this response. The initial brief relaxation phase in response to simulated ischaemia 
described by Kwan et al. (1990) was not endothelium dependent; it was 
antagonised by a product of the phospholipase A2 pathway and possibly caused by 
a vasodilator released immediately after the onset of simulated ischaemia. In the 
experiments reported here, acidosis caused a transient rise and fall in perfusion 
pressure followed by a sustained constriction (figure 51). This response and the 
effect of selected pharmacological antagonists on this constriction are in agreement 
with the findings of Kwan et al. (1990). In view of the difficulty in removing the 
endothelium of the coronary vasculature whilst maintaining the viability of the 
heart, no evidence for the endothelium-dependence of the coronary constriction in 
response to acidosis was obtained in this set of experiments.
There is little evidence in the literature for a vasoconstrictor response of the 
coronary vasculature in response to acidosis. The present investigations provide 
evidence for the involvement of cyclooxygenase products in the mediation of the 
response of the coronary vasculature to acidosis, although the exact mechanism is 
by not clear. It seems unlikely that the ability of reduced glutathione to potentiate 
the acidosis-induced coronary vasoconstriction is related to its free sulphydryl 
group in view of the opposing effect of cysteine. In contrast to GSH, ImM cysteine 
completely abolished the pressor response to acidosis whilst both ImM cysteine 
and GSH both caused a similar vasodilation when perfused at pH 7.4. Experiments 
using the sulphur containing compounds methionine and taurine are required to 
determine whether the presence of a free -SH group is essential for these effects or 
whether this is just incidental. This is also in view of the observation that both 
methionine and taurine attenuate stress-induced hypertension in rats (Yamori et al., 
1983) and that taurine can protect against the calcium paradox (iChapman and 
Rodrigo, 1990). In addition to cysteine, the effect of the other component amino 
acids of glutathione on the physiological response of the heart to acidosis were 
investigated and it was shown that glutamate potentiated the acidosis-induced 
coronary vasoconstriction. It would, therefore, be of interest to further investigate
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the effect of other excitatory and non-excitatory amino acids, such as aspartate and 
methionine, under similar conditions.
The data presented here shows that the acidosis-induced coronary constriction was 
significantly attenuated by a non-specific alpha-adrenoceptor antagonist, 
phentolamine, as was the reduced glutathione-induced potentiation of the 
constriction. These results suggest that acidosis may cause catecholamine release 
mediating coronary constriction and that GSH may exert its effect, at least in part, 
via increasing catecholamine release or by potentiating the effects of 
catecholamines. There is also the possibility that GSH affects the uptake 
mechanisms that remove catecholamines thereby potentiating their effect. From the 
preliminary experiments presented in this thesis, GSH was shown to have no effect 
on noradrenaline overflow during myocardial ischaemia and, therefore, it is 
unlikely that it has any effect on catecholamine uptake. A reduction in the activity 
of the uptake mechanisms would not be expected in the absence of an increase in 
noradrenaline overflow during acidosis. Acidosis, in the presence and absence of 
GSH, may increase receptor sensitivity resulting in an increased pressor response 
in the absence of an increase in noradrenaline release. Dart and Riemersma (1989) 
were unable to detect any direct effect of acidosis (pH 6.5) on noradrenaline 
release from the isolated perfused heart. Although they showed catecholamine 
release to be increased during acidosis this was found to be statisically 
insignificant Therefore, local concentrations of catecholamines may be high 
enough to elicit a coronary vasoconstriction in the absence of significant net 
increase in noradrenaline overflow in response to acidosis. Alternatively, the actual 
bioassay system (i.e. coronary vasoconstriction) may be more sensitive than the 
physiochemical assay (HPLC of perfusate noradrenaline levels). Therefore, a 
relatively small and undetectable increase in local noradrenaline concentrations 
may elict coronary constriction. There is also the possibility that the effect of 
phentolamine may be independent of alpha-adrenoceptor blockade and due to other 
unknown non-specific effects. It would be of interest to investigate whether 
cysteine attenuates basal myocardial catecholamine release which may represent a 
method by which it attenuates the acidosis-induced coronary vasoconstriction. 
Catecholamine release from rat myocardium in response to acidosis was not
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assessed in the present investigations which would help resolve the mechanism of 
this response. In addition, the effect of GSH and cysteine on the response of the 
coronary vasculature to bolus injections of noradrenaline should be investigated.
In vitro, neuropeptide Y (NPY) has a vasoconstrictor action in the coronary 
circulation and isolated blood vessels. It is a co-transmitter with noradrenaline and 
potentiates the action of other vasoactive substances, such as noradrenaline, 
phenylephrine, histamine and angiotensin II, at lower doses than are required for a 
direct response. Recently it has been shown that NPY is co-released with 
noradrenaline from the human heart during exercise and hypoxia and, therefore, 
may contribute to an acidosis-induced coronary constriction either directly or by 
potentiating the pressor effect of noradrenaline. (Walker et al., 1991). There is also 
the possibility that acidosis may evoke a general release of neurotransmitters. 
Acetylcholine, for example, causes both vasodilation and vasoconstriction in the 
coronary circulation (Kalsner, 1989) although the muscarinic constrictor action is 
predominant. Whether acetylcholine, neuropeptide Y or other potent coronary 
vasoconstrictors, such as endothelin, contribute significantly towards the acidosis- 
induced constriction remains to be seen.
Selected cyclooxygenase/lipoxygense inhibitors attenuated both the constrictor 
response to acidosis and the potentiation of this response by GSH. Therefore, the 
involvement of thromboxane A2 in this response was investigated using a potent 
and selective thromboxane A2 receptor antagonist, GR 3219IB. The hypothesis 
was that acidosis may increase basal thromboxane A2 synthesis and release which 
has a constrictor action on the coronary vasculature. This, linked with a possible 
reduction in prostacyclin release (which causes coronary vasodilation) may 
contribute to the coronary constriction in response to acidosis. lOpM GR 3219IB 
attenuated the acidosis-induced coronary constriction, indicating that thromboxane 
A2 is released under acidotic conditions and contributes to an increase in coronary 
tone. Acidosis may increase thromboxane A2 synthesis or increase its half-life 
resulting in coronary constriction. In a similar set of experiments, cysteine was 
found to attenuate thromboxane A2 release during myocardial acidosis. This may 
be due to cysteine reducing the activity of thromboxane synthase and/or increasing 
prostacyclin synthesis resulting in a net attenuation of the pH-dependent
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vasoconstriction. Further experimental analysis of the effects of acidosis on 
thromboxane synthesis and perfusate-levels of the stable prostacyclin metabolite, 
6-keto PGFjttf, are required to clarify the role of these vasoactive substances in this 
response. A change in pH may affect the activity of a diverse array of intra- and 
extracellularly located enzymes which makes the situation complex. Under these 
conditions the cell may lose its ability to maintain ionic homeostasis due to a 
change in the activity of key enzyme systems involved in cell regulation. In a 
separate part of these investigations the acidosis-induced inhibition of Na/K 
ATPase was demonstrated. In the absence of any other effects of acidosis on other 
enzyme systems, a reduction in Na/K ATPase activity may lead to an increase in 
intracellular sodium that may exchange for calcium leading to a concomitant 
increase in coronary tone.
L-NG-nitro-arginine is a novel, potent and reversible inhibitor of endothelium- 
dependent vasodilation in vitro (Moore et al., 1990) and it was for this reason that 
it was used to investigate the possible involvement of EDRF in the ability of 
cysteine to attenuate acidosis-induced coronary constriction. lOOpM L-NG- 
nitro-arginine had no effect on the coronary constriction alone or on the attenuation 
of the constriction by 0.1M cysteine. Therefore, the involvement of EDRF in the 
action of cysteine in this model is unlikely. In addition, the guinea-pig taenia coli 
preparation was used to investigate whether cysteine has any L-type calcium 
channel antagonist activity. These experiments show that cysteine (l.OmM) has no 
effect on the contractile response of this preparation to an increasing calcium 
concentration (27-2700 pM). The mode of action by which cysteine attenuates a 
pH-dependent vasoconstriction of the coronary vasculature remains unclear. At the 
present time there is no data available on the effect of cysteine on prostacyclin 
release during acidosis or on the synthesis and release of other endogenous 
vasoconstrictors or vasodilators. The data presented here shows that cysteine 
increases cGMP release during acidosis. Cysteine is involved in the regulation of 
guanyl cyclase (Needleman et al., 1973) and so its inhibitory effect on the 
acidosis-induced vasoconstriction could be a consequence of guanyl cyclase 
activation.
Acidosis, in the presence and absence of GSH, may cause coronary constriction in 
this model by the activation of L-type calcium channels in the vascular smooth
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muscle or by alterations in the Na/Ca exchange process resulting in calcium influx. 
Vogel and Sperelakis (1977) have shown L-type calcium channels to be inhibited 
in the acidotic myocardium. Further experiments need to be performed to 
investigate the effect of verapamil and nifedipine on the physiological response of 
the heart to acidosis and whether these calcium channel antagonists can reverse an 
established acidosis-induced coronary constriction. GSH potentiates the pH 
dependent vasoconstriction and, therefore, it would also be of interest to 
investigate whether GSH potentiates the effect of the calcium channel activator 
BAY K8644 which, as a bolus injection, produces a concentration-dependent 
coronary vasoconstriction ( Mestre e t  a l . ,  19$5 ).
If myocardial acidosis causes coronary constriction in vivo during ischaemia, the 
effect of GSH may be beneficial. Increased coronary constriction would result in a 
relatively slow restoration of oxygen and washout of metabolic substrates that has 
been shown to be protective against reperfusion-induced arrhythmias. These 
observations are of interest as they indicate that the amino acid composition of the 
plasma and the glutathione or thiol status of the heart could have a role in the 






The work described here has shown that reduced glutathione (GSH) and other 
related compounds may be involved in the modulation of several cardiovascular 
regulatory systems under normal and ischaemic conditions. Although at the present 
time the mode(s) of action are unclear, the intracellular ratio of reduced glutathione 
: oxidised glutathione (GSH/GSSG) may be a critical factor, especially under 
ischaemic/reperfusion conditions when oxidising/reducing species may also cause 
deleterious conformational changes in ion translocating systems.
The current research provides the first evidence that GSH attenuates ischaemic 
contracture, possibily via indirect interaction with the Na/K pump. In whole hearts, 
GSH attenuated reperfusion-induced 86Rb efflux indicating a potassium sparing 
action which may be accounted for by a stimulatory action on the Na/K pump. 
However, interactions with other myocardial potassium channels, such as 
ATP-dependent potassium channels (Noma et al., 1990), cannot be ruled out and 
should be a focus of future investigations.
Although the literature contains information on the structure of the Na/K pump and 
locality of free sulphydryls and disulphides within this intrinsic protein, it is 
difficult to determine where GSH and GSSG are acting from the preliminary data 
described here. A potential experimental approach to elucidate these sites is the 
isoelectricfocusing of Na/K pump proteins, previously exposed to varying 
concentrations of GSH/GSSG, and the determination of whether Na/K pump is 
S-thiolated under normal and/or ischaemic conditions. This is a prime objective for 
future work. One complication is the determination of any sidedness of interactions 
of GSH and GSSG with the Na/K pump. Basal intracellular levels of GSH are 
within the 0.5-10mM range and, therefore, the removal of intracellular GSH by 
dialysis and replacement with known GSH and/or GSSG concentrations is a 
method of investigating how changes in cellular redox state affect the structure and 
activity of membrane bound proteins. Using compounds such as glutathione, 
diamide, pHMPSA and diethylmaleate as pharmacological tools may help elucidate 
how this ion pump is regulated in vivo under normal and ischaemic conditions. It is 
unlikely that the Na/K pump is the only ion translocating mechanism whose 
activity can be modulated by cellular redox or glutathione status. It seems 
reasonable to suggest that the Na/Ca and Na/H excange mechanisms, as well as
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other selected receptors and ion channels, may also be affected by similar 
conditions. Therefore, a profile of the effect of GSH, and related compounds, on a 
range of ion translocating mechanisms, channels and receptors under normal and 
ischaemic conditions is a priority.
In preliminary studies to investigate whether GSH affects the Na/H mechanism, 
the physiological response of the heart to acidosis, in the presence and absence of 
GSH, was investigated. In contrast to its vasodilator action at pH 7.4, ImM GSH 
potentiated an acidosis-induced coronary vasoconstriction at pH 6.8 and evidence 
has been provided for the potential involvement of cyclooxygenase metabolites in 
this response. Acidosis has contrasting effects in several isolated vascular beds and 
tissues. Therefore, preparations such as the aorta, mesentery and isolated heart may 
be useful in the elucidation of the mechanism(s) underlying the hearts 
physiological response to acidosis. The mechanism by which cysteine attenuates an 
acidosis-induced coronary constriction and the potentiation of this constriction by 
GSH remains unclear. There is some evidence for a reduction of acidosis-induced 
thromboxane A2 release in the presence of cysteine, although this cyclooxygenase 
metabolite is not entirely responsible for the pressor response. In addition, cysteine 
increased cGMP release under basal and acidotic conditions and, therefore, its 
inhibitory effect on the acidosis induced vasoconstriction could be a consequence 
of guanyl cyclase activation. Clearly, in vivo, the situation is more complex due to 
the presence of circulating platelets that also release several vasoactive compounds 
which may influence vessel tone under control and acidotic conditions. Future 
work should include studies on the effect of extracellular acidosis, in the presence 
and absence of GSH and related compounds, on cyclooxygenase metabolism and 
aggregation in isolated cell types, such a platelets. These observations are of 
considerable interest as they indicate that the amino acid composition of the 
plasma, and the glutathione or thiol status of the heart could play an important role 
in modulating cardiovascular responses under normal and ischaemic/acidotic 
conditions.
Questions that need to be resolved in subsequent investigations are, firstly, how 
does the glutathione status of the heart affect the ability of membrane-bound 
proteins involved in ionic homeostasis to function normally? It is possible to
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manipulate the glutathione content of whole hearts, atria, myocytes, aorta and the 
mesenteric vasculature by the use of selective pharmacological agents. N- 
ethylmalemide, diethylmaleate, r-butyl hydroperoxide, diamide and buthionine 
sulphoximine all deplete GSH, while intracellular GSH can be increased by the use 
of A-acetylcysteine, L-2-oxothiazolidine-4-carboxylate or glutathione isopropyl 
ester. By modulating the GSH/GSSG ratio using a combination of these agents, the 
effect of cellular thiol status on physiological responses to acidosis can be 
investigated in a variety of tissue and cell types.
Secondly, how do GSH, thiols and amino acids modulate the response of the heart 
and other vascular preparations to acidosis? In the isolated heart it is possible that 
other amino acids, as well as cysteine, could affect vascular responses to acidosis 
which may be due to the release of one or more vasoactive substances. Any future 
investigations into the effect of amino acids on coronary tone during acidosis 
should include radioimmuno- and bioassays of thromboxane A2, prostacyclin and 
catecholamine release as a starting point.
Finally, myocytes, vascular smooth muscle cells, platelets and neutrophils, for 
example, arc exposed to acidotic conditions and an altered thiol status during 
ischaemia in vivo and it is, therefore, important to determine how GSH/GSSG, 
thiol-containing compounds and amino acids affect ion movements in these 
individual isolated cells. The preliminary, fluorimetric data obtained has shown that 
GSH reduces while GSSG increases intracellular free calcium, in a concentration- 
dependent manner. These studies had one major experimental draw back in that it 
was not posssible to alter the composition of the suspension medium during the 
course of an experiment. One approach to overcome this problem in the future will 
be to use adherent myocytes in a superfusion set-up linked to a microscope 
attachment on the fluorimeter, allowing the composition of the superfusate to be 
changed. With this apparatus it would be possible to alter the GSH status of cells 
and isolated atria and simultaneosly monitor intracellular calcium, pH and sodium 
under acidotic and simulated-ischaemic conditions. These investigations would 
yield data on the actions of GSH and amino acids on cardiac contractility and ion 
movements under acidotic/ischaemic conditions, independent of vascular changes.
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APPENDIX 1.
IN D IV ID U A L RUBIDIUM  EFFLUX PROGRAMME.
T h i s  c o m p u t e r  p r o g ra m m e  w a s  u s e d  t o  c a l c u l a t e  R b  e f f l u x  r a t e  
c o e f f i c i e n t s  ( e r c ' s )  w i t h  d a t a  o b t a i n e d  f r o m  l i q u i d  s c i n t i l l a t i o n  
c o u n t i n g  o f  p e r f u s a t e  a n d  t i s s u e  s a m p l e s .  T h e  p r o g r a m m e  w a s  m o d i f i e d  
b y  D r  C .  B l a c k w e l l  f r o m  t h a t  o r i g i n a l l y  d e v i s e d  b y  D r  M. C o l d w e l l  
( S m i t h K l i n e  B e e c h a m s  P h a r m a c e u t i c a l s ,  H a r l o w ,  E s s e x )  a n d  w a s  w r i t t e n  
f o r  u s e  o n  t h e  BBC M a s t e r  S e r i e s  m i c r o c o m p u t e r .
10
2 0  REM IN D IV ID U A L  RU BID IU M  EFFLUX PROGRAMME
3 0  REM
4 0  @%=10
5 0  CLEAR
6 0  CLS
7 0  VDU2
8 0  P R IN T  TAB ( 1 2 )  "R U B ID IU M  EFFLUX"
9 0  P R IN T  T A B ( 1 2 ) S T R I N G $ ( 1 5 ," = " )
1 0 0  VDU3
1 1 0  IN PU T "D A T E  (DD-M M -YY) "DATE$
1 2 0  VDU2
1 3 0  P R IN T "D A T E  "D A TE$
1 4 0  VDU3
1 5 0  REM DATA ENTRY
1 6 0  REM AND CALCULATIONS 
1 7 0
1 8 0  IN PU T  "C O N D IT IO N S "  CCN D ITIQ N S$
1 9 0  VDU2
2 0 0  P R IN T "C O N D IT IO N S  "  C C N D ITIC N S$
2 1 0  VDU3
2 2 0  IN P U T  "NUMBER O F EFFLUX TU BES" E 
2 3 0  D IM  A ( E )  3 ( E )  , D ( E )  , L ( E )  ,M (E )  ,P ( E )  3 ( E )
2 4 0  IN P U T "S T A R T  T IM E (M IN S )"  T  
2 5 0  * F X 2 2 9 , 1
2 6 0  P R IN T "E N T E R  EFFLU X  COUNTS"
2 6 5  PR IN T "A N D  CO LLECTIO N  P E R IO D  "
2 7 0  FOR N = 1  TO E  
2 8 0  P R IN T  N ;
2 9 0  IN P U T  A ( N ) ; L ( N )
3 0 0  R ( N ) = R ( N - 1 ) + L ( N )
3 1 0  NEXT
3 2 0  REM INCO RRECT VALUE TRAP 
3 3 0
3 4 0  CLS
3 5 0  IN P U T  "A R E  THE VALUES CORRECT? (Y /N )  "  Y E S$
3 6 0  I F  Y E S $ =  " Y "  THEN 4 9 0  
3 7 0  CLS
3 8 0  IN P U T  "W HICH SAMPLE NUMBER I S  WRONG? "WRONGSAMP 
3 9 0  IN P U T  "WHAT I S  THE CORRECT VALUE? "  RIGHTVAL 
4 0 0  A(W RONGSAMP)=RIGHTVAL 
4 1 0  CLS
4 2 0  FOR N = 1  TO  E  
4 3 0  P R IN T  N ,A ( N )
4 4 0  I F  N = 2 0  R E PE A T : P R IN T  "P R E S S  SPACE BAR TO CONTINUE11: U N TIL  G E T = 3  2 :  CLS 
4 5 0  NEXT N
4 6 0  IN P U T  "NOW ARE THE VALUES CORRECT? (Y /N )  "Y E S 2 $
4
4 7 0  I F  Y E S 2 $ = " Y "  THEN 4 9 0  
4 8 0  GOTO 3 7 0  
4 9 0  CLS
5 0 0  FO R N = 1  TO E
5 1 0  B ( N ) = B ( N - 1 ) + ( A ( N ) * L ( N ) )
5 2 0  NEXT 
5 3 0  PR IN T *
5 4 0  IN P U T  " T IS S U E  COUNTS 11 C 
5 5 0  P R IN T
5 6 0  IN P U T  " T IS S U E  WEIGHT (m g ) "  W
5 7 0  P R IN T
5 8 0
5 9 0  ,* F X 2 2 9 , 0
6 0 0  @ % =& 20309
6 1 0  FOR N = 1  T O E
6 2 0  D ( N ) = ( B ( E ) + C ) - B ( N - 1 )
6 3 0  P ( N ) = A ( N ) / D ( N )
6 4 0  NEXT 
6 5 0
6 6 0  REM P R IN T IN G
6 7 0  REM O F RESULTS
6 8 0
6 9 0  VDU2 
7 0 0  P R IN T
7 1 0  P R IN T "  EFFLUX " ; "  CUMUL. TOTAL e r e  "
7 2 0  P R IN T "  COUNTS TOTALS " ; "  COUNTS " ; M - ( / m i n )  "
7 3 0  P R IN T "  ( c p m )  " ; "  (c p m )  ( c p m )  "
7 4 0  FO R N = 1  TO E
7 5 0  P R IN T  T A B ( 5 ) ;A ( N )  ;T A B (1 7 )  ;B (N )  ;T A B ( 2 8 )  ;D ( N )  ; T A B ( 4 0 ) ;P ( N )
7 6 0  NEXT 
7 7 0  P R IN T  
7 8 0  P R IN T
7 9 0  P R IN T * 'T IS S U E  COUNTS " ; C ; "  c p m " ; "  T IS S U E  WEIGHT " ; W ; "  m g "
8 0 0  P R IN T  
8 1 0  VDU3 
8 2 0  @%=10 
8 3 0  P R IN T
8 4 0  P R IN T -.P R IN T : P R IN T : P R IN T
8 5 0  IN P U T "D O  YOU WANT TH E EFFLUX CURVE PLOTTED (CN  THE S C R E E N )? (Y /N )* * Y E S 3 $  
8 6 0  I F  Y E S 3 $ = " Y "  THEN 9 4 0  
8 7 0  P R IN T :@ % = 10:V D U 3
8 8 0  PR IN T*'D O  YOU HAVE FURTHER D A T A ? (Y /N )"
8 9 0  IN P U T  A $
9 0 0  I F  A $ = " Y "  THEN 1 0  
9 1 0  P R IN T "T H E  END"
9 2 0  END 
9 3 0
9 4 0  REM CURVE PL O T T IN G
9 5 0  M0DE4 
: 9 6 0  V D U 24 , 0 ;  0 ; 1 2 7 9 ; 1 0 2 3 ;
9 6 5  V D U 2 8 ,1 1 , 1 , 3 9 , 0  
| 9 7 0  X = 2 0
! 9 8 0  X L E N G T H = 1100+ 100  
I 9 9 0  MOVE 1 0 0 , 1 0 0 : DRAW X L E N G 1 H ,1 0 0  
1 0 0 0  MOVE 1 0 0 , 1 0 0 -.DRAW 1 0 0 , 9 4 0  
1 0 1 0  FOR Y = 1  TO 4
1 0 2 0  MOVE 1 0 0 ,Y * 2 1 0 + 1 0 0 :D R A W  1 1 6 ,Y * 2 1 0 + 1 0 0
1 0 3 0  NEXT Y
1 0 4 0  FO R N = 1  TO E
1 0 5 0  MOVE 1 0 0 + ( T * X ) + ( R ( N ) * X )  ,1 0 0
1 0 6 0  DRAW 1 0 0 + ( T * X ) + ( R ( N ) * X )  , 8 0
1 0 7 0  MOVE ( T + R ( 1 ) ) * X + 1 0 0 , ( P ( l ) * 7 0 0 0 ) + 1 0 0
|1 0 7 5  NEXT N
1 1080  FOR N = 2  TO E
1 0 9 0  DRAW (T + R (N )  ) * X + 1 0 0 ,  ( P ( N ) * 7 0 0 0 ) + 1 0 0
1 1 0 0  NEXT N
1 1 1 0  VDU5
1 1 2 0  PLO T 4 , 0 , 1 0 0 0 : P R I N T ,le r c ( / m i n ) lf 
1 1 3 0  PL O T  4 , 0 , 9 5 2 : P R IN T " . 1 2 "  
j 1 1 4 0  PLO T 4 , 0 , 7 4 2 : P R I N T " .0 9 "
! 1 1 5 0  PLO T 4 , 0 , 5 3 2 : P R I N T " .0 6 "
1 1 6 0  PLO T 4 , 0 , 3 2 2 :P R I N T " . 0 3 "
11 1 7 0  PLO T 4 , 0 , 1 1 2 : P R I N T " .0 0 "
11 1 8 0  Z = R (E )  D IV  1 0  
1 1 9 0  FO R N = 1  TO Z 
1 2 0 0  MOVE 1 0 0 +  (N * X * 1 0 ) ,  1 0 0
1 2 1 0  DRAW 1 0 0 + ( N * X * 1 0 ) ,  7 0
; 1 2 1 5  ' P R IN T ;
1 2 2 0  P R IN T  ;N * 1 0  
11 2 3 0  NEXT N
1 2 4 0  PLO T 4 , 4 2 5 , 3 2 :  P R I N T " T IM E (m in ) "
1 2 5 0  VDU4
1 2 6 0  P R IN T " F R IN T  GRAPH " ; :  IN P U T  GRAPH$
1 2 7 0  P R IN T  S T R I N G $ ( 1 4 ,"  " )
1 2 8 0  P R I N T " e r c  : PE R  T IM E  P E R IO D "
1 2 9 0
1 3 0 0  I F  G R A FH $= "Y " OR G R A P H $= "y"  PROCSDUMP E L S E  GOTO 1 3 3 0  
1 3 1 0  P R IN T  " P R E S S  SPACE BAR TO CONTINUE"
1 3 2 0  REPEA T U N T IL  GET = 3 2  
1 3 3 0  P R IN T  
1 3 4 0  @%=10 
1 3 5 0  VDU3
1 3 6 0  M 3DE7 :GOTO 8 8 0  
1 3 7 0  D E F PROCSDUMP 
1 3 8 0  *SDUMP 
1 3 9 0  ENDPROC
4
